10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2021

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number: 1-11442

CHART INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

Delaware	34-1712937
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

3055 Torrington Drive, Ball Ground, Georgia 30107

(Address of principal executive offices) (ZIP Code)

(770) 721-8800

(Registrant's telephone number, including area code)

NOT APPLICABLE

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01	GTLS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  x   No  o 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes  ☐     No  x

As of July 19, 2021, there were 36,375,627 outstanding shares of the Company’s common stock, par value $0.01 per share.

CHART INDUSTRIES, INC.

INDEX

Part I. Financial Information
Item 1. Financial Statements	Page
Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Income and Comprehensive Income	5
Condensed Consolidated Statements of Cash Flows	6
Condensed Consolidated Statements of Equity	8
Notes to the Unaudited Condensed Consolidated Financial Statements	9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	33
Item 3. Quantitative and Qualitative Disclosures About Market Risk	48
Item 4. Controls and Procedures	48
Part II. Other Information
Item 1. Legal Proceedings	50
Item 1A. Risk Factors	50
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	50
Item 4. Mine Safety Disclosures	50
Item 6. Exhibits	51
Signatures	52

2

PART I. FINANCIAL INFORMATION

Item 1.Financial Statements

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Dollars in millions, except per share amounts)

	June 30, 2021		December 31, 2020
ASSETS
Current Assets
Cash and cash equivalents	$	197.8	$	125.1
Accounts receivable, less allowances of $7.5 and $8.4, respectively	220.0		200.8
Inventories, net	310.1		248.4
Unbilled contract revenue	68.2		79.4
Prepaid expenses	23.3		20.0
Other current assets	55.9		29.3
Total Current Assets	875.3		703.0
Property, plant, and equipment, net	414.0		414.5
Goodwill	896.1		865.9
Identifiable intangible assets, net	491.0		493.1
Investments	121.4		78.9
Other assets	32.2		15.1
TOTAL ASSETS	$	2,830.0	$	2,570.5
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable	$	170.4	$	140.1
Customer advances and billings in excess of contract revenue	126.1		118.9
Accrued salaries, wages, and benefits	31.1		39.7
Accrued income taxes	17.3		46.5
Current portion of warranty reserve	10.7		11.0
Current convertible notes	255.5		220.9
Operating lease liabilities, current	5.0		5.1
Other current liabilities	59.7		52.6
Total Current Liabilities	675.8		634.8
Long-term debt	450.6		221.6
Long-term deferred tax liabilities	46.3		60.2
Accrued pension liabilities	8.5		9.6
Operating lease liabilities, non-current	22.2		23.6
Other long-term liabilities	42.8		41.4
Total Liabilities	1,246.2		991.2

3

Equity
Common stock, par value $0.01 per share – 150,000,000 shares authorized, 36,375,301 and 36,185,829 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively	0.4		0.4
Additional paid-in capital	753.3		780.8
Treasury stock; 760,782 shares at both June 30, 2021 and December 31, 2020	(19.3)		(19.3)
Retained earnings	851.2		808.4
Accumulated other comprehensive (loss) income	(9.2)		2.4
Total Chart Industries, Inc. Shareholders’ Equity	1,576.4		1,572.7
Noncontrolling interests	7.4		6.6
Total Equity	1,583.8		1,579.3
TOTAL LIABILITIES AND EQUITY	$	2,830.0	$	2,570.5

See accompanying notes to these unaudited condensed consolidated financial statements.

4

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(UNAUDITED)

(Dollars and shares in millions, except per share amounts)

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Sales	$	322.0	$	289.5	$	610.5	$	591.4
Cost of sales	238.8		206.2		443.4		425.8
Gross profit	83.2		83.3		167.1		165.6
Selling, general, and administrative expenses	48.0		43.5		94.2		96.0
Amortization expense	9.6		14.0		18.4		28.0
Operating expenses	57.6		57.5		112.6		124.0
Operating income	25.6		25.8		54.5		41.6
Interest expense, net	2.2		7.6		4.2		14.8
Unrealized loss (gain) on investments in equity securities	12.5		(1.0)		9.2		3.8
Financing costs amortization	1.1		1.1		2.3		2.1
Foreign currency loss and other	1.7		1.2		1.5		1.5
Income from continuing operations before income taxes	8.1		16.9		37.3		19.4
Income tax expense	1.3		2.2		4.4		2.6
Net income from continuing operations	6.8		14.7		32.9		16.8
Income from discontinued operations, net of tax	—		6.3		—		12.7
Net income	6.8		21.0		32.9		29.5
Less: Income attributable to noncontrolling interests of continuing operations, net of taxes	0.3		0.9		0.8		0.9
Net income attributable to Chart Industries, Inc.	$	6.5	$	20.1	$	32.1	$	28.6
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$	6.5	$	13.8	$	32.1	$	15.9
Income from discontinued operations, net of tax	—		6.3		—		12.7
Net income attributable to Chart Industries, Inc.	$	6.5	$	20.1	$	32.1	$	28.6
Basic earnings per common share attributable to Chart Industries, Inc.:
Income from continuing operations	$	0.18	$	0.39	$	0.90	$	0.45
Income from discontinued operations	—		0.18		—		0.36
Net income attributable to Chart Industries, Inc.	$	0.18	$	0.57	$	0.90	$	0.81
Diluted earnings per common share attributable to Chart Industries, Inc.
Income from continuing operations	$	0.16	$	0.39	$	0.79	$	0.45
Income from discontinued operations	—		0.18		—		0.35
Net income attributable to Chart Industries, Inc.	$	0.16	$	0.57	$	0.79	$	0.80
Weighted-average number of common shares outstanding:
Basic	35.61		35.18		35.58		35.48
Diluted	40.81		35.31		40.72		35.66
Comprehensive income, net of taxes	$	14.4	$	28.9	$	21.3	$	27.5
Less: Comprehensive income attributable to noncontrolling interests, net of taxes	0.3		0.9		0.8		0.9
Comprehensive income attributable to Chart Industries, Inc., net of taxes	$	14.1	$	28.0	$	20.5	$	26.6

See accompanying notes to these unaudited condensed consolidated financial statements.

5

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Dollars in millions)

	Six Months Ended June 30,
	2021		2020
OPERATING ACTIVITIES
Net income	$	32.9	$	29.5
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	39.3		47.5
Interest accretion of convertible notes discount	—		3.9
Employee share-based compensation expense	5.8		4.9
Financing costs amortization	2.3		2.1
Unrealized foreign currency transaction gain	(2.9)		(1.1)
Unrealized loss on investments in equity securities	9.2		3.8
Other non-cash operating activities	1.7		3.5
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	(19.4)		18.1
Inventories	(65.1)		(29.2)
Unbilled contract revenues and other assets	(36.5)		13.3
Accounts payable and other liabilities	(4.4)		(21.8)
Customer advances and billings in excess of contract revenue	8.8		5.8
Net Cash (Used In) Provided By Operating Activities	(28.3)		80.3
INVESTING ACTIVITIES
Acquisition of businesses, net of cash acquired	(55.0)		—
Investments	(52.9)		—
Capital expenditures	(26.7)		(21.0)
Proceeds from sale of assets	—		0.8
Government grants	0.3		—
Net Cash Used In Investing Activities	(134.3)		(20.2)
FINANCING ACTIVITIES
Borrowings on revolving credit facilities	424.1		93.5
Repayments on revolving credit facilities	(192.5)		(121.4)
Repayments on term loan	—		(5.6)
Payments for debt issuance costs	—		(1.9)
Proceeds from exercise of stock options	6.6		2.6
Common stock repurchases from share-based compensation plans	(3.2)		(1.7)
Common stock repurchases (1)	—		(19.3)
Net Cash Provided By (Used In) Financing Activities	235.0		(53.8)
Effect of exchange rate changes on cash and cash equivalents	0.3		(2.8)
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents (2)	72.7		3.5
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period (3)	126.1		120.0
CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD (3)	$	198.8	$	123.5

6

(1)Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

(2)Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents represents cash flows of consolidated operations for all periods presented. For cash flows of discontinued operations, refer to Note 2, “Discontinued Operations.”

(3)Includes restricted cash and restricted cash equivalents of $1.0 in other current assets as of both June 30, 2021 and December 31, 2020 and $1.0 in other assets as of both June 30, 2020 and December 31, 2019. For further information regarding restricted cash and restricted cash equivalents balances, refer to Note 9, “Debt and Credit Arrangements.”

See accompanying notes to these unaudited condensed consolidated financial statements.

7

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)

(Dollars in millions)

	Common Stock			Additional Paid-in Capital						Accumulated Other Comprehensive Income (Loss)		Non-controlling Interests
	Shares Outstanding	Amount				Treasury Stock		Retained Earnings						Total Equity
Balance at December 31, 2020	36.19	$	0.4	$	780.8	$	(19.3)	$	808.4	$	2.4	$	6.6	$	1,579.3
Net income	—	—		—		—		25.6		—		0.5		26.1
Cumulative effect of change in accounting principle (1)	—	—		(36.9)		—		10.7		—		—		(26.2)
Other comprehensive loss	—	—		—		—		—		(19.2)		—		(19.2)
Share-based compensation expense	—	—		3.4		—		—		—		—		3.4
Common stock issued from share-based compensation plans	0.18	—		5.6		—		—		—		—		5.6
Common stock repurchases from share-based compensation plans	(0.02)	—		(3.0)		—		—		—		—		(3.0)
Other	—	—		0.1		—		—		—		(0.1)		—
Balance at March 31, 2021	36.35	0.4		750.0		(19.3)		844.7		(16.8)		7.0		1,566.0
Net income	—	—		—		—		6.5		—		0.3		6.8
Other comprehensive income	—	—		—		—		—		7.6		—		7.6
Share-based compensation expense	—	—		2.4		—		—		—		—		2.4
Common stock issued from share-based compensation plans	0.03	—		0.9		—		—		—		—		0.9
Other	—	—		—		—		—		—		0.1		0.1
Balance at June 30, 2021	36.38	$	0.4	$	753.3	$	(19.3)	$	851.2	$	(9.2)	$	7.4	$	1,583.8

	Common Stock			Additional Paid-in Capital						Accumulated Other Comprehensive Loss		Non-controlling Interests
	Shares Outstanding	Amount				Treasury Stock		Retained Earnings						Total Equity
Balance as of December 31, 2019	35.80	$	0.4	$	762.8	$	—	$	500.3	$	(35.9)	$	4.8	$	1,232.4
Net income	—	—		—		—		8.5		—		—		8.5
Other comprehensive loss	—	—		—		—		—		(9.9)		—		(9.9)
Share-based compensation expense	—	—		2.9		—		—		—		—		2.9
Common stock issued from share-based compensation plans	0.16	—		2.0		—		—		—		—		2.0
Common stock repurchases (2)	—	—		—		(19.3)		—		—		—		(19.3)
Common stock repurchases from share-based compensation plans	(0.01)	—		(1.7)		—		—		—		—		(1.7)
Balance at March 31, 2020	35.95	0.4		766.0		(19.3)		508.8		(45.8)		4.8		1,214.9
Net income	—	—		—		—		20.1		—		0.9		21.0
Other comprehensive income	—	—		—		—		—		7.9		—		7.9
Share-based compensation expense	—	—		2.0		—		—		—		—		2.0
Common stock issued from share-based compensation plans	0.04	—		0.6		—		—		—		—		0.6
Balance at June 30, 2020	35.99	$	0.4	$	768.6	$	(19.3)	$	528.9	$	(37.9)	$	5.7	$	1,246.4

_______________

(1)Refer to Note 1, “ Basis of Preparation” for discussion regarding the cumulative effect of change in accounting principle.

(2)Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

See accompanying notes to these unaudited condensed consolidated financial statements.

8

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts)

NOTE 1 — Basis of Preparation

The accompanying unaudited condensed consolidated financial statements of Chart Industries, Inc. and its consolidated subsidiaries (herein referred to as the “Company,” “Chart,” “we,” “us,” or “our”) have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021.

Nature of Operations: We are a leading independent global manufacturer of highly engineered equipment servicing multiple applications in the energy and industrial Gas markets. Our unique product portfolio is used in every phase of the liquid gas supply chain, including upfront engineering, service and repair. Being at the forefront of the clean energy transition, Chart is a leading provider of technology, equipment and services related to liquefied natural gas, hydrogen, biogas and CO2 Capture amongst other applications. We are committed to excellence in environmental, social and corporate governance (ESG) issues both for our company as well as our customers. With over 25 global locations from the United States to Asia, Australia, India, Europe and South America, we maintain accountability and transparency to our team members, suppliers, customers and communities.

Principles of Consolidation: The unaudited condensed consolidated financial statements include the accounts of Chart Industries, Inc. and its subsidiaries. Intercompany accounts and transactions are eliminated in consolidation.

Reclassifications: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (CYRX) (refer to Note 2, “Discontinued Operations” for further information). Furthermore, we reorganized our reporting structure such that the composition of our reportable segments changed effective October 1, 2020 (refer to Note 3, “Reportable Segments” for further information). As such, certain reclassifications have been made to the statements of income and comprehensive income for the three and six months ended June 30, 2020 and certain notes to the unaudited condensed consolidated financial statements in order to conform to the 2021 presentation.

Use of Estimates: The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. These estimates may also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions. While our production has been considered “essential” in all locations we operate in, we have experienced, and may again experience in the future, temporary facility closures while awaiting appropriate government approvals in certain jurisdictions. The Covid-19 outbreak could also disrupt our supply chain and materially adversely impact our ability to secure supplies for our facilities, which could materially adversely affect our operations. There may also be long-term effects on our customers in and the economies of affected countries. As a result of these uncertainties, actual results could differ from those estimates and assumptions. If the economy or markets in which we operate remain weak or deteriorate further, our business, financial condition and results of operations may be materially and adversely impacted.

Share Repurchase Program: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on March 11, 2020, our Board of Directors authorized a share repurchase program for up to $75 million of the Company’s common stock over the next twelve months through various means, including open market transactions, block purchases, privately negotiated transactions or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. During the first quarter of 2020, we repurchased 0.76 shares of our common stock at an average price of $25.40 per share for a total purchase price of $19.3. We suspended the program on March 20, 2020 (the “Suspension Date”) in light of uncertainty resulting from the Covid-19 pandemic and the desire to conserve cash resources. On March 11, 2021, the share repurchase program expired with no further repurchases since the Suspension Date.

Recently Issued Accounting Standards (Not Yet Adopted): In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” and in January 2021, the FASB subsequently issued ASU 2021-01,

9

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

“Reference Rate Reform (Topic 848): Scope.” ASU 2020-04 and the subsequent modifications are identified as Accounting Standards Codification (“ASC”) 848 (“ASC 848”). ASC 848 simplifies the accounting for modifying contracts (including those in hedging relationships) that refer to LIBOR and other interbank offered rates that are expected to be discontinued due to reference rate reform. The amendments in ASC 848 are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments in ASC 848 must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. We expect application of the amendments to impact accounting for our senior secured revolving credit facility due June 2024. We are currently assessing the effect ASC 848 will have on our financial position, results of operations, and disclosures.

Recently Adopted Accounting Standards: In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entities Own Equity (Subtopic 815-40).” This ASU simplifies accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance effective January 1, 2021 under the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods.

As a result of the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our June 30, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our June 30, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. Lastly, we derecognized deferred income taxes associated with the convertible notes debt discount and adjusted deferred incomes taxes relative to unamortized debt issuance costs associated with our convertible notes due November 2024.

Interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized. Interest accretion of convertible notes discount and net income from continuing operations attributable to Chart Industries, Inc. for the three months ended June 30, 2021 would have been $2.1 and $4.9, respectively, without the adoption of ASU 2020-06. As such, net income from continuing operations attributable to Chart Industries, Inc. per common share (both basic and diluted) for the three months ended June 30, 2021 is $0.04 higher due to the effect of adoption of ASU 2020-06.

Interest accretion of convertible notes discount and net income from continuing operations attributable to Chart Industries, Inc. for the six months ended June 30, 2021 would have been $4.1 and $28.9, respectively, without the adoption of ASU 2020-06. As such, net income from continuing operations attributable to Chart Industries, Inc. per common share for the six months ended June 30, 2021 is $0.09 (basic) and $0.08 (diluted) higher due to the effect of adoption of ASU 2020-06.

As further described in Note 9, “Debt and Credit Arrangements,” on December 31, 2020, we amended the Indenture governing our convertible notes due November 2024 to eliminate share settlement thus leaving us with two settlement options: (1) cash settlement or (2) cash for par and any combination of cash and shares for the excess settlement amount above the $258.8 principal amount of our convertible notes due November 2024. ASU 2020-06 requires usage of the if-converted method to compute diluted earnings per share for our convertible notes due November 2024, however, based on the terms of the amended Indenture and the cessation of interest accretion expense recognition from the transition at adoption, the if-converted method was modified such that interest expense is no longer added to the numerator, and the denominator only includes incremental shares that would be issued upon conversion.

10

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Impacts on Financial Statements

The following table summarizes the cumulative effect of the changes to our condensed consolidated balance sheet as of December 31, 2020 from the adoption of ASU 2020-06:

	Balance at December 31, 2020		Adjustments due to ASU 2020-06 adoption		Balance at January 1, 2021
Liabilities
Accrued income taxes	$	46.5	$	(0.2)	$	46.3
Current convertible notes (1)	220.9		34.0		254.9
Long-term deferred tax liabilities	60.2		(7.6)		52.6
Equity
Additional paid-in-capital	$	780.8	$	(36.9)	$	743.9
Retained earnings	808.4		10.7		819.1

_______________

(1)Current convertible notes is presented net of unamortized discount and debt issuance costs of $34.8 and $3.1, respectively at December 31, 2020. Current convertible notes is presented net of unamortized debt issuance costs of $3.9 at January 1, 2021.

In January 2020, the FASB issued ASU 2020-01, “Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).” This ASU clarifies the interactions between the measurement alternative in Topic 321, the equity method of accounting in Topic 323 and the application of guidance for certain forward contracts and purchased options that upon settlement or exercise would be accounted for under the equity method of accounting in Topic 815. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance effective January 1, 2021. The adoption of this guidance did not have a material impact on our financial position, results of operations or disclosures.

11

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

NOTE 2 — Discontinued Operations

As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (NASDAQ: CYRX) (the “Cryobiological Divestiture”). Our cryobiological products business asset group met the criteria to be held for sale. Furthermore, we determined that the assets held for sale qualified for discontinued operations. As such, the financial results of the cryobiological products business are reflected in our unaudited condensed consolidated statements of income and comprehensive income as discontinued operations for all prior periods presented.

Summarized Financial Information of Discontinued Operations

The following table represents income from discontinued operations, net of tax:

	Three Months Ended June 30, 2020		Six Months Ended June 30, 2020
Sales	$	20.9	$	40.1
Cost of sales	11.8		21.9
Selling, general and administrative expenses	1.5		2.9
Operating income (1)	7.6		15.3
Income before income taxes from discontinued operations	8.0		15.7
Income tax expense	1.7		3.0
Income from discontinued operations, net of tax	$	6.3	$	12.7

________________

(1)Includes depreciation expense of $0.3 and $0.6 for the three and six months ended June 30, 2020.

The following table represents a summary of cash flows related to discontinued operations:

	Three Months Ended June 30, 2020		Six Months Ended June 30, 2020
Net cash provided by (used in):
Operating activities	$	7.7	$	14.9
Investing activities	—		(0.1)
Net cash provided by discontinued operations	$	7.7	$	14.8

NOTE 3 — Reportable Segments

As reported in our Annual Report on Form 10-K for the year ended December 31, 2020, the structure of our internal organization is divided into the following four reportable segments, which are also our operating segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products and Repair, Service & Leasing.

Our Cryo Tank Solutions segment, which has principal operations in the United States, Europe and Asia, supplies bulk, microbulk and mobile equipment used in the storage, distribution, vaporization, and application of industrial gases and other applications. Our Heat Transfer Systems segment, which has principal operations in the United States, Europe and India, supplies mission critical engineered equipment and systems used in the separation, liquefaction, and purification of hydrocarbon and industrial gases that span gas-to-liquid applications. Our Specialty Products segment with locations globally supplies products used in our specialty market applications including hydrogen and helium equipment, HLNG vehicle tanks, carbon capture, utilization, and storage (“CO2 Capture”), food and beverage, space exploration, lasers, cannabis and water treatment, amongst others. Our Repair, Service & Leasing segment, which includes repair and service centers globally, provides installation, service, repair, maintenance, and refurbishment of cryogenic products as well as global equipment leasing solutions.

Corporate includes operating expenses for executive management, accounting, tax, treasury, corporate development, human resources, information technology, investor relations, legal, internal audit and risk management. Corporate support functions are not currently allocated to the segments. All prior period amounts presented in the tables below have been reclassified based on our current reportable segments.

12

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

We evaluate performance and allocate resources based on operating income as determined in our condensed consolidated statements of income and comprehensive income.

Segment Financial Information

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	97.8	$	65.2	$	106.8	$	54.6	$	(2.4)	$	—	$	322.0
Depreciation and amortization expense	3.8		9.5		3.4		2.7		—		0.4		19.8
Operating income (loss) (1) (2)	13.4		(0.5)		23.4		5.6		—		(16.3)		25.6

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	105.3	$	97.3	$	48.6	$	40.1	$	(1.8)	$	—	$	289.5
Depreciation and amortization expense	4.6		14.2		1.0		3.0		—		0.5		23.3
Operating income (loss) (1)	15.9		7.2		11.7		7.6		—		(16.6)		25.8

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	201.7	$	134.4	$	184.1	$	96.0	$	(5.7)	$	—	$	610.5
Depreciation and amortization expense	7.7		19.0		6.5		5.3		—		0.8		39.3
Operating income (loss) (1) (2)	29.0		3.4		41.3		13.9		—		(33.1)		54.5

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	203.3	$	210.2	$	101.5	$	80.8	$	(4.4)	$	—	$	591.4
Depreciation and amortization expense	9.0		28.3		2.4		6.3		—		0.9		46.9
Operating income (loss) (1)	27.5		12.7		25.5		12.2		—		(36.3)		41.6

_______________

(1)Restructuring costs for the:

•three months ended June 30, 2021 were $0.3 ($0.3 - Heat Transfer Systems).

•three months ended June 30, 2020 were $5.6 ($1.1 - Cryo Tank Solutions, $2.9 - Heat Transfer Systems, $1.6 - Corporate).

•six months ended June 30, 2021 were $1.0 ($0.3 - Cryo Tank Solutions, $0.7 - Heat Transfer Systems).

•six months ended June 30, 2020 were $10.8 ($2.9 - Cryo Tank Solutions, $5.7 - Heat Transfer Systems, $2.2 - Corporate).

(2)Includes acquisition-related contingent consideration adjustments of $1.2 and $2.0 in our Specialty Products segment for the three and six months ended June 30, 2021, respectively.

13

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Sales by Geography

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	34.4	$	42.2	$	43.3	$	29.5	$	(1.0)	$	148.4
Europe, Middle East, Africa and India	32.7		8.8		53.3		9.1		(0.7)		103.2
Asia-Pacific	29.1		14.0		9.6		15.9		(0.7)		67.9
Rest of the World	1.6		0.2		0.6		0.1		—		2.5
Total	$	97.8	$	65.2	$	106.8	$	54.6	$	(2.4)	$	322.0

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	43.7	$	71.1	$	26.1	$	28.3	$	(0.9)	$	168.3
Europe, Middle East, Africa and India	32.2		10.2		19.9		9.8		(0.5)		71.6
Asia-Pacific	28.4		15.8		2.5		1.9		(0.4)		48.2
Rest of the World	1.0		0.2		0.1		0.1		—		1.4
Total	$	105.3	$	97.3	$	48.6	$	40.1	$	(1.8)	$	289.5

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	75.5	$	88.5	$	69.4	$	58.5	$	(2.7)	$	289.2
Europe, Middle East, Africa and India	70.4		16.6		98.9		19.6		(1.7)		203.8
Asia-Pacific	53.3		28.8		15.2		17.7		(1.3)		113.7
Rest of the World	2.5		0.5		0.6		0.2		—		3.8
Total	$	201.7	$	134.4	$	184.1	$	96.0	$	(5.7)	$	610.5

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	84.3	$	153.3	$	51.0	$	60.4	$	(2.2)	$	346.8
Europe, Middle East, Africa and India	66.5		19.7		45.5		16.5		(1.2)		147.0
Asia-Pacific	48.5		36.7		4.7		3.6		(0.9)		92.6
Rest of the World	4.0		0.5		0.3		0.3		(0.1)		5.0
Total	$	203.3	$	210.2	$	101.5	$	80.8	$	(4.4)	$	591.4

Total Assets

Corporate assets mainly include cash and cash equivalents and long-term deferred income taxes as well as certain corporate-specific property, plant and equipment, net and certain investments. Our allocation methodology for property, plant and equipment, net of the reportable segments differs from our allocation method of depreciation expense of a reportable segment and therefore, depreciation expense does not entirely align with the related depreciable assets of the reportable

14

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

segments. Furthermore, since finite-lived intangible assets are excluded from total assets of reportable segments while amortization expense is allocated to each of our reportable segments, amortization expense by segment inherently does not align with the related amortizable intangible assets of the reportable segments.

	June 30, 2021		December 31, 2020
Cryo Tank Solutions	$	400.4	$	399.2
Heat Transfer Systems	243.0		247.2
Specialty Products	265.6		178.3
Repair, Service & Leasing	175.2		142.6
Total assets of reportable segments	1,084.2		967.3
Goodwill (1)	896.1		865.9
Identifiable intangible assets, net (1)	491.0		493.1
Corporate	358.7		244.2
Total	$	2,830.0	$	2,570.5

_______________

(1)See Note 8, “Goodwill and Intangible Assets,” for further information related to goodwill and identifiable intangible assets, net.

NOTE 4 — Revenue

Disaggregation of Revenue

The following tables represent a disaggregation of revenue by timing of revenue along with the reportable segment for each category:

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	89.8	$	5.2	$	73.4	$	37.8	$	(1.5)	$	204.7
Over time	8.0		60.0		33.4		16.8		(0.9)		117.3
Total	$	97.8	$	65.2	$	106.8	$	54.6	$	(2.4)	$	322.0

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	94.4	$	8.1	$	32.6	$	25.9	$	(0.7)	$	160.3
Over time	10.9		89.2		16.0		14.2		(1.1)		129.2
Total	$	105.3	$	97.3	$	48.6	$	40.1	$	(1.8)	$	289.5

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	188.5	$	10.8	$	135.3	$	64.5	$	(4.4)	$	394.7
Over time	13.2		123.6		48.8		31.5		(1.3)		215.8
Total	$	201.7	$	134.4	$	184.1	$	96.0	$	(5.7)	$	610.5

15

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	184.2	$	15.2	$	71.4	$	53.9	$	(2.2)	$	322.5
Over time	19.1		195.0		30.1		26.9		(2.2)		268.9
Total	$	203.3	$	210.2	$	101.5	$	80.8	$	(4.4)	$	591.4

Refer to Note 3, “Reportable Segments,” for a table of revenue by reportable segment disaggregated by geography.

Contract Balances

The following table represents changes in our contract assets and contract liabilities balances:

	June 30, 2021		December 31, 2020		Year-to-date Change ($)		Year-to-date Change (%)
Contract assets
Accounts receivable, net of allowances	$	220.0	$	200.8	$	19.2	9.6	%
Unbilled contract revenue	68.2		79.4		(11.2)		(14.1)	%
Contract liabilities
Customer advances and billings in excess of contract revenue	$	126.1	$	118.9	$	7.2	6.1	%
Long-term deferred revenue	1.0		1.9		(0.9)		(47.4)	%

Revenue recognized for the three months ended June 30, 2021 and 2020, that was included in the contract liabilities balance at the beginning of each year was $25.1 and $34.8, respectively. Revenue recognized for the six months ended June 30, 2021 and 2020, that was included in the contract liabilities balance at the beginning of each year was $77.6 and $51.9, respectively. The amount of revenue recognized during the three and six months ended June 30, 2021 from performance obligations satisfied or partially satisfied in previous periods as a result of changes in the estimates of variable consideration related to long-term contracts, was not significant.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price of firm signed purchase orders or other written contractual commitments from customers for which work has not been performed, or is partially completed, and excludes unexercised contract options and potential orders. As of June 30, 2021, the estimated revenue expected to be recognized in the future related to remaining performance obligations was $1,083.9. We expect to recognize revenue on approximately 79.6% of the remaining performance obligations over the next 12 months and with the remaining over the next few years thereafter.

NOTE 5 — Investments

Investments in equity securities

We measure certain of our investments in equity securities at fair value on a recurring basis. Furthermore, we categorize these investments in equity securities according to the fair value hierarchy as defined in Note 2, “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2020. Mark-to-market fair value adjustments in these investments in equity securities are classified as unrealized loss (gain) on investments in equity securities in our condensed consolidated statements of income and comprehensive income.

For certain other investments in equity securities that are not measured at fair value on a recurring basis, we measure such investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

For additional information, see Note 6, “Investments” in our Annual report on form 10-K for the year ended December 31, 2020.

The following table summarizes the components of our investments in equity securities:

16

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

	Investment in Equity Securities, Level 1 (1)		Investment in Equity Securities, Level 2 (1)		Subtotal		Investments in Equity Securities, All Others (3)		Investments in Equity Securities, Total
Balance at December 31, 2020	$	53.8	$	4.1	$	57.9	$	15.7	$	73.6
New investments (2)	—		—		—		45.0		45.0
(Decrease) increase in fair value of investments in equity securities	(19.8)		10.6		(9.2)		—		(9.2)
Foreign currency translation (losses) gains	(1.6)		—		(1.6)		0.4		(1.2)
Balance at June 30, 2021	$	32.4	$	14.7	$	47.1	$	61.1	$	108.2

_______________

(1)Our investment in McPhy (Euronext Paris: MCPHY - ISIN; FR001742329) represents a Level 1 investment while our investment in Stabilis Energy, Inc. represents a Level 2 investment. For the three and six months ended June 30, 2021, we recognized an unrealized loss of $17.2 and $19.8, respectively, in our Level 1 investment and an unrealized gain of $4.7 and $10.6, respectively, in our Level 2 investment.

(2)During the second quarter of 2021, we completed an investment in Earthly Labs Inc. (“Earthly Labs”) in the amount of $5.0 for approximately 15% of its equity. Earthly Labs is the leading provider of small-scale carbon capture systems offering an affordable, small footprint technology platform called “CiCi ®” to capture, recycle, reuse, track and sell CO2. Earthly Labs proprietary approach includes hardware, software and services to address half of all existing carbon dioxide emissions from industrial sources while converting molecules to value.

During the first quarter of 2021, we completed an investment in Transform Materials LLC (“Transform Materials”) in the amount of $25.0 for approximately 5% of its equity. Transform Materials is a sustainable chemical technology company that uses microwave plasma to convert natural gas into acetylene and hydrogen. Its highly selective, cost-effective, net-carbon-negative process converts the methane in natural gas into high-value products suitable for direct use or downstream reactions.

Also, during the first quarter of 2021, we completed an investment in Svante Inc. (“Svante”) in the amount of $15.0 for under 10% of its capital stock on a fully diluted basis. Svante offers companies in emissions-intensive industries a commercially viable way to capture large-scale CO2 emissions from existing infrastructure, either for safe storage or to be recycled for further industrial use in a closed loop.

(3)Our investments in HTEC Hydrogen Technology & Energy Corporation, Svante, Transform Materials and Earthly Labs are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.

Equity method accounting investments

Our equity investments accounted for under the equity method of accounting include a 50% ownership interest in a joint venture with Hudson Products de Mexico S.A. de CV which totaled $2.9 and $2.8 at June 30, 2021 and December 31, 2020, respectively. This investment is operated and managed by our joint venture partner and as such, we do not have control over the joint venture and therefore it is not consolidated. Additionally, we have a 25% ownership interest in Liberty LNG, which was valued at $2.3 and $2.1 at June 30, 2021 and December 31, 2020, respectively.

During the second quarter of 2021, on May 19, 2021, we completed an investment in Cryomotive GmbH (“Cryomotive”) in the amount of 6.5 million euros (equivalent to $7.9) for a 24.9% ownership interest. Our equity method investment in Cryomotive was $7.7 at June 30, 2021. Cryomotive is a leading green-tech mobility startup in Germany developing a disruptive clean hydrogen storage and refueling technology platform focused on compressed cold hydrogen and cryogenic high-pressure storage. Cryomotive’s proprietary CcH2 CRYOGAS technology aims to decarbonize long-haul commercial vehicles while keeping the range and fueling times similar to diesel powered vehicles.

Our equity in earnings from these equity method accounting investments were not material for the periods presented.

17

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

NOTE 6 — Leases

As of June 30, 2021 and December 31, 2020, operating right-of-use (“ROU”) assets and lease liabilities were $27.5 and $27.2 ($5.0 of which was current) and $29.0 and $28.7 ($5.1 of which was current), respectively. The weighted-average remaining term for lease contracts was 5.2 years at June 30, 2021, with maturity dates ranging from July 2021 to February 2029. The weighted-average discount rate was 2.3% at June 30, 2021. ROU assets are classified as property, plant and equipment, net in the condensed consolidated balance sheets.

We incurred $3.0 of rental expense under operating leases for both the three months ended June 30, 2021 and 2020, and $6.0 and $5.9 for the six months ended June 30, 2021 and 2020, respectively. Certain operating leases contain rent escalation clauses and lease concessions that require additional rental payments in the later years of the term. Rent expense for these types of leases is recognized on a straight-line basis over the minimum lease term. Adjustments for straight-line rental expense for the respective periods was not material and as such, the majority of expense recognized was reflected in cash provided by operating activities for the respective periods. This expense consisted primarily of payments for base rent on building and equipment leases. Payments related to short-term lease costs and taxes and variable service charges on leased properties were immaterial. In addition, we have the right, but no obligation, to renew certain leases for various renewal terms.

The following table summarizes future minimum lease payments for non-cancelable operating leases as of June 30, 2021:

2021	$	3.8
2022	6.4
2023	5.8
2024	5.3
2025	4.5
Thereafter (1)	3.6
Total future minimum lease payments	$	29.4

_______________

(1)     As of June 30, 2021, future minimum lease payments for non-cancelable operating leases for the period subsequent to 2025 relate to eight leased facilities.

NOTE 7 — Inventories

The following table summarizes the components of inventory:

	June 30, 2021		December 31, 2020
Raw materials and supplies	$	161.2	$	124.7
Work in process	68.1		57.8
Finished goods	80.8		65.9
Total inventories, net	$	310.1	$	248.4

The allowance for excess and obsolete inventory balance at June 30, 2021 and December 31, 2020 was $9.9 and $9.7, respectively. For discussion regarding the change in inventories, net, refer to Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Quarterly Report on Form 10-Q.

18

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

NOTE 8 — Goodwill and Intangible Assets

Goodwill

The following table represents the changes in goodwill by segment:

	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Consolidated
Balance at December 31, 2020	$	93.2	$	435.2	$	172.4	$	165.1	$	865.9
Goodwill acquired during the period (1)	—		—		34.5		—		34.5
Foreign currency translation adjustments and other	(3.4)		(1.9)		0.1		—		(5.2)
Purchase price adjustments (2)	—		—		0.9		—		0.9
Balance at June 30, 2021	$	89.8	$	433.3	$	207.9	$	165.1	$	896.1

_______________

(1)For further information regarding goodwill acquired and the purchase price adjustments during the period refer to Note 11, “Business Combinations.”

(2)During the first six months of 2021, we recorded purchase price adjustments that decreased goodwill by $0.9 in Specialty Products related to the Blue-In-Green, LLC acquisition.

Amounts included in accumulated goodwill impairment loss at both June 30, 2021 and December 31, 2020 were $129.0 ($23.5 - Cryo Tank Solutions, $49.3 - Heat Transfer Systems, $35.8 - Specialty Products, $20.4 - Repair, Service & Leasing).

Intangible Assets

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill) (1):

		June 30, 2021				December 31, 2020
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Customer relationships	13 years	$	311.6	$	(71.2)	$	302.5	$	(59.9)
Unpatented technology	12 years	115.5		(26.9)		110.4		(22.3)
Patents and other	6 years	5.0		(0.2)		8.4		(1.8)
Trademarks and trade names	13 years	3.5		(1.7)		3.6		(1.4)
Land use rights	50 years	11.2		(1.5)		11.1		(1.4)
Total finite-lived intangible assets	14 years	446.8		(101.5)		436.0		(86.8)
Indefinite-lived intangible assets:
Trademarks and trade names		145.7		—		143.9		—
Total intangible assets		$	592.5	$	(101.5)	$	579.9	$	(86.8)

_______________

(1)Amounts include the impact of foreign currency translation. Fully amortized or impaired amounts are written off.

19

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Amortization expense for intangible assets subject to amortization was $9.6 and $14.0 for the three months ended June 30, 2021 and 2020, respectively, and $18.4 and $28.0 for the six months ended June 30, 2021 and 2020, respectively. We estimate amortization expense to be recognized during the next five years as follows:

For the Year Ending December 31,
2021	$	37.2
2022	36.1
2023	35.6
2024	35.2
2025	34.3

Government Grants

We received certain government grants related to land use rights for capacity expansion in China (“China Government Grants”). China Government Grants are generally recorded in other current liabilities and other long-term liabilities in the unaudited condensed consolidated balance sheets and generally recognized into income over the useful life of the associated assets (10 to 50 years).

China Government Grants are presented in our unaudited condensed consolidated balance sheets as follows:

	June 30, 2021		December 31, 2020
Current	$	0.5	$	0.5
Long-term	7.3		7.3
Total China Government Grants	$	7.8	$	7.8

NOTE 9 — Debt and Credit Arrangements

Summary of Outstanding Borrowings

The following table represents the components of our borrowings:

	June 30, 2021		December 31, 2020
Senior secured revolving credit facility and term loan:
Term loan due June 2024 (1)	$	103.1	$	103.1
Senior secured revolving credit facility due June 2024 (2) (3)	351.8		123.5
Unamortized debt issuance costs	(4.3)		(5.0)
Senior secured revolving credit facility and term loan, net of debt issuance costs	450.6		221.6
Convertible notes due November 2024:
Principal amount	258.8		258.8
Unamortized discount (4)	—		(34.8)
Unamortized debt issuance costs	(3.3)		(3.1)
Convertible notes due November 2024, net of unamortized discount and debt issuance costs	255.5		220.9
Total debt, net of unamortized discount and debt issuance costs	706.1		442.5
Less: current maturities	255.5		220.9
Long-term debt	$	450.6	$	221.6

_______________

(1)As of June 30, 2021, there were $103.1 in borrowings outstanding under the term loan due June 2024, which is due at maturity, bearing an interest rate of 2.0% (2.5% as of December 31, 2020).

20

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

(2)The senior secured revolving credit facility due 2024 includes $100.0 sub limit for letters of credit, a $250.0 sub limit for discretionary letters of credit and $50.0 sub limit for swingline loans. As of June 30, 2021, there were $351.8 in borrowings outstanding under the senior secured revolving credit facility due 2024 bearing a weighted-average interest rate of 1.9% (2.1% as of December 31, 2020) and $45.2 in letters of credit and bank guarantees outstanding supported by the senior secured revolving credit facility due 2024. As of June 30, 2021, the senior secured revolving credit facility due 2024 had availability of $153.0.

(3)A portion of borrowings outstanding under our senior secured revolving credit facility due 2024 are denominated in euros (“EUR Revolver Borrowings”). EUR Revolver Borrowings outstanding were 86.5 million euros (equivalent to $102.8) and 74.5 million euros (equivalent to $91.4) at June 30, 2021 and December 31, 2020, respectively. During the three and six months ended June 30, 2021, we recognized an unrealized foreign currency gain of $8.9 and $5.0, respectively, relative to the translation of the EUR Revolver Borrowings outstanding during the reporting period. This unrealized foreign currency gain is classified as foreign currency loss and other in the condensed consolidated statements of income for the three and six months ended June 30, 2021.

(4)We derecognized the debt discount associated with the convertible notes due November 2024 upon adoption of ASU 2020-06 on January 1, 2021.

Senior Secured Revolving Credit Facility and Term Loan

On June 14, 2019, we entered into the Fourth Amended and Restated Credit Agreement, which includes a senior secured revolving credit facility (the “SSRCF”) and a term loan (together, the “2024 Credit Facilities”). The 2024 Credit Facilities mature on June 14, 2024.

•The SSRCF has a borrowing capacity of $550.0.

•The principal amount of the term loan is $450.0.

•The 2024 Credit Facilities bear interest at a base rate margin determined on a leveraged-based scale which ranges from 25 to 150 basis points for alternative base rate loans and 125 to 250 basis points for LIBOR loans.

•Interest and fees are payable on a quarterly basis (or if earlier, at the end of each interest period for LIBOR loans).

Significant financial covenants for the 2024 Credit Facilities include financial maintenance covenants that, as of the last day of any fiscal quarter ending on and after June 30, 2019, (i) require the ratio of the amount of Chart and its subsidiaries’ consolidated total net indebtedness to consolidated EBITDA to be less than specified maximum ratio levels and (ii) require the ratio of the amount of Chart and its subsidiaries’ consolidated EBITDA to consolidated cash interest expense to be greater than a specified minimum ratio level. The 2024 Credit Facilities include a number of other customary covenants including, but not limited to, restrictions on our ability to incur additional indebtedness, create liens or other encumbrances, sell assets, enter into sale and lease-back transactions, make certain payments, investments, loans, advances or guarantees, make acquisitions and engage in mergers or consolidations and pay dividends or distributions. At June 30, 2021, we were in compliance with all covenants.

The 2024 Credit Facilities also contain customary events of default. If such an event of default occurs, the lenders thereunder would be entitled to take various actions, including the acceleration of amounts due and all actions permitted to be taken by a secured creditor. The 2024 Credit Facilities are guaranteed by Chart and substantially all of its U.S. subsidiaries and secured by substantially all of the assets of Chart and our U.S. subsidiaries and 65% of the capital stock of our material non-U.S. subsidiaries (as defined by the Fourth Amended and Restated Credit Agreement) that are owned by U.S. subsidiaries.

On September 28, 2020 and April 20, 2020, we amended our 2024 Credit Facilities. The amendments, among other things, (i) reduce the LIBO Screen Rate (as defined in the Credit Agreement) floor by half, effectively reducing all interest payable by Chart (ii) provide Chart with further flexibility to complete divestitures at its discretion by changing the “catch-all” permitted divestiture basket from a small annual cap to a more substantial life-of the-facility cap, (iii) adjust the pricing grid in order to accommodate potentially higher leverage ratios, (iv) adjust factoring related definitions and other related provisions to provide Chart with greater flexibility to enter into such arrangements in the future, (v) incorporate a “cash hoarding” prevention covenant and (vi) incorporate various amendments to reflect interest rate floor and other changes to the Loan Syndications and Trading Association and Loan Market Association market standards for credit agreements. The terms and conditions under the 2024 Credit Facilities are otherwise substantially the same as those prior to the amendments. We recorded $1.9 in deferred debt issuance costs related to these amendments which are being amortized over the remaining term of the 2024 Credit Facilities.

21

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

We recorded $6.1 in deferred debt issuance costs in conjunction with the 2024 Credit Facilities, which is included in long-term debt in the unaudited condensed consolidated balance sheet at June 30, 2021, associated with the term loan, which is being amortized over its five-year term beginning in July 2019.

We paid $11.9 in deferred debt issuance costs related to the SSRCF. Deferred debt issuance costs are presented in other assets in the unaudited condensed consolidated balance sheets and are being amortized over the term of the SSRCF. At June 30, 2021, unamortized debt issuance costs associated with the SSRCF were $6.7.

The following table summarizes interest expense and financing costs amortization related to the 2024 Credit Facilities:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Interest expense, term loan due June 2024	$	0.5	$	4.0	$	1.1	$	8.2
Interest expense, senior secured revolving credit facility due June 2024	1.3		0.6		2.0		1.2
Interest expense, senior secured revolving credit facility and term loan due June 2024	$	1.8	$	4.6	$	3.1	$	9.4
Financing costs amortization, senior secured revolving credit facility and term loan due June 2024	$	0.8	$	0.9	$	1.8	$	1.7

2024 Convertible Notes

On November 6, 2017, we issued 1.00% Convertible Senior Subordinated Notes due November 2024 (the “2024 Notes”) in the aggregate principal amount of $258.8, pursuant to an Indenture, dated as of such date (the “Indenture”). On December 31, 2020, we entered into the First Supplemental Indenture (the “Supplemental Indenture”) to the Indenture, between Chart and Wells Fargo Bank, National Association, as trustee, governing the 2024 Notes. Pursuant to the Supplemental Indenture, Chart irrevocably elected (i) to eliminate Chart’s option to elect Physical Settlement (as defined in the Indenture) on any conversion of 2024 Notes that occurs on or after the date of the Supplemental Indenture and (ii) that, with respect to any Combination Settlement (as defined in the Indenture) for a conversion of 2024 Notes, the Specified Dollar Amount (as defined in the Indenture) that will be settled in cash per $1,000 principal amount of the Notes shall be no lower than $1,000. The 2024 Notes bear interest at an annual rate of 1.00%, payable on May 15 and November 15 of each year, beginning on May 15, 2018, and will mature on November 15, 2024 unless earlier converted or repurchased.

The 2024 Notes are senior subordinated unsecured obligations of the Company and are not guaranteed by any of our subsidiaries. The 2024 Notes are senior in right of payment to our future subordinated debt, equal in right of payment with the Company’s future senior subordinated debt and are subordinated in right of payment to our existing and future senior indebtedness, including indebtedness under our existing credit agreement.

Prior to December 31, 2020, a conversion of the 2024 Notes could have been settled in cash, shares of our common stock or a combination of cash and shares of our common stock, at our election (subject to, and in accordance with, the settlement provisions of the Indenture). After December 31, 2020, a conversion of the 2024 Notes may be settled in either (1) cash or (2) cash for the principal amount of the 2024 Notes and any combination of cash and shares for the excess settlement amount above the principal amount of the 2024 Notes, at our election (subject to, and in accordance with, the settlement provisions of the Indenture and Supplemental Indenture). The initial conversion rate for the 2024 Notes is 17.0285 shares of common stock (subject to adjustment as provided for in the Indenture) per $1,000 principal amount of the 2024 Notes, which is equal to an initial conversion price of approximately $58.725 per share, representing a conversion premium of approximately 35% above the closing price of our common stock of $43.50 per share on October 31, 2017. In addition, following certain corporate events that occur prior to the maturity date as described in the Indenture, we will pay a make-whole premium by increasing the conversion rate for a holder who elects to convert its 2024 Notes in connection with such a corporate event in certain circumstances. For purposes of calculating earnings per share, if the average market price of our common stock exceeds the applicable conversion price during the periods reported, shares contingently issuable under the 2024 Notes will have a dilutive effect with respect to our common stock. Since our closing common stock price of $146.32 at the end of the period exceeded the conversion price of $58.725, the if-converted value exceeded the principal amount of the 2024 Notes by approximately $386.0 at June 30, 2021. As described below, we entered into convertible note hedge transactions, which are expected to reduce the potential dilution with respect to our common stock upon conversion of the 2024 Notes.

22

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Holders of the 2024 Notes may convert their 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding August 15, 2024 only under the following circumstances: (1) during any fiscal quarter commencing after December 31, 2017 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Notes for each trading day of such measurement period was less than 97% of the product of the last reported sale price of our common stock and the applicable conversion rate for the 2024 Notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after August 15, 2024 until the close of business on the second scheduled trading day immediately preceding November 15, 2024, holders may convert their 2024 Notes at the option of the holder regardless of the foregoing circumstances.

As of July 1, 2021, the 2024 Notes continue to be convertible at the option of the shareholders. This conversion right, which will remain available until September 30, 2021, was triggered since the closing price of our common stock was greater than or equal to $76.3425 (130% of the conversion price of the 2024 Notes) for at least 20 trading days during the last 30 trading days ending on June 30, 2021. Since the holders of the 2024 Notes could potentially convert their 2024 Notes at their option during the three month period subsequent to June 30, 2021, the $258.8 principal amount of the 2024 Notes was classified as a current liability in the consolidated balance sheet at June 30, 2021. As of December 31, 2020, the 2024 Notes were convertible at the option of the holders, and the liability component of the 2024 Notes was classified as a current liability. We will reassess the convertibility of the 2024 Notes and the related balance sheet classification on a quarterly basis. There have been no conversions as of the date of this filing.

Prior to the adoption of ASU 2020-06, we allocated the gross proceeds of the 2024 Notes between the liability and equity components of the 2024 Notes. The initial liability component of $200.1, which was recorded as long-term debt, represented the fair value of similar debt instruments that have no conversion rights. The initial equity component of $58.7, which was recorded as additional paid-in capital, represented the debt discount and was calculated as the difference between the fair value of the liability component and gross proceeds of the 2024 Notes. The liability component was recognized at the present value of its associated cash flows using a 4.8% straight-debt rate and was being accreted to interest expense over the term of the 2024 Notes.

After the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our June 30, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our June 30, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06 and transition, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Refer to Note 1, “Basis of Preparation” for further discussion.

Prior to the adoption of ASU 2020-06, we recorded $5.3 in deferred debt issuance costs associated with the 2024 Notes, which was being amortized over the term of the 2024 Notes using the effective interest method. We also recorded $1.5 in equity issuance costs, which was recorded as a reduction to additional paid-in capital. After the adoption of ASU 2020-06, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. We amortize the adjusted unamortized debt issuance costs balance over the term of the 2024 Notes using the effective interest method. Refer to Note 1, “Basis of Preparation” for further discussion. Furthermore, interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized.

23

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

The following table summarizes interest accretion of the 2024 Notes discount, 1.0% contractual interest coupon and financing costs amortization associated with the 2024 Notes:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
2024 Notes, interest accretion of convertible notes discount	$	—	$	2.0	$	—	$	3.9
2024 Notes, 1.0% contractual interest coupon	0.7		0.7		1.3		1.3
2024 Notes, total interest expense	$	0.7	$	2.7	$	1.3	$	5.2
2024 Notes, financing costs amortization	$	0.3	$	0.2	$	0.5	$	0.4

Convertible Note Hedge and Warrant Transactions Associated with the 2024 Notes

In connection with the pricing of the 2024 Notes, we entered into convertible note hedge transactions (the “Note Hedge Transactions”) with certain parties, including the initial purchasers of the 2024 Notes (the “Option Counterparties”). The Note Hedge Transactions are expected generally to reduce the potential dilution upon any future conversion of the 2024 Notes. Payments for the Note Hedge Transactions totaled approximately $59.5 and were recorded as a reduction to additional paid-in capital in the December 31, 2017 consolidated balance sheet.

We also entered into separate, privately negotiated warrant transactions (the “Warrant Transactions”) with the Option Counterparties to acquire up to 4.41 shares of our common stock. Proceeds received from the issuance of the Warrant Transactions totaled approximately $46.0 and were recorded as an addition to additional paid-in capital in the December 31, 2017 consolidated balance sheet. The strike price of the Warrant Transactions will initially be $71.775 per share (subject to adjustment), which is approximately 65% above the last reported sale price of our common stock on October 31, 2017. The Warrant Transactions could have a dilutive effect to our stockholders to the extent that the market price per share of our common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.

The Note Hedge Transactions and Warrant Transactions effectively increased the conversion price of the 2024 Notes. The net cost of the Note Hedge Transactions and Warrant Transactions was approximately $13.5.

Foreign Facilities

In various markets where we do business, we have local credit facilities to meet local working capital demands, fund letters of credit and bank guarantees, and support other short-term cash requirements. The facilities generally have variable interest rates and are denominated in local currency but may, in some cases, facilitate borrowings in multiple currencies. We are permitted to borrow up to USD equivalent $77.2 under certain of our foreign facilities. As of June 30, 2021 and December 31, 2020 there were none outstanding in USD equivalent in borrowings outstanding under these facilities.

Certain of our foreign facilities allow us to request bank guarantees and letters of credit. None of these facilities allow revolving credit borrowings. We have foreign letters of credit and bank guarantees that totaled USD equivalent $51.4 and $47.7 as of June 30, 2021 and December 31, 2020, respectively.

Letters of Credit

Chart Energy & Chemicals, Inc., a wholly-owned subsidiary of the Company, had $1.0 in deposits in a bank outside of the SSRCF to secure letters of credit. The deposits are treated as restricted cash and restricted cash equivalents in the unaudited condensed consolidated balance sheets $1.0 in other current assets at both June 30, 2021 and December 31, 2020.

Fair Value Disclosures

The fair value of the 2024 Notes was approximately 255% and 210% of their par value as of June 30, 2021 and December 31, 2020, respectively. The 2024 Notes are actively quoted instruments and, accordingly, the fair value of the 2024 Notes was determined using Level 1 inputs.

24

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

NOTE 10 — Product Warranties

We provide product warranties with varying terms and durations for the majority of our products. We estimate our warranty reserve by considering historical and projected warranty claims, historical and projected cost-per-claim, and knowledge of specific product issues that are outside our typical experience. We record warranty expense in cost of sales in the unaudited condensed consolidated statements of income and comprehensive income. Product warranty claims not expected to occur within one year are included as part of other long-term liabilities in the unaudited condensed consolidated balance sheets.

The following table represents changes in our consolidated warranty reserve:

Balance at December 31, 2020	$	11.9
Issued – warranty expense	(2.7)
Warranty usage	2.4
Balance at June 30, 2021	$	11.6

NOTE 11 — Business Combinations

Cryo Technologies Acquisition

On February 16, 2021, we acquired 100% of the equity interests of Cryogenic Gas Technologies, Inc. (“Cryo Technologies”) for approximately $55.0 in cash (subject to certain customary adjustments), net of $0.6 cash acquired. Cryo Technologies is a global leader in custom engineered process systems to separate, purify, refrigerate, liquefy and distribute high value industrial gases such as hydrogen, helium, argon and hydrocarbons with design capabilities for cold boxes for hydrogen and helium use. The distribution systems Cryo Technologies supplies are located within the helium and hydrogen liquefaction facilities and are inclusive of trailer loading systems, which facilitates the first step in product distribution. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $20.5 and $34.5, respectively. The purchase price allocation reported at March 31, 2021 was preliminary and was based on provisional fair values. During the second quarter of 2021 we received and analyzed new information about certain intangible assets and subsequently increased their fair value by $17.6. Net assets includes $19.5 in intangible assets, which consists of customer relationships, unpatented technology, trademarks and trade names, backlog and non-competition agreements. The acquisition consideration allocation is preliminary and shall be further revised as we finalize third-party valuations and other analyses to include identifiable intangible assets during the remainder of the measurement period, which shall not exceed twelve months from the closing of the acquisition.

Sustainable Energy Solutions, Inc. Acquisition

On December 23, 2020, we completed the acquisition of Sustainable Energy Solutions, Inc. (“SES”). SES’s Cryogenic Carbon Capture™ (CCC) technology eliminates most emissions from fossil fuels while enabling better use of intermittent renewables through grid-scale energy storage. The stock purchase was completed for a closing purchase price of $20.0 in cash at closing, subject to a post-closing working capital adjustment, plus a potential earn-out not to exceed $25.0. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $13.4 and $24.0, respectively. Net assets includes $17.3 in intangible assets, which consists of unpatented technology, trade names and non-compete contracts.

BlueInGreen, LLC Acquisition

On November 3, 2020, we completed the acquisition of BlueInGreen, LLC (“BIG”), a leading dissolved-gas expert providing custom-engineered solutions for water treatment and industrial process applications that delivers tangible economic, social and environmental value. The stock purchase was completed for a purchase price of $20.0 in cash at closing (subject to customary adjustments), plus a potential earn-out not to exceed $6.0. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $7.9 and $15.7, respectively. The purchase price allocation reported at December 31, 2020 was preliminary and was based on provisional fair values. During the first six months of 2021, we received and analyzed new information about certain intangible assets and subsequently decreased their estimated fair value by $0.9. Net assets includes $6.2 in intangible assets, which consists of non-compete contracts, unpatented technology, trademarks and trade names, certifications and licenses and customer relationships.

25

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Alabama Trailers Acquisition

On October 13, 2020, we completed the acquisition of the Theodore, Alabama cryogenic trailer and hydrogen trailer (transport) assets of Worthington Industries, Inc. (NYSE: WOR) for $10.0 in cash (“Alabama Trailers”). Worthington Industries, Inc. exited the hydrogen trailer business and sold the business to Chart at a discount. As a result of the acquisition, we recorded a bargain purchase gain of $5.0. Alabama Trailers designs, manufactures and sells cryogenic trailers and hydrogen trailers used in industrial gas and energy applications.

The purchase price allocations of Cryo Technologies, SES, BIG and Alabama Trailers are preliminary and are based on provisional fair values and subject to revision as we finalize third-party valuations and other analyses. Final determination of the fair values may result in further adjustments to the value of net assets acquired.

Contingent Consideration

The fair value of contingent consideration was $16.9 for SES and $3.2 for BIG at the date of acquisitions and was valued according to a discounted cash flow approach, which included assumptions regarding the probability of achieving certain targets and a discount rate applied to the potential payments. Potential payments are measured between the period commencing July 1, 2021 and ending on December 31, 2028 based on the attainment of certain earnings targets. The potential payments related to both SES and BIG contingent consideration on a combined basis is between $0.0 and $31.0. For the three and six months ended June 30, 2021, the estimated fair value of contingent consideration related to SES increased by $1.3 and $2.0, respectively. For the three months ended June 30, 2021, the estimated fair value of contingent consideration related to BIG decreased by $0.1. For the six months ended June 30, 2021 the estimated fair value of contingent consideration related to BIG was unchanged.

Valuations are performed using Level 3 inputs as defined in Note 2, “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2020 and are evaluated on a quarterly basis based on forecasted sales and earnings targets. Contingent consideration liabilities are classified as other current liabilities and other long-term liabilities in the condensed consolidated balance sheets. Changes in fair value of contingent consideration, including accretion, are recorded as selling, general and administrative expenses in the condensed consolidated statements of income and comprehensive income.

The following table represents the changes to our contingent consideration liabilities:

	SES		BIG		Total
Balance at December 31, 2020	$	16.9	$	3.2	$	20.1
Increase in fair value of contingent consideration liabilities	2.0		—		2.0
Balance at June 30, 2021	$	18.9	$	3.2	$	22.1

NOTE 12 — Accumulated Other Comprehensive (Loss) Income

The components of accumulated other comprehensive (loss) income are as follows:

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at March 31, 2021	$	(5.8)	$	(11.0)	$	(16.8)
Other comprehensive income	7.3		—		7.3
Amounts reclassified from accumulated other comprehensive loss, net of income taxes	—		0.3		0.3
Net current-period other comprehensive income, net of taxes	7.3		0.3		7.6
Balance at June 30, 2021	$	1.5	$	(10.7)	$	(9.2)

26

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at March 31, 2020	$	(35.2)	$	(10.6)	$	(45.8)
Other comprehensive income	7.5		—		7.5
Amounts reclassified from accumulated other comprehensive loss, net of income taxes	—		0.4		0.4
Net current-period other comprehensive income, net of taxes	7.5		0.4		7.9
Balance at June 30, 2020	$	(27.7)	$	(10.2)	$	(37.9)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive income (loss)
Balance at December 31, 2020	$	13.8	$	(11.4)	$	2.4
Other comprehensive loss	(12.3)		—		(12.3)
Amounts reclassified from accumulated other comprehensive income (loss), net of taxes	—		0.7		0.7
Net current-period other comprehensive (loss) income, net of taxes	(12.3)		0.7		(11.6)
Balance at June 30, 2021	$	1.5	$	(10.7)	$	(9.2)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at December 31, 2019	$	(25.0)	$	(10.9)	$	(35.9)
Other comprehensive loss	(2.7)		—		(2.7)
Amounts reclassified from accumulated other comprehensive loss, net of taxes	—		0.7		0.7
Net current-period other comprehensive (loss) income, net of taxes	(2.7)		0.7		(2.0)
Balance at June 30, 2020	$	(27.7)	$	(10.2)	$	(37.9)

27

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

NOTE 13 — Earnings Per Share

The following table represents calculations of net earnings per share of common stock:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$	6.5	$	13.8	$	32.1	$	15.9
Income from discontinued operations, net of tax	—		6.3		—		12.7
Net income attributable to Chart Industries, Inc.	$	6.5	$	20.1	$	32.1	$	28.6
Earnings per common share – basic:
Income from continuing operations	$	0.18	$	0.39	$	0.90	$	0.45
Income from discontinued operations	—		0.18		—		0.36
Net income attributable to Chart Industries, Inc.	$	0.18	$	0.57	$	0.90	$	0.81
Earnings per common share – diluted:
Income from continuing operations	$	0.16	$	0.39	$	0.79	$	0.45
Income from discontinued operations	—		0.18		—		0.35
Net income attributable to Chart Industries, Inc.	$	0.16	$	0.57	$	0.79	$	0.80
Weighted average number of common shares outstanding – basic	35.61		35.18		35.58		35.48
Incremental shares issuable upon assumed conversion and exercise of share-based awards	0.31		0.13		0.32		0.18
Incremental shares issuable due to dilutive effect of convertible notes	2.64		—		2.61		—
Incremental shares issuable due to dilutive effect of warrants	2.25		—		2.21		—
Weighted average number of common shares outstanding – diluted	40.81		35.31		40.72		35.66

Diluted earnings per share does not reflect the following potential common shares as the effect would be anti-dilutive:

	Three Months Ended June 30,		Six Months Ended June 30,
	2021	2020	2021	2020
Share-based awards	0.06	0.65	0.06	0.51
Convertible note hedge and capped call transactions (1)	2.64	—	2.61	—
Warrants	—	4.41	—	4.41
Total anti-dilutive securities	2.70	5.06	2.67	4.92

 _______________

(1)The convertible note hedge offsets any dilution upon actual conversion of the 2024 Notes up to a common stock price of $71.775 per share. For further information, refer to Note 9, “Debt and Credit Arrangements.”

NOTE 14 — Income Taxes

Income tax expense of $1.3 and $2.2 for the three months ended June 30, 2021 and 2020, respectively, represents taxes on both U.S. and foreign earnings at a combined effective income tax rate of 16.0% and 13.0%, respectively. Income tax expense of $4.4 and $2.6 for the six months ended June 30, 2021 and 2020, respectively, represents taxes on both U.S. and foreign earnings at a combined effective income tax rate of 11.8% and 13.4%, respectively.

28

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

The effective income tax rate of 16.0% and 11.8% for the three and six months ended June 30, 2021 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by some of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by our certain foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

The effective income tax rate of 13.0% and 13.4% for the three and six months ended June 30, 2020 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by certain of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by certain of our foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

As of both June 30, 2021 and December 31, 2020, we had a liability for gross unrecognized tax benefits of $1.9. This amount includes $1.3 of unrecognized tax benefits as of both June 30, 2021 and December 31, 2020, which, if ultimately recognized, would reduce our annual effective income tax rate. We recognized interest and penalties of $0.3 related to uncertain tax positions in income tax expense as of June 30, 2021.

NOTE 15 — Share-based Compensation

During the six months ended June 30, 2021, we granted 0.06 stock options, 0.05 restricted stock units and 0.03 performance units. The total fair value of awards granted to employees during the six months ended June 30, 2021 was $12.5. In addition, our non-employee directors received stock awards with a total fair value of $0.2. During the six months ended June 30, 2021, participants in our stock option plans exercised options to purchase 0.12 shares of our common stock.

Stock options generally have a four-year graded vesting period. Restricted stock and restricted stock units generally vest ratably over a three-year period. Performance units generally vest at the end of a three-year performance period based on the attainment of certain pre-determined performance condition targets. During the six months ended June 30, 2021, 0.08 restricted stock and restricted stock units vested and 0.01 performance units vested.

Share-based compensation expense was $2.4 and $2.0 for the three months ended June 30, 2021 and 2020, respectively and $5.8 and $4.9 for the six months ended June 30, 2021 and 2020, respectively. Share-based compensation expense is included in selling, general, and administrative expenses in the unaudited condensed consolidated statements of income and comprehensive income. As of June 30, 2021, total share-based compensation of $15.2 is expected to be recognized over the weighted-average period of approximately 2.2 years.

NOTE 16 — Commitments and Contingencies

Environmental

We are subject to federal, state, local, and foreign environmental laws and regulations concerning, among other matters, waste water effluents, air emissions, and handling and disposal of hazardous materials, such as cleaning fluids. We are involved with environmental compliance, investigation, monitoring, and remediation activities at certain of our owned and formerly owned manufacturing facilities and at one owned facility that is leased to a third party, and, except for these continuing remediation efforts, believe we are currently in substantial compliance with all known environmental regulations. At June 30, 2021 and December 31, 2020, we had undiscounted accrued environmental reserves of $0.2 and $0.3, respectively.

Legal Proceedings

Stainless Steel Cryobiological Tank Legal Proceedings

During the second quarter of 2018, Chart was named in a number of lawsuits (including lawsuits filed in the U.S. District Court for the Northern District of California) filed against Chart and other defendants with respect to the alleged failure of a stainless steel cryobiological storage tank (model MVE 808AF-GB) at the Pacific Fertility Center in San Francisco, California. In May and June of 2021, the first five of the federal lawsuits went to trial, and on June 10, 2021, the jury reached a verdict against Chart in favor of the plaintiffs in those lawsuits in the amount of $14.9, of which 90% ($13.5) is attributable to Chart.

Chart strongly disagrees with the June 10, 2021 verdict. In response to the June 10, 2021 verdict, we intend to file post-trial motions, once the judgment is entered. Additionally, we have the option to file an appeal. While we continue to vigorously contest the result in this case, we have recorded a loss contingency accrual and corresponding charge to net income for $13.5 in the amount of the jury verdict attributable to Chart. The loss contingency accrual is included in other current liabilities in our unaudited condensed consolidated balance sheet at June 30, 2021. Chart expects that any potential loss

29

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

associated with the verdict will be covered by existing product liability insurance, subject to previously issued reservations of rights by the insurance carriers. Accordingly, we have recorded an offsetting $13.5 loss recovery receivable with a corresponding credit to net income. The loss recovery receivable is included in other current assets in our unaudited condensed consolidated balance sheet at June 30, 2021.

There remain approximately 139 additional individual cases with respect to the Pacific Fertility Center incident on the docket in the U.S. District Court for the Northern District of California, the next five of which are currently scheduled for trial in January 2022. In addition to the cases filed in the U.S. District Court for the Northern District of California, Chart is currently a defendant in 50 individual cases in the San Francisco Superior Court.

We have asserted various defenses against the claims in the lawsuits, which remain in various stages of development, including a defense that since manufacture, we were not in any way involved with the installation, ongoing maintenance or monitoring of the tank or related fertility center cryogenic systems at any time since the initial delivery of the tank. We continue to evaluate the merits of such claims for each specific case in light of the information available to date regarding use, maintenance and operation of the tank that was sold to the Pacific Fertility Center through an independent distributor, and which had been out of our control for six years prior to the alleged failure. Based on our current evaluation of the remaining cases, an accrual related to any damages that may result from the remaining lawsuits has not been recorded as of June 30, 2021 because a potential loss is not currently probable. Although a loss associated with the claims in the lawsuits is reasonably possible, an estimate of such potential loss cannot be made. In connection with the Cryobiological Divestiture, Chart retained certain potential liabilities and claims, including the claims asserted in connection with this litigation.

We are occasionally subject to various legal claims related to performance under contracts, product liability, taxes, employment matters, environmental matters, intellectual property, and other matters incidental to the normal course of our business. Based on our historical experience in litigating these claims, as well as our current assessment of the underlying merits of the claims and applicable insurance, if any, management believes that the final resolution of these matters, including the Pacific Fertility Center cases described above, will not have a material adverse effect on our financial position, liquidity, cash flows, or results of operations. Future developments may, however, result in resolution of these legal claims in a way that could have a material adverse effect.

NOTE 17 — Restructuring Activities

Restructuring costs of $0.3 and $1.0 for the three and six months ended June 30, 2021, respectively, were primarily related to employee severance costs. As previously reported, on July 17, 2020, we announced internally our intention to transfer operations of our heat exchanger leased facility in Tulsa, Oklahoma to our Beasley, Texas location at which we own 260 acres of land. This transfer is a cost reduction measure within our Heat Transfer Systems segment to continue to structure the business for profitable growth and capacity efficiency. During the first six months of 2021, the leased facility in Tulsa, Oklahoma was repurposed as a flexible manufacturing, engineering and research and development site serving multiple applications across our operating segments. Total costs related to this transfer and Tulsa facility repurposing, are expected to be approximately $9.0, of which $2.7 was spent in 2020. With respect to 2021, we incurred $0.3 and $0.7 of restructuring costs for the three and six months ended June 30, 2021, respectively, primarily related to employee severance costs, which is reflected in the tables below under the Heat Transfer Systems segment. We incurred an additional $4.8 and $5.2 in costs (not reflected in the tables below) for the three and six months ended June 30, 2021, respectively, which are associated with moving and facility start-up costs attributable to the relocation of our air cooled heat exchangers product lines from our Tulsa, Oklahoma facility to our Beasley, Texas facility. This project is complete as of June 30, 2021 although we may incur further costs in the remainder of 2021. We are closely monitoring our end markets and order rates and will continue to take appropriate and timely actions as necessary.

Restructuring costs of $5.6 and $10.8 for the three and six months ended June 30, 2020, respectively, were related to certain cost reduction actions taken primarily in our Cryo Tank Solutions and Heat Transfer Systems segments. These costs were primarily related to employee severance costs.

30

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

The following table summarizes severance and other restructuring costs, which includes employee-related costs, facility rent and exit costs, relocation, recruiting, travel and other:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Severance:
Cost of sales	$	—	$	1.6	$	—	$	3.9
Selling, general, and administrative expenses	—		1.9		0.3		4.8
Total severance costs	—		3.5		0.3		8.7
Other restructuring:
Cost of sales	0.3		—		0.7		—
Selling, general, and administrative expenses	—		2.1		—		2.1
Total other restructuring costs	0.3		2.1		0.7		2.1
Total restructuring costs	$	0.3	$	5.6	$	1.0	$	10.8

The following tables summarize our restructuring activities for the three and six months ended June 30, 2021 and 2020:

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at March 31, 2021	$	0.5	$	—	$	—	$	—	$	—	$	0.5
Restructuring charges	—		0.3		—		—		—		0.3
Cash payments and other	(0.2)		(0.4)		—		—		—		(0.6)
Balance at June 30, 2021	$	0.3	$	(0.1)	$	—	$	—	$	—	$	0.2

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at March 31, 2020	$	1.5	$	0.5	$	—	$	—	$	0.8	$	2.8
Restructuring charges	1.1		2.9		—		—		1.6		5.6
Cash payments and other	(1.2)		(3.2)		—		—		(2.1)		(6.5)
Balance at June 30, 2020	$	1.4	$	0.2	$	—	$	—	$	0.3	$	1.9

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 31, 2020	$	0.5	$	0.2	$	—	$	—	$	0.1	$	0.8
Restructuring charges	0.3		0.7		—		—		—		1.0
Cash payments and other	(0.5)		(1.0)		—		—		(0.1)		(1.6)
Balance at June 30, 2021	$	0.3	$	(0.1)	$	—	$	—	$	—	$	0.2

31

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – June 30, 2021

(Dollars and shares in millions, except per share amounts) – Continued

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 31, 2019	$	0.5	$	0.2	$	—	$	—	$	0.2	$	0.9
Restructuring charges	2.9		5.7		—		—		2.2		10.8
Cash payments and other	(2.0)		(5.7)		—		—		(2.1)		(9.8)
Balance at June 30, 2020	$	1.4	$	0.2	$	—	$	—	$	0.3	$	1.9

NOTE 18 — Subsequent Event

Subsequent to the end of the second quarter of 2021, on July 1, 2021, we acquired 100% of the equity interests of L.A. Turbine (“LAT”) for approximately $80 million in cash (subject to certain customary adjustments). LAT is a global leader in turboexpander design, engineering, manufacturing, assembly and testing process for new and aftermarket equipment, with significant in-house engineering expertise. Due to the timing of the LAT acquisition, the initial accounting for the business combination is incomplete. As such, we are unable to disclose certain information with respect to the LAT acquisition including the preliminary estimated fair value of the assets acquired and liabilities assumed. We anticipate that we will complete the initial accounting for the business combination during the third quarter of 2021.

32

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our results of operations and financial condition should be read in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements. Actual results may differ materially from those discussed below. See “Forward-Looking Statements” at the end of this discussion and Item 1A. “Risk Factors” for a discussion of the uncertainties, risks and assumptions associated with this discussion.

Overview

We are a leading independent global manufacturer of highly engineered equipment servicing multiple applications in the energy and industrial Gas markets. Our unique product portfolio is used in every phase of the liquid gas supply chain, including upfront engineering, service and repair. Being at the forefront of the clean energy transition, Chart is a leading provider of technology, equipment and services related to liquefied natural gas, hydrogen, biogas and CO2 Capture amongst other applications. We are committed to excellence in environmental, social and corporate governance (ESG) issues both for our company as well as our customers. With over 25 global locations from the United States to Asia, Australia, India, Europe and South America, we maintain accountability and transparency to our team members, suppliers, customers and communities.

Covid-19 Update

The outbreak and continued uncertainty associated with the coronavirus (Covid-19) did not have a material adverse effect on our reported results for the first six months of 2021, however, we continue to actively monitor the impact of the Covid-19 outbreak on our results of operations for the remainder of 2021 and beyond. The extent to which our operations will be impacted by the outbreak will largely depend on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity, or reemergence, of the outbreak and actions by government authorities to contain the outbreak or treat its impact, among other things.

Second Quarter 2021 Highlights

Orders of $447.9 million during the second quarter of 2021 were the highest in our history and beat the previous orders record of $417.2 million set last quarter. The increase in orders was driven by broad based demand including the continuing recovery in certain end markets, continued demand for our clean products supporting the strongest current macroeconomic trend of sustainability, and the combination of larger liquefaction orders for LNG, hydrogen and helium. Total orders increased in our Cryo Tank Solutions and Specialty Products segments during the second quarter 2021 as compared to the second quarter 2020 and were also record order quarters for these two segments. The continued record level order activity contributed to record ending total backlog as of June 30, 2021 of $1,083.9 million compared to $686.7 million as of June 30, 2020 and $934.1 million as of March 31, 2021 (then a record), representing increases of $397.2 million or 57.8% and $149.8 million or 16.0%, respectively. These increases were largely driven by record orders in our Specialty Products segment mainly driven by orders in hydrogen and helium equipment, HLNG vehicle tanks, lasers and LNG regasification applications. Cryo Tank Solutions segment backlog was $327.1 million as of June 30, 2021, a record, as compared to $209.8 million and $245.8 million as of June 30, 2020 and March 31, 2021, respectively. Specialty Products segment backlog was $374.0 million as of June 30, 2021, also a record, as compared to $145.8 million and $270.5 million as of June 30, 2020 and March 31, 2021, respectively.

Consolidated sales increased to $322.0 million in the second quarter 2021 from $289.5 million in the second quarter 2020 and $288.5 million in the first quarter of 2021, which was mainly driven by our Specialty Products and Repair, Service & Leasing segments, each of which had double digit growth on a prior year same quarter comparative basis and sequential quarter comparative basis. This increase was partially offset by lower sales in our Heat Transfer Systems segment mainly due to industry-wide softness in demand for midstream and upstream compression equipment. However, we are beginning to see a recovery in market conditions as indicated by an increase in customer order activity and inquiry. Second quarter 2021 Specialty Products segment sales of $106.8 million and gross profit of $36.7 million were records for the segment and improved by $29.5 million (38.2%) and $8.5 million (30.1%), respectively, as compared to the first quarter of 2021. On a consolidated basis, gross profit decreased during the second quarter of 2021 compared to the second quarter of 2020 by $0.1 million or 0.1%, and first quarter 2021 gross margin as a percent of sales of 25.8% decreased from 28.8% in the second quarter of 2020. The decrease in margin as a percent of sales in the current quarter over second quarter of 2020 was primarily driven by higher material prices due to market conditions for all segments overall and Calcasieu Pass volume mix which drove higher margins in the second quarter of 2020 in our Heat Transfer Systems segment.

33

Consolidated selling, general and administrative (“SG&A”) expenses as a percentage of consolidated sales in the second quarter of 2021 decreased by 110 basis points as compared to the prior quarter and 10 basis points as compared to the second quarter of 2020 mainly due to the effect of cost reduction actions we took in 2020.

Outlook

Our 2021 full year outlook reflects execution on the clean energy transition including growth in small scale LNG opportunities and our Specialty Products business, especially in water treatment, over the road trucking, hydrogen and helium applications driven by strength in year-to-date 2021 orders, including specific liquefaction projects and commercial opportunities increasing from our inorganic investments, acquisitions completed in the past nine months and the beginning of recovery in our air cooled heat exchangers business relative to traditional midstream and upstream energy applications.

Our 2021 sales outlook is inclusive of $25 million and $10 million of 2021 revenue from the acquisitions of Cryo Technologies and L.A. Turbine, respectively. There is no additional Big LNG revenue included in our outlook although we strongly believe that there is the opportunity for up to four Big LNG projects with our equipment and/or IPSMR® to move to Final Investment Decision (“FID”) in the first half of 2022. We continue to invest in our automation, process improvement, and productivity activities across Chart, with total anticipated 2021 capital expenditures spend of $40.0 million to $50.0 million.

Consolidated Results for the Three Months Ended June 30, 2021 and 2020, and March 31, 2021

The following table includes key metrics used to evaluate our business and measure our performance and represents selected financial data for our operating segments for the three months ended June 30, 2021 and 2020 and March 31, 2021 (dollars in millions). Financial data for the three months ended March 31, 2021 has been included to provide additional information regarding our business trends on a sequential quarter basis.

34

Selected Financial Information

	Three Months Ended									Current Quarter vs. Prior Year Same Quarter				Current Quarter vs. Prior Sequential Quarter
	June 30, 2021			June 30, 2020			March 31, 2021			Variance  ($)		Variance (%)		Variance  ($)		Variance (%)
Sales
Cryo Tank Solutions	$	97.8		$	105.3		$	103.9		$	(7.5)	(7.1)	%	$	(6.1)	(5.9)	%
Heat Transfer Systems	65.2			97.3			69.2			(32.1)		(33.0)	%	(4.0)		(5.8)	%
Specialty Products	106.8			48.6			77.3			58.2		119.8	%	29.5		38.2	%
Repair, Service & Leasing	54.6			40.1			41.4			14.5		36.2	%	13.2		31.9	%
Intersegment eliminations	(2.4)			(1.8)			(3.3)			(0.6)		33.3	%	0.9		(27.3)	%
Consolidated	$	322.0		$	289.5		$	288.5		$	32.5	11.2	%	$	33.5	11.6	%
Gross Profit
Cryo Tank Solutions	$	23.2		$	25.8		$	25.2		$	(2.6)	(10.1)	%	$	(2.0)	(7.9)	%
Heat Transfer Systems	11.2			26.8			15.8			(15.6)		(58.2)	%	(4.6)		(29.1)	%
Specialty Products	36.7			17.0			28.2			19.7		115.9	%	8.5		30.1	%
Repair, Service & Leasing	12.1			13.7			14.7			(1.6)		(11.7)	%	(2.6)		(17.7)	%
Consolidated	$	83.2		$	83.3		$	83.9		$	(0.1)	(0.1)	%	$	(0.7)	(0.8)	%
Gross Profit Margin
Cryo Tank Solutions	23.7		%	24.5		%	24.3		%
Heat Transfer Systems	17.2		%	27.5		%	22.8		%
Specialty Products	34.4		%	35.0		%	36.5		%
Repair, Service & Leasing	22.2		%	34.2		%	35.5		%
Consolidated	25.8		%	28.8		%	29.1		%
SG&A Expenses
Cryo Tank Solutions	$	9.1		$	8.5		$	8.9		$	0.6	7.1	%	$	0.2	2.2	%
Heat Transfer Systems	6.6			10.0			7.0			(3.4)		(34.0)	%	(0.4)		(5.7)	%
Specialty Products	11.6			4.9			9.1			6.7		136.7	%	2.5		27.5	%
Repair, Service & Leasing	4.4			3.5			4.4			0.9		25.7	%	—		—	%
Corporate	16.3			16.6			16.8			(0.3)		(1.8)	%	(0.5)		(3.0)	%
Consolidated	$	48.0		$	43.5		$	46.2		$	4.5	10.3	%	$	1.8	3.9	%
SG&A Expenses (% of Sales)
Cryo Tank Solutions	9.3		%	8.1		%	8.6		%
Heat Transfer Systems	10.1		%	10.3		%	10.1		%
Specialty Products	10.9		%	10.1		%	11.8		%
Repair, Service & Leasing	8.1		%	8.7		%	10.6		%
Consolidated	14.9		%	15.0		%	16.0		%

	Three Months Ended									Current Quarter vs. Prior Year Same Quarter				Current Quarter vs. Prior Sequential Quarter
	June 30, 2021			June 30, 2020			March 31, 2021			Variance  ($)		Variance (%)		Variance  ($)		Variance (%)
Operating Income (Loss) (1)
Cryo Tank Solutions (2)	$	13.4		$	15.9		$	15.6		$	(2.5)	(15.7)	%	$	(2.2)	(14.1)	%
Heat Transfer Systems	(0.5)			7.2			3.9			(7.7)		(106.9)	%	(4.4)		(112.8)	%
Specialty Products (3)	23.4			11.7			17.9			11.7		100.0	%	5.5		30.7	%
Repair, Service & Leasing	5.6			7.6			8.3			(2.0)		(26.3)	%	(2.7)		(32.5)	%
Corporate (4)	(16.3)			(16.6)			(16.8)			0.3		(1.8)	%	0.5		(3.0)	%
Consolidated	$	25.6		$	25.8		$	28.9		$	(0.2)	(0.8)	%	$	(3.3)	(11.4)	%
Operating Margin
Cryo Tank Solutions	13.7		%	15.1		%	15.0		%
Heat Transfer Systems	(0.8)		%	7.4		%	5.6		%
Specialty Products	21.9		%	24.1		%	23.2		%
Repair, Service & Leasing	10.3		%	19.0		%	20.0		%
Consolidated	8.0		%	8.9		%	10.0		%

_______________

(1)Restructuring costs for the three months ended:

•June 30, 2021 were $0.3 ($0.3 - Heat Transfer Systems).

•June 30, 2020 were $5.6 ($1.1 - Cryo Tank Solutions, $2.9 - Heat Transfer Systems and $1.6 - Corporate).

•March 31, 2021 were $0.7 ($0.3 - Cryo Tank Solutions and $0.4 - Heat Transfer Systems).

(2)Includes a $2.6 gain on sale of a facility in China for the three months ended June 30, 2020.

(3)Acquisition-related contingent consideration adjustments in our Specialty Products segment for the three months ended:

•June 30, 2021 were $1.2.

•March 31, 2021 were $0.8.

(4)Includes transaction-related costs of $0.8 for the three months ended June 30, 2021 related to the acquisitions of Cryogenic Gas Technologies, Inc., Sustainable Energy Solutions, Inc., BlueInGreen, LLC and Alabama Trailers and the July 1, 2021 acquisition of L.A. Turbine.

Results of Operations for the Three Months Ended June 30, 2021 and 2020, and March 31, 2021

Sales for the second quarter of 2021 compared to the same quarter in 2020 increased by $32.5 million, from $289.5 million to $322.0 million, or 11.2%. The increase in sales on a prior year same quarter comparative basis was primarily driven by growth in our Specialty Products segment on favorable sales in HLNG vehicle tanks, hydrogen, laser and food & beverage applications and in our Repair, Service & Leasing segment on favorable sales in our Cryo-Lease business. This increase was partially offset by the continued softness in demand for midstream and upstream compression equipment and timing of sales recognized relative to Venture Global’s Calcasieu Pass LNG export terminal project (“Calcasieu Pass”) within our Heat Transfer Systems segment.

Gross profit decreased during the second quarter of 2021 compared to the second quarter of 2020 by $0.1 million or 0.1%, and first quarter 2021 gross margin as a percent of sales of 25.8% decreased from 28.8% in the second quarter of 2020. The decrease in margin as a percent of sales in the current quarter over second quarter of 2020 was primarily driven by higher material prices due to market conditions for all segments overall and Calcasieu Pass volume mix which drove higher margins in the second quarter of 2020 in our Heat Transfer Systems segment. Restructuring costs recorded to cost of sales were $0.3 million and $1.6 million for the three months ended June 30, 2021 and 2020, respectively.

Consolidated SG&A expenses increased by $4.5 million or 10.3% during the second quarter of 2021 compared to the same quarter in 2020 primarily driven by ramp up in our Specialty Products business, partially offset by a decrease in restructuring costs which were $0.0 million (zero) and $4.0 million for the three months ended June 30, 2021 and 2020, respectively.

35

Interest Expense, Net and Financing Costs Amortization

Interest expense, net for the three months ended June 30, 2021 and 2020 was $2.2 million and $7.6 million, respectively, representing a decrease of $5.4 million. The decrease in interest expense, net, is primarily due to lower borrowings outstanding on our term loan due June 2024 during the second quarter of 2021 as compared to the second quarter of 2020. Furthermore, we no longer recognize interest accretion of convertible notes discount due to a change in accounting principle adopted at the beginning of fiscal year 2021 whereas we recognized $2.0 million in interest accretion expense in the second quarter of 2020. For further information regarding the change in accounting principle, refer to Note 1, “Basis of Preparation” to our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report. Interest expense, net for both the three months ended June 30, 2021 and 2020 included $0.7 million of 1.0% cash interest expense related to our convertible notes due November 2024 and $1.8 million and $4.6 million, respectively, in interest related to borrowings on our senior secured revolving credit facility and term loan due 2024. Financing costs amortization was $1.1 million for both the three months ended June 30, 2021 and 2020.

Unrealized Loss (Gain) On Investments In Equity Securities

During the second quarter of 2021, we recognized an unrealized loss on investments in equity securities of $12.5 million, which was driven by a $17.2 million unrealized loss on the mark-to-market adjustment of our investment in McPhy, partially offset by a $4.7 million unrealized gain on the mark-to-market adjustment of our investment in Stabilis. During second quarter of 2020, we recognized an unrealized gain of $1.0 million on the mark-to-market adjustment of our investment in Stabilis.

Foreign Currency Loss and Other

For the three months ended June 30, 2021 and 2020, foreign currency loss and other was $1.7 million and $1.2 million, respectively. The variance between periods was primarily driven by fluctuations in the U.S dollar as compared to the euro and Chinese yuan.

Income Tax Expense

Income tax expense of $1.3 million and $2.2 million for the three months ended June 30, 2021 and 2020, respectively, represents taxes on both U.S. and foreign earnings at a combined effective income tax rate of 16.0% and 13.0%, respectively. The effective income tax rate of 16.0% for the three months ended June 30, 2021 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by some of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by our certain foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

The effective income tax rate of 13.0% for the three months ended June 30, 2020 differed from the U.S. federal statutory rate of 21% primarily due to excess tax benefits associated with share-based compensation, partially offset by the effect of income earned by certain of our foreign entities being taxed at higher rates than the U.S. federal statutory rate and losses incurred by certain of our foreign operations for which no benefit was recorded.

Net Income from Continuing Operations

As a result of the foregoing, net income attributable to Chart for the three months ended June 30, 2021 and 2020 was $6.5 million and $13.8 million, respectively.

Discontinued Operations

The results from our cryobiological related products business formerly reported in our Distribution & Storage Western Hemisphere segment are reflected in our condensed consolidated financial statements as discontinued operations for the three months ended June 30, 2020. For further information, refer to Note 2, “Discontinued Operations” of our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report.

36

Consolidated Results for the six months ended June 30, 2021 and 2020

The following table includes key metrics used to evaluate our business and measure our performance and represents selected financial data for our operating segments for the six months ended June 30, 2021 and 2020 (dollars in millions):

Selected Financial Information

	Six Months Ended						Current Year-to-date vs. Prior Year-to-date Period
	June 30, 2021			June 30, 2020			Variance ($)		Variance (%)
Sales
Cryo Tank Solutions	$	201.7		$	203.3		$	(1.6)	(0.8)	%
Heat Transfer Systems	134.4			210.2			(75.8)		(36.1)	%
Specialty Products	184.1			101.5			82.6		81.4	%
Repair, Service & Leasing	96.0			80.8			15.2		18.8	%
Intersegment eliminations	(5.7)			(4.4)			(1.3)		29.5	%
Consolidated	$	610.5		$	591.4		$	19.1	3.2	%
Gross Profit
Cryo Tank Solutions	$	48.4		$	49.9		$	(1.5)	(3.0)	%
Heat Transfer Systems	27.0			52.9			(25.9)		(49.0)	%
Specialty Products	64.9			37.3			27.6		74.0	%
Repair, Service & Leasing	26.8			25.5			1.3		5.1	%
Consolidated	$	167.1		$	165.6		$	1.5	0.9	%
Gross Profit Margin
Cryo Tank Solutions	24.0		%	24.5		%
Heat Transfer Systems	20.1		%	25.2		%
Specialty Products	35.3		%	36.7		%
Repair, Service & Leasing	27.9		%	31.6		%
Consolidated	27.4		%	28.0		%
SG&A Expenses
Cryo Tank Solutions	$	18.0		$	19.6		$	(1.6)	(8.2)	%
Heat Transfer Systems	13.6			21.2			(7.6)		(35.8)	%
Specialty Products	20.7			11.0			9.7		88.2	%
Repair, Service & Leasing	8.8			7.9			0.9		11.4	%
Corporate	33.1			36.3			(3.2)		(8.8)	%
Consolidated	$	94.2		$	96.0		$	(1.8)	(1.9)	%
SG&A Expenses % of Sales
Cryo Tank Solutions	8.9		%	9.6		%
Heat Transfer Systems	10.1		%	10.1		%
Specialty Products	11.2		%	10.8		%
Repair, Service & Leasing	9.2		%	9.8		%
Consolidated	15.4		%	16.2		%

37

Operating Income (Loss) (1)
Cryo Tank Solutions (2)	$	29.0		$	27.5		$	1.5	5.5	%
Heat Transfer Systems	3.4			12.7			(9.3)		(73.2)	%
Specialty Products (3)	41.3			25.5			15.8		62.0	%
Repair, Service & Leasing	13.9			12.2			1.7		13.9	%
Corporate (4)	(33.1)			(36.3)			3.2		(8.8)	%
Consolidated	$	54.5		$	41.6		$	12.9	31.0	%
Operating Margin
Cryo Tank Solutions	14.4		%	13.5		%
Heat Transfer Systems	2.5		%	6.0		%
Specialty Products	22.4		%	25.1		%
Repair, Service & Leasing	14.5		%	15.1		%
Consolidated	8.9		%	7.0		%

(1)Restructuring costs for the six months ended:

•June 30, 2021 were $1.0 ($0.3 - Cryo Tank Solutions and $0.7 - Heat Transfer Systems).

•June 30, 2020 were $10.8 ($2.9 - Cryo Tank Solutions, $5.7 - Heat Transfer Systems and $2.2 - Corporate).

(2)Includes a $2.6 gain on sale of a facility in China for the six months ended June 30, 2020.

(3)Includes acquisition-related contingent consideration adjustments of $2.0 in our Specialty Products segment for the six months ended June 30, 2021.

(4)Includes transaction-related costs of $1.8 for the six months ended June 30, 2021 related to the acquisitions of Cryogenic Gas Technologies, Inc., Sustainable Energy Solutions, Inc., BlueInGreen, LLC and Alabama Trailers and the July 1, 2021 acquisition of L.A. Turbine.

Results of Operations for the Six Months Ended June 30, 2021 and 2020

Sales for the first six months of 2021 compared to the same period in 2020 increased by $19.1 million, from $591.4 million to $610.5 million, or 3.2%. Similar to the comments in the results of operations for the three months ended June 30, 2021 and 2020 section above, this increase was primarily driven by growth in our Specialty Products segment on favorable sales in HLNG vehicle tanks, hydrogen, laser and food & beverage applications and in our Repair, Service & Leasing segment on favorable sales in our Cryo-Lease business. This increase was partially offset by the continued softness in demand for midstream and upstream compression equipment and timing of sales recognized for Calcasieu Pass within our Heat Transfer Systems segment.

Gross profit increased during the first six months of 2021 compared to the first six months of 2020 by $1.5 million or 0.9%, and year-to-date 2021 on higher volume while gross margin as a percent of sales of 27.4% for the first six months of 2021 decreased from 28.0% in the first six months of 2020. Similar to the comments in the results of operations for the three months ended June 30, 2021 and 2020 section above, the decrease in margin as a percent of sales for the first six months of 2021 compared to the first six months of 2020 was primarily driven by higher material prices due to market conditions for all segments overall and Calcasieu Pass volume mix which drove higher margins during the first six months of 2020 in our Heat Transfer Systems segment. Restructuring costs recorded to cost of sales were $0.7 million and $3.9 million for the six months ended June 30, 2021 and 2020, respectively.

Consolidated SG&A expenses decreased by $1.8 million or 1.9% during the first six months of 2021 compared to the same period in 2020 primarily driven by lower restructuring costs recorded to consolidated SG&A expenses, which were $0.3 million and $6.9 million for the six months ended June 30, 2021 and 2020, respectively and lower employee related costs, partially offset by a ramp up in our Specialty Products business which drove higher SG&A expenses in the segment.

38

Interest Expense, Net and Financing Costs Amortization

Interest expense, net for the six months ended June 30, 2021 and 2020 was $4.2 million and $14.8 million, respectively, representing a decrease of $10.6 million. The decrease in interest expense, net, is primarily due to lower borrowings outstanding on our term loan due June 2024 during the first six months of 2021 as compared to the first six months of 2020. Furthermore, we no longer recognize interest accretion of convertible notes discount due to a change in accounting principle adopted at the beginning of fiscal year 2021 whereas we recognized $3.9 million in interest accretion expense in the first six months of 2020. For further information regarding the change in accounting principle, refer to Note 1, “Basis of Preparation” to our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report. Interest expense, net for both the six months ended June 30, 2021 and 2020 included $1.3 million of 1.0% cash interest expense related to our convertible notes due November 2024 and $3.1 million and $9.4 million, respectively, in interest related to borrowings on our senior secured revolving credit facility and term loan due 2024. Financing costs amortization was $2.3 million for the six months ended June 30, 2021 as compared to $2.1 million for the six months ended June 30, 2020.

Unrealized Loss On Investments In Equity Securities

During the first six months of 2021, we recognized an unrealized loss on investments in equity securities of $9.2 million, which was driven by a $19.8 million unrealized loss on the mark-to-market adjustment of our investment in McPhy, partially offset by a $10.6 million unrealized gain on the mark-to-market adjustment of our investment in Stabilis. During the first six months of 2020, we recognized an unrealized loss of $3.8 million on the mark-to-market adjustment of our investment in Stabilis.

Foreign Currency Loss and Other

For both the six months ended June 30, 2021 and 2020, foreign currency loss and other was $1.5 million.

Income Tax Expense

Income tax expense of $4.4 million and $2.6 million for the six months ended June 30, 2021 and 2020, respectively, represents taxes on both U.S. and foreign earnings at a combined effective income tax rate of 11.8% and 13.4%, respectively. The effective income tax rate of 11.8% for the six months ended June 30, 2021 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by some of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by our certain foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

The effective income tax rate of 13.4% for the six months ended June 30, 2020 differed from the U.S. federal statutory rate of 21% primarily due to excess tax benefits associated with share-based compensation, partially offset by the effect of income earned by certain of our foreign entities being taxed at higher rates than the U.S. federal statutory rate and losses incurred by certain of our foreign operations for which no benefit was recorded.

Net Income from Continuing Operations

As a result of the foregoing, net income attributable to Chart for the six months ended June 30, 2021 and 2020 was $32.1 million and $15.9 million, respectively.

Discontinued Operations

The results from our cryobiological related products business formerly reported in our Distribution & Storage Western Hemisphere segment are reflected in our condensed consolidated financial statements as discontinued operations for the six months ended June 30, 2020. For further information, refer to Note 2, “Discontinued Operations” of our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report.

Segment Results

Our reportable and operational segments include: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products, and Repair, Service & Leasing. Corporate includes operating expenses for executive management, accounting, tax, treasury, corporate development, human resources, information technology, investor relations, legal, internal audit, and risk management. Corporate support functions are not currently allocated to the segments. For further information, refer to Note 3, “Reportable Segments” of our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report. The following tables include key metrics used to evaluate our business and measure our performance and represents selected financial data for our operating segments for the three and six months ended June 30, 2021 and 2020 (dollars in millions):

39

Cryo Tank Solutions — Results of Operations for the Three Months Ended June 30, 2021 and 2020

	Three Months Ended						Current Quarter vs. Prior Year Same Quarter
	June 30, 2021			June 30, 2020			Variance ($)		Variance (%)
Sales	$	97.8		$	105.3		$	(7.5)	(7.1)	%
Gross Profit	23.2			25.8			(2.6)		(10.1)	%
Gross Profit Margin	23.7		%	24.5		%
SG&A Expenses	$	9.1		$	8.5		$	0.6	7.1	%
SG&A Expenses (% of Sales)	9.3		%	8.1		%
Operating Income	$	13.4		$	15.9		$	(2.5)	(15.7)	%
Operating Margin	13.7		%	15.1		%

For the second quarter of 2021, Cryo Tank Solutions sales decreased by $7.5 million as compared to the same quarter in 2020 primarily due to lower sales in engineered systems, partially offset by higher sales in storage equipment.

During the second quarter of 2021, Cryo Tank Solutions segment gross profit decreased by $2.6 million as compared to the same quarter in 2020. The decrease in gross profit was mainly driven by volume while the decrease in the related margin was mainly driven by higher material prices due to market conditions.

Cryo Tank Solutions segment SG&A expenses increased by $0.6 million during the second quarter of 2021 as compared to the same quarter in 2020. In the second quarter of 2020, we recognized a $2.6 million gain on sale of a facility in China. Excluding the impact of the gain on sale, Cryo Tank Solutions segment SG&A expenses decreased mainly due to lower employee-related costs and lower restructuring costs.

Cryo Tank Solutions — Results of Operations for the Six Months Ended June 30, 2021 and 2020

	Six Months Ended						Current Year-to-date vs. Prior Year-to-date Period
	June 30, 2021			June 30, 2020			Variance ($)		Variance (%)
Sales	$	201.7		$	203.3		$	(1.6)	(0.8)	%
Gross Profit	48.4			49.9			(1.5)		(3.0)	%
Gross Profit Margin	24.0		%	24.5		%
SG&A Expenses	$	18.0		$	19.6		$	(1.6)	(8.2)	%
SG&A Expenses (% of Sales)	8.9		%	9.6		%
Operating Income	$	29.0		$	27.5		$	1.5	5.5	%
Operating Margin	14.4		%	13.5		%

    

For the first six months of 2021, Cryo Tank Solutions sales decreased by $1.6 million as compared to the same period in 2020 primarily due to lower sales in engineered systems, partially offset by higher sales in storage equipment.

During the first six months of 2021, Cryo Tank Solutions segment gross profit decreased by $1.5 million as compared to the same period in 2020. The decrease in gross profit was mainly driven by volume while the decrease in the related margin was mainly driven by higher material prices due to market conditions.

Cryo Tank Solutions segment SG&A expenses decreased by $1.6 million during the first six months of 2021 as compared to the same period in 2020. Furthermore, Cryo Tank Solutions segment SG&A expenses as a percentage of Cryo Tank Solutions segment sales improved by 70 basis points in the first six months of 2021 as compared to the same period in 2020 primarily driven by the effect of cost reduction efforts completed in 2021, lower severance costs and lower employee-related costs. Also, in the first six months of 2020, we recognized a $2.6 million gain on sale of a facility in China.

40

Heat Transfer Systems — Results of Operations for the Three Months Ended June 30, 2021 and 2020

	Three Months Ended						Current Quarter vs. Prior Year Same Quarter
	June 30, 2021			June 30, 2020			Variance ($)		Variance (%)
Sales	$	65.2		$	97.3		$	(32.1)	(33.0)	%
Gross Profit	11.2			26.8			(15.6)		(58.2)	%
Gross Profit Margin	17.2		%	27.5		%
SG&A Expenses	$	6.6		$	10.0		$	(3.4)	(34.0)	%
SG&A Expenses (% of Sales)	10.1		%	10.3		%
Operating (Loss) Income	$	(0.5)		$	7.2		$	(7.7)	(106.9)	%
Operating Margin	(0.8)		%	7.4		%

For the second quarter of 2021, Heat Transfer Systems segment sales decreased by $32.1 million as compared to the same quarter in 2020. During the second quarter of 2021, we recognized $5.4 million in sales relative to Calcasieu Pass as compared to $23.8 million recognized during the second quarter of 2020. We continue to experience industry-wide softness in demand for midstream and upstream compression equipment. However, we are beginning to see a recovery in market conditions as indicated by an increase in customer order activity and inquiry.

During the second quarter of 2021, Heat Transfer Systems segment gross profit decreased by $15.6 million as compared to the same quarter in 2020 mainly driven by lower volume partially offset by lower restructuring costs. Heat Transfer Systems segment gross profit as a percentage of Heat Transfer Systems segment sales was 17.2% in the second quarter of 2021 as compared to 27.5% in the second quarter of 2020, which is a decline of 1,030 basis points on a quarter over prior year quarter basis primarily due to overall product and project volume mix which drove higher margins in the second quarter of 2020.

Heat Transfer Systems segment SG&A expenses decreased during the second quarter of 2021 as compared to the same quarter in 2020 mainly due to lower restructuring costs and lower employee-related costs.

Heat Transfer Systems — Results of Operations for the Six Months Ended June 30, 2021 and 2020

	Six Months Ended						Current Year-to-date vs. Prior Year-to-date Period
	June 30, 2021			June 30, 2020			Variance ($)		Variance (%)
Sales	$	134.4		$	210.2		$	(75.8)	(36.1)	%
Gross Profit	27.0			52.9			(25.9)		(49.0)	%
Gross Profit Margin	20.1		%	25.2		%
SG&A Expenses	$	13.6		$	21.2		$	(7.6)	(35.8)	%
SG&A Expenses (% of Sales)	10.1		%	10.1		%
Operating Income	$	3.4		$	12.7		$	(9.3)	(73.2)	%
Operating Margin	2.5		%	6.0		%

For the first six months of 2021, Heat Transfer Systems segment sales decreased by $75.8 million as compared to the same period in 2020. During the first six months of 2021, we recognized $20.1 million in sales relative to Calcasieu Pass as compared to $46.7 million recognized during the same period in 2020. As mentioned in the results of operations for the three months ended June 30, 2021 and 2020 comments above, we are experiencing industry-wide softness in demand for midstream and upstream compression equipment. However, we are beginning to see a recovery in market conditions as indicated by an increase in customer order activity and inquiry.

During the first six months of 2021, Heat Transfer Systems segment gross profit decreased by $25.9 million as compared to the same period in 2020 mainly driven by lower volume partially offset by lower restructuring costs. Heat Transfer Systems segment gross profit as a percentage of Heat Transfer Systems segment sales was 20.1% in the first six months of 2021 as compared to 25.2% in the same period of 2020, which is a decline of 510 basis points on a current over prior year period basis primarily due to overall product and project volume mix which drove higher margins in the first six months of 2020.

Heat Transfer Systems segment SG&A expenses decreased during the first six months of 2021 as compared to the same period in 2020 mainly due to lower restructuring costs and lower employee-related costs.

41

Specialty Products — Results of Operations for the Three Months Ended June 30, 2021 and 2020

	Three Months Ended						Current Quarter vs. Prior Year Same Quarter
	June 30, 2021			June 30, 2020			Variance ($)		Variance (%)
Sales	$	106.8		$	48.6		$	58.2	119.8	%
Gross Profit	36.7			17.0			19.7		115.9	%
Gross Profit Margin	34.4		%	35.0		%
SG&A Expenses	$	11.6		$	4.9		$	6.7	136.7	%
SG&A Expenses (% of Sales)	10.9		%	10.1		%
Operating Income	$	23.4		$	11.7		$	11.7	100.0	%
Operating Margin	21.9		%	24.1		%

Specialty Products segment sales increased by $58.2 million during the second quarter of 2021 as compared to the same quarter in 2020. This increase was primarily driven by favorable sales in HLNG vehicle tanks, hydrogen, and laser applications, each of which had double digit growth during the second quarter of 2021 as compared to the second quarter of 2020. The increase in sales was also attributed to an increase in food & beverage applications.

Specialty Products segment gross profit increased by $19.7 million during the second quarter of 2021 as compared to the same quarter in 2020 primarily due to higher volume. The related margin decreased driven by higher material prices due to market conditions.

Specialty Products segment SG&A expenses increased by $6.7 million during the second quarter of 2021 as compared to the same quarter in 2020 primarily driven by ramp up in the business. Furthermore, Specialty Products segment SG&A expenses included $1.2 million relative to acquisition-related contingent consideration adjustments recognized during the second quarter of 2021.

Specialty Products — Results of Operations for the Six Months Ended June 30, 2021 and 2020

	Six Months Ended						Current Year-to-date vs. Prior Year-to-date Period
	June 30, 2021			June 30, 2020			Variance ($)		Variance (%)
Sales	$	184.1		$	101.5		$	82.6	81.4	%
Gross Profit	64.9			37.3			27.6		74.0	%
Gross Profit Margin	35.3		%	36.7		%
SG&A Expenses	$	20.7		$	11.0		$	9.7	88.2	%
SG&A Expenses (% of Sales)	11.2		%	10.8		%
Operating Income	$	41.3		$	25.5		$	15.8	62.0	%
Operating Margin	22.4		%	25.1		%

Specialty Products segment sales increased by $82.6 million during the first six months of 2021 as compared to the same period in 2020. Similar to the comments in results of operations for the three months ended June 30, 2021 and 2020 above, the increase in Specialty Products sales was primarily driven by favorable sales in HLNG vehicle tanks, hydrogen, and laser applications, each of which had double digit growth during the first six months of 2021 as compared to the first six months of 2020. The increase in sales was also attributed to an increase in food & beverage applications.

Specialty Products segment gross profit increased by $27.6 million during the first six months of 2021 as compared to the same period in 2020 primarily due to higher volume. Similar to the comments in results of operations for the three months ended June 30, 2021 and 2020 above, the related margin decreased driven by higher material prices due to market conditions.

Specialty Products segment SG&A expenses increased by $9.7 million during the first six months of 2021 as compared to the same period in 2020 primarily driven by ramp up in the business. Furthermore, Specialty Products segment SG&A expenses included $2.0 million relative to acquisition-related contingent consideration adjustments recognized year-to-date during 2021.

42

Repair, Service & Leasing — Results of Operations for the Three Months Ended June 30, 2021 and 2020

	Three Months Ended						Current Quarter vs. Prior Year Same Quarter
	June 30, 2021			June 30, 2020			Variance ($)		Variance (%)
Sales	$	54.6		$	40.1		$	14.5	36.2	%
Gross Profit	12.1			13.7			(1.6)		(11.7)	%
Gross Profit Margin	22.2		%	34.2		%
SG&A Expenses	$	4.4		$	3.5		$	0.9	25.7	%
SG&A Expenses (% of Sales)	8.1		%	8.7		%
Operating Income	$	5.6		$	7.6		$	(2.0)	(26.3)	%
Operating Margin	10.3		%	19.0		%

For the second quarter of 2021, Repair, Service & Leasing segment sales increased by $14.5 million as compared to the same quarter in 2020. This increase was mainly driven by favorable sales in our Cryo-Lease business.

During the second quarter of 2021, Repair, Service & Leasing segment gross profit decreased by $1.6 million as compared to the same quarter in 2020, and the related margin percentage decreased by 1,200 basis points mainly due to unfavorable material costs relative to our Cryo-Lease business and fewer high margin, short-lead time replacement equipment sales in the second quarter of 2021 as compared to the second quarter of 2020.

Repair, Service & Leasing segment SG&A expenses increased by $0.9 million during the second quarter of 2021 as compared to the same quarter in 2020, yet as a percentage of sales, SG&A expenses decreased during the period.

Repair, Service & Leasing —Results of Operations for the Six Months Ended June 30, 2021 and 2020

	Six Months Ended						Current Year-to-date vs. Prior Year-to-date Period
	June 30, 2021			June 30, 2020			Variance ($)		Variance (%)
Sales	$	96.0		$	80.8		$	15.2	18.8	%
Gross Profit	26.8			25.5			1.3		5.1	%
Gross Profit Margin	27.9		%	31.6		%
SG&A Expenses	$	8.8		$	7.9		$	0.9	11.4	%
SG&A Expenses (% of Sales)	9.2		%	9.8		%
Operating Income	$	13.9		$	12.2		$	1.7	13.9	%
Operating Margin	14.5		%	15.1		%

For the first six months of 2021, Repair, Service & Leasing segment sales increased by $15.2 million as compared to the same period in 2020. This increase was mainly driven by favorable sales in our Cryo-Lease business, partially offset by lower aftermarket air cooled heat exchanger sales.

During the first six months of 2021, Repair, Service & Leasing segment gross profit increased by $1.3 million as compared to the same period in 2020, while the related margin percentage decreased by 364 basis points. Similar to the comments in results of operations for the three months ended June 30, 2021 and 2020 above, the decrease in the margin percentage was mainly driven by unfavorable material costs relative to our Cryo-Lease business and fewer high margin, short-lead time replacement equipment sales in the first six months of 2021 as compared to the first six months of 2020.

Repair, Service & Leasing segment SG&A expenses increased by $1.7 million as compared to the same period in 2020 mainly due to higher employee-related costs. Repair, Service & Leasing segment SG&A expenses as a percentage of sales decreased by 60 basis points in the first six months of 2021 as compared to the first six months of 2020.

Corporate

Corporate SG&A expenses decreased by $0.3 million during the second quarter of 2021 as compared to the same quarter in 2020 mainly due to lower restructuring costs. Corporate SG&A expenses decreased by $3.2 million in the first six months of 2021 as compared to the same period in 2020 primarily due to lower employee-related costs and restructuring costs.

43

Liquidity and Capital Resources

Debt Instruments and Related Covenants

Our debt instruments and related covenants are described in Note 9, “Debt and Credit Arrangements” to our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report.

Sources and Uses of Cash

Our cash and cash equivalents totaled $197.8 million at June 30, 2021, an increase of $72.7 million from the balance at December 31, 2020. Our foreign subsidiaries held cash of approximately $100.2 million and $102.7 million, at June 30, 2021, and December 31, 2020, respectively, to meet their liquidity needs. No material restrictions exist to accessing cash held by our foreign subsidiaries. We expect to meet our U.S. funding needs without repatriating non-U.S. cash and incurring incremental U.S. taxes. Cash equivalents are primarily invested in money market funds that invest in high quality, short-term instruments, such as U.S. government obligations, certificates of deposit, repurchase obligations, and commercial paper issued by corporations that have been highly rated by at least one nationally recognized rating organization, and in the case of cash equivalents in China, obligations of local banks. We believe that our existing cash and cash equivalents, funds available under our senior secured revolving credit facility due June 2024 (“SSRCF”) or other financing alternatives, and cash provided by operations will be sufficient to meet our normal working capital needs, capital expenditures, investments and prioritize the pay down of debt for the foreseeable future.

Cash used in operating activities was $28.3 million for the six months ended June 30, 2021, a decrease of $108.6 million compared to cash provided by operating activities of $80.3 million for the six months ended June 30, 2020 primarily due to a decrease in operating cash provided by working capital, particularly within inventory, during the six months ended June 30, 2021.

Cash used in investing activities was $134.3 million and $20.2 million for the six months ended June 30, 2021 and 2020, respectively. During the six months ended June 30, 2021, we used approximately $55.0 million for the acquisition of Cryo Technologies. We used $52.9 million for investments in Svante, Transform Materials, Cryomotive and Earthly Labs. During the six months ended June 30, 2021, we paid approximately $26.7 million for capital expenditures as compared to $21.0 million for the six months ended June 30, 2020.

Cash provided by financing activities was $235.0 million for the six months ended June 30, 2021 compared to cash used in financing activities of $53.8 million for the for the six months ended June 30, 2020. During the six months ended June 30, 2021, we borrowed $424.1 million on credit facilities and repaid $192.5 million in borrowings on credit facilities primarily to fund the acquisition of Cryo Technologies and investments in Svante, Transform Materials, Cryomotive and Earthly Labs. Furthermore, we borrowed $80.0 million on our senior secured revolving credit facility at the end of June 2021 to fund the July 1, 2021 acquisition of L.A. Turbine. During the six months ended June 30, 2020, we borrowed $93.5 million on credit facilities to fund working capital needs and to fund our share repurchase program and repaid $121.4 million in borrowings on credit facilities. We used $19.3 million to repurchase shares of Chart common stock related to our share purchase program during the six months ended June 30, 2020. We suspended the program on March 20, 2020 (the “Suspension Date”) in light of uncertainty resulting from the Covid-19 pandemic and the desire to conserve cash resources. On March 11, 2021, the share repurchase program expired with no further repurchases since the Suspension Date.

Cash Requirements

We do not currently anticipate any unusual cash requirements for working capital needs for the year ending December 31, 2021. Management anticipates we will be able to satisfy cash requirements for our ongoing business for the foreseeable future with cash generated by operations, existing cash balances and available borrowings under our credit facilities. Capital expenditures for the remaining six months of 2021 is expected to be in the range of $13.5 million to $23.5 million.

Inventories, net

Our inventories, net, balance was $310.1 million at June 30, 2021 compared to $248.4 million at December 31, 2020, representing an increase of $61.7 million (24.8%). This increase was primarily driven by cost and availability of materials to ensure that we have sufficient stock to meet demand.

Accrued Income Taxes

Our accrued income taxes balance was $17.3 million at June 30, 2021 compared to $46.5 million at December 31, 2020, representing a decrease of $29.2 million (62.8%). This decrease was primarily driven by $24.9 million in payments for income taxes related to the gain recognized on the cryobiological products divestiture.

44

Orders and Backlog

We consider orders to be those for which we have received a firm signed purchase order or other written contractual commitments from the customer. Backlog is comprised of the portion of firm signed purchase orders or other written contractual commitments from customers for which work has not been performed, or is partially completed, that we have not recognized as revenue and excludes unexercised contract options and potential orders. Our backlog as of June 30, 2021 was $1,083.9 million, inclusive of $0.8 million of backlog remaining on Calcasieu Pass, compared to $686.7 million, inclusive of $72.0 million of Calcasieu Pass backlog as of June 30, 2020 and $934.1 million, inclusive of $6.4 million of Calcasieu Pass backlog as of March 31, 2021. Excluding Calcasieu Pass, backlog increased by $468.4 million or 76.2% in the current quarter compared to the prior year same quarter and $155.4 million or 16.8% compared to the prior quarter.

The tables below represent orders received and backlog by segment for the periods indicated (dollars in millions):

	Three Months Ended
	June 30, 2021		June 30, 2020		March 31, 2021
Orders
Cryo Tank Solutions	$	175.3	$	85.5	$	129.5
Heat Transfer Systems	48.4		55.4		104.9
Specialty Products	190.6		64.4		144.5
Repair, Service & Leasing	41.4		41.4		40.5
Intersegment eliminations	(7.8)		(2.2)		(2.2)
Consolidated	$	447.9	$	244.5	$	417.2

	As of
	June 30, 2021		June 30, 2020		March 31, 2021
Backlog
Cryo Tank Solutions	$	327.1	$	209.8	$	245.8
Heat Transfer Systems	345.1		296.1		361.4
Specialty Products	374.0		145.8		270.5
Repair, Service & Leasing	44.3		37.4		57.4
Intersegment eliminations	(6.6)		(2.4)		(1.0)
Consolidated	$	1,083.9	$	686.7	$	934.1

Cryo Tank Solutions segment orders for the three months ended June 30, 2021 were $175.3 million compared to $85.5 million for the three months ended June 30, 2020 and $129.5 million for the three months ended March 31, 2021. The increase in Cryo Tank Solutions segment orders during the three months ended June 30, 2021 when compared to the same quarter last year was primarily driven by strong order intake for standard tanks and mobile equipment. Cryo Tank Solutions orders were negatively impacted in the first quarter of 2020 due to Covid-19-related shut downs. Cryo Tank Solutions segment backlog at June 30, 2021 totaled $327.1 million and is a record high compared to $209.8 million as of June 30, 2020 and $245.8 million as of March 31, 2021.

Heat Transfer Systems segment orders for the three months ended June 30, 2021 were $48.4 million compared to $55.4 million for the three months ended June 30, 2020, and $104.9 million for the three months ended March 31, 2021. The decrease in Heat Transfer Systems segment orders during the three months ended June 30, 2021 when compared to the same quarter last year was primarily driven by large project orders for ethylene and natural gas liquefaction. Heat Transfer Systems segment backlog at June 30, 2021 totaled $345.1 million, up 16.5% over the second quarter of 2020 and down 4.5% over the first quarter of 2021. Included in Heat Transfer Systems segment backlog for all periods presented is approximately $40.0 million related to the previously announced Magnolia LNG order where production release is delayed. As we previously reported, in general, similar projects previously put on hold in the market are beginning to move ahead as the clean energy infrastructure build out ramps up.

Specialty Products segment orders for the three months ended June 30, 2021 were $190.6 million compared to $64.4 million for the three months ended June 30, 2020 and $144.5 million for the three months ended March 31, 2021. The increases over prior quarter and prior year same quarter were mainly driven by strong orders in hydrogen and helium equipment, HLNG

45

vehicle tanks, lasers and LNG regasification applications. Specialty Products segment backlog totaled $374.0 million as of June 30, 2021, compared to $145.8 million as of June 30, 2020 and $270.5 million as of March 31, 2021.

Repair, Service & Leasing segment orders for both the three months ended June 30, 2021 and 2020 were $41.4 million and $40.5 million for the three months ended March 31, 2021. Repair, Service & Leasing segment backlog totaled $44.3 million as of June 30, 2021, compared to $37.4 million as of June 30, 2020 and $57.4 million as of March 31, 2021.

Off-Balance Sheet Arrangements

We do not have any material off-balance sheet arrangements.

Application of Critical Accounting Policies

Our unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles. As such, some accounting policies have a significant impact on amounts reported in these unaudited condensed consolidated financial statements. A summary of those significant accounting policies can be found in our Annual Report on Form 10-K for the year ended December 31, 2020. In particular, judgment is used in areas such as revenue from contracts with customers, goodwill, indefinite-lived intangibles, long-lived assets (including finite-lived intangible assets), product warranty costs, and pensions. There have been no significant changes to our critical accounting policies since December 31, 2020.

Forward-Looking Statements

We are making this statement in order to satisfy the “safe harbor” provisions contained in the Private Securities Litigation Reform Act of 1995. This Quarterly Report on Form 10-Q includes “forward-looking statements.” These forward-looking statements include statements concerning the Company’s business plans, including statements regarding completed acquisitions, investments, cost synergies and efficiency savings, objectives, future orders, revenues, margins, segment slaes mix, earnings or performance, liquidity and cash flow, inventory levels, capital expenditures, materials costs and pricing increases, business trends, clean energy market opportunities, governmental initiatives, including executive orders and other information that is not historical in nature.  Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of such terms or comparable terminology.

Forward-looking statements contained herein (including future cash contractual obligations, liquidity, cash flow, orders, results of operations, projected revenues, margins, capital expenditures, industry and business trends, cost synergies and savings objectives, clean energy market opportunities and government initiatives, among other matters) or in other statements made by us are made based on management’s expectations and beliefs concerning future events impacting us and are subject to uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control, that could cause the Company’s actual results to differ materially from those expressed or implied by forward-looking statements made by us or on our behalf. These include: the other factors discussed in Item 1A. “Risk Factors” and the factors discussed in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2020, which should be reviewed carefully; risks relating to the outbreak and continued uncertainty associated with the coronavirus (Covid-19); Chart’s ability to successfully integrate recent acquisitions, and achieve the anticipated revenue, earnings, accretion and other benefits from these acquisitions; slower than anticipated growth and market acceptance of new clean energy product offerings; inability to achieve expected pricing increases or continued volatility in raw materials cost and supply; estimated segment revenues, future revenue, earnings, cash flows and margin targets and run rates; our ability to remediate the material weaknesses identified during the preparation of the consolidated financial statements which are included in our Annual Report on Form 10-K for the year ended December 31, 2020. These factors should not be construed as exhaustive and there may also be other risks that we are unable to predict at this time.

All forward-looking statements attributable to us or persons acting on our behalf apply only as of the date of this Quarterly Report and are expressly qualified in their entirety by the cautionary statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as the same may be updated from time to time. We undertake no obligation to update or revise forward-looking statements which may be made to reflect events or circumstances that arise after the filing date of this document or to reflect the occurrence of unanticipated events, except as otherwise required by law.

46

Item 3.Quantitative and Qualitative Disclosures About Market Risk

In the normal course of business, our operations are exposed to fluctuations in interest rates and foreign currency values that can affect the cost of operating and financing. Accordingly, we address a portion of these risks through a program of risk management.

Interest Rate Risk: Our primary interest rate risk exposure results from the SSRCF’s various floating rate pricing mechanisms. If interest rates were to increase 100 basis points (1 percent) from the weighted-average interest rate of 1.9% at June 30, 2021, and assuming no changes in the $351.8 million of borrowings outstanding under the SSRCF at June 30, 2021, our additional annual expense would be approximately $3.5 million on a pre-tax basis.

Foreign Currency Exchange Rate Risk: We operate in the United States and other foreign countries, which creates exposure to foreign currency exchange fluctuations in the normal course of business, which can impact our financial position, results of operations, cash flows, and competitive position. The financial statements of foreign subsidiaries are translated into their U.S. dollar equivalents at end-of-period exchange rates for assets and liabilities, while income and expenses are translated at average monthly exchange rates. Translation gains and losses are components of other comprehensive income as reported in the unaudited condensed consolidated statements of income and comprehensive income. Translation exposure is primarily with the euro, the Czech koruna, the Chinese yuan, and the Indian rupee. During the second quarter of 2021, the U.S. dollar weakened in relation to the Chinese yuan by 2%, the euro by 1%, the Czech koruna by 4% and remained relatively flat in relation to the Japanese Yen, strengthening by less than 1%. Additionally, the euro weakened in relation to the Czech koruna by 3%. At June 30, 2021, a hypothetical 10% weakening of the U.S. dollar would not materially affect our financial statements.

Chart’s primary transaction exchange rate exposures are with the euro, the Chinese yuan, the Czech koruna, the Indian rupee, the Australian dollar, the British pound, the Canadian dollar and the Japanese yen. Transaction gains and losses arising from fluctuations in currency exchange rates on transactions denominated in currencies other than the functional currency are recognized in the unaudited condensed consolidated statements of income and comprehensive income as a component of foreign currency loss and other. We enter into foreign exchange forward contracts to hedge anticipated and firmly committed foreign currency transactions. We do not use derivative financial instruments for speculative or trading purposes. The terms of the contracts are generally one year or less. At June 30, 2021, a hypothetical 10% weakening of the U.S. dollar would not materially affect our outstanding foreign exchange forward contracts. Additionally, assuming no changes in the 86.5 million euros in EUR Revolver Borrowings outstanding under the SSRCF and an additional 100 basis points (1 percent) strengthening in the U.S dollar in relation to the euro as of the beginning of 2021, during the three months ended June 30, 2021, our additional unrealized foreign currency gain would be approximately $1.1 million on a pre-tax basis.

Market Price Sensitive Instruments

In connection with the pricing of the 2024 Notes, we entered into privately-negotiated convertible note hedge transactions (the “Note Hedge Transactions”) with certain parties, including affiliates of the initial purchasers of the 2024 Notes (the “Option Counterparties”). These Note Hedge Transactions are expected to reduce the potential dilution upon any future conversion of the 2024 Notes.

We also entered into separate, privately-negotiated warrant transactions with the Option Counterparties to acquire up to 4.41 million shares of our common stock. The warrant transactions will have a dilutive effect with respect to our common stock to the extent that the price per share of our common stock exceeds the strike price of the warrants unless we elect, subject to certain conditions, to settle the warrants in cash. The strike price of the warrant transactions related to the 2024 Notes was initially $71.775 per share. Further information is located in Note 9, “Debt and Credit Arrangements” to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Item 4.Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We performed an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”) as of June 30, 2021. As a result of the material weaknesses, which we disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020 and described below, our Chief Executive Officer and Chief Financial Officer have concluded that as of June 30, 2021, our disclosure controls and procedures were not effective to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act (1) is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (2) is

47

accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow for timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management has assessed the effectiveness of its internal control over financial reporting as of December 31, 2020 based on the framework established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) (the “COSO criteria”).

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the registrant’s annual or interim financial statements will not be prevented or detected on a timely basis.

As a result of its review during the preparation of the consolidated financial statements which are included in our Annual Report on Form 10-K for the year ended December 31, 2020, management concluded that we had material weaknesses in our internal control over financial reporting that were identified in connection with our annual goodwill and trademark impairment testing, consisting of the following:

•Control Activities – The Company did not maintain effective control activities based on criteria established by the COSO framework as the control activities that involve more complex judgments did not adequately consider the competency of personnel assigned to perform the review.

•Goodwill and Identifiable Intangible Assets, Net – As a result of the material weakness identified above, the Company failed to adequately design and implement internal controls over the review of its goodwill and indefinite-lived intangible assets for impairment.

Based on the evaluation of our disclosure controls and procedures as of December 31, 2020, our Chief Executive Officer and Chief Financial Officer concluded that, as a result of the material weaknesses in the Company’s internal control over financial reporting described above, as of such date, our disclosure controls and procedures were not effective.

In response to the material weaknesses described above, during the three months ended June 30, 2021, we began implementing, evaluating, and designing new controls and procedures. The following measures have been implemented effective June 30, 2021:

•Evaluated and re-assessed the design of our goodwill and intangible asset impairment process, including control activities associated with the review of data provided to third-party valuation specialists and evaluated the appropriateness of the assumptions and methodology used to measure fair value of reporting units and the reasonableness of the conclusions in the third-party valuation specialists’ reports;

•Evaluated the assignment of responsibilities associated with the accounting for goodwill and intangible asset impairment, including hiring additional resources and providing additional training to existing resources; and

•In order to ensure the quality and consistency of accounting treatments and interpretation across the impairment analysis process and maintain effective control activities, designated one of our senior accounting personnel to provide enhanced oversight to monitor the process, provided guidance on accounting treatment and assumptions and ensured quality-control for the process.

With respect to our annual impairment analysis, we plan to complete the formal review of the annual forecast by no later than September 30, 2021.

Our remediation of the identified material weaknesses and strengthening our internal control environment is ongoing. We will test the ongoing design and implementation and operating effectiveness of the new and existing controls in future periods. The material weaknesses cannot be considered remediated until the applicable controls have operated for a sufficient period of time and management has concluded, through testing, that these controls are designed and operating effectively. Accordingly, we will continue to monitor and evaluate the effectiveness of our internal control over financial reporting in the areas affected by the material weaknesses described above.

48

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

As disclosed in Note 16, “Commitments and Contingencies”, Chart was named in lawsuits (including lawsuits filed in the U.S. District Court for the Northern District of California) filed against Chart and other defendants with respect to the alleged failure of a stainless steel cryobiological storage tank (model MVE 808AF-GB) at the Pacific Fertility Center in San Francisco, California. We hereby incorporate by reference into this Item 1 the disclosure under the headings “Note 16, Commitments and Contingencies – Stainless Steel Cryobiological Tank Legal Proceedings.”

We are occasionally subject to various legal claims related to performance under contracts, product liability, taxes, employment matters, environmental matters, intellectual property, and other matters incidental to the normal course of our business. Based on our historical experience in litigating these claims, as well as our current assessment of the underlying merits of the claims and applicable insurance, if any, management believes that the final resolution of these matters will not have a material adverse effect on our financial position, liquidity, cash flows, or results of operations. Future developments may, however, result in resolution of these legal claims in a way that could have a material adverse effect.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Item 1A. “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

	Issuer Purchases of Equity Securities
Period	Total Number of Shares Purchased (1)	Average Price Paid Per Share (1)		Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
April 1 - 30, 2021	—	$	—	—	$	—
May 1 – 31, 2021	1,102	142.84		—	—
June 1 – 30, 2021	9	133.16		—	—
Total	1,111	142.76		—	$	—

_______________

(1)Includes shares of common stock surrendered to us during the second quarter of 2021 by participants under our share-based compensation plans to satisfy tax withholding obligations relating to the vesting or payment of equity awards for an aggregate purchase price of approximately $158,606. The total number of shares repurchased represents the net shares issued to satisfy tax withholdings. All such repurchased shares were subsequently retired during the three months ended June 30, 2021.

Item 4. Mine Safety Disclosures

Not applicable.

49

Item 6.Exhibits

The following exhibits are included with this report:    

31.1    Rule 13a-14(a) Certification of the Company’s Chief Executive Officer and President (Principal Executive Officer). (x)

31.2    Rule 13a-14(a) Certification of the Company's Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer). (x)

32.1    Section 1350 Certification of the Company’s Chief Executive Officer and President (Principal Executive Officer). (xx)

32.2    Section 1350 Certification of the Company's Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer). (xx)

101.INS    XBRL Instance Document *

101.SCH    XBRL Taxonomy Extension Schema Document

101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF    XBRL Taxonomy Extension Definition Linkbase Document

101.LAB    XBRL Taxonomy Extension Label Linkbase Document

101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document

_______________

(x)    Filed herewith.

(xx)     Furnished herewith.

*    The Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

50

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Chart Industries, Inc.

(Registrant)

Date:	July 22, 2021	By:	/s/ Jillian C. Evanko
			Jillian C. Evanko
			Chief Executive Officer and President
			(Principal Executive Officer)
Date:	July 22, 2021	By:	/s/ Scott W. Merkle
			Scott W. Merkle
			Vice President, Chief Financial Officer and Treasurer
			(Principal Financial Officer)

51

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Jillian C. Evanko, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Chart Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 22, 2021

    /s/ Jillian C. Evanko

Jillian C. Evanko

Chief Executive Officer and President

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Scott W. Merkle, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Chart Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 22, 2021

    /s/ Scott W. Merkle

Scott W. Merkle

Vice President, Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Chart Industries, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer's knowledge, that:

(a)The Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b)The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Form 10-Q.

Dated: July 22, 2021

  /s/ Jillian C. Evanko

Jillian C. Evanko

Chief Executive Officer and President

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Chart Industries, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer's knowledge, that:

(a)The Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b)The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Form 10-Q.

Dated: July 22, 2021

  /s/ Scott W. Merkle

Scott W. Merkle

Vice President, Chief Financial Officer and Treasurer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	6 Months Ended
	Jun. 30, 2021	Jul. 19, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	1-11442
Entity Registrant Name	CHART INDUSTRIES, INC.
Entity Incorporation, State	DE
Entity Tax Identification Number	34-1712937
Street Address	3055 Torrington Drive
Entity City or Town	Ball Ground
Entity State or Province	GA
Entity Postal Zip Code	30107
City Area Code	770
Local Phone Number	721-8800
Title of each class	Common Stock, par value $0.01
Trading Symbol(s)	GTLS
Name of each exchange on which registered	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		36,375,627
Amendment Flag	false
Document Fiscal Period Focus	Q2
Entity Central Index Key	0000892553
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Current Assets
Cash and cash equivalents	$ 197.8	$ 125.1
Accounts receivable, less allowances of $7.5 and $8.4, respectively	220.0	200.8
Inventories, net	310.1	248.4
Unbilled contract revenue	68.2	79.4
Prepaid expenses	23.3	20.0
Other current assets	55.9	29.3
Total Current Assets	875.3	703.0
Property, plant, and equipment, net	414.0	414.5
Goodwill	896.1	865.9
Identifiable intangible assets, net	491.0	493.1
Investments	121.4	78.9
Other assets	32.2	15.1
TOTAL ASSETS	2,830.0	2,570.5
Current Liabilities
Accounts payable	170.4	140.1
Customer advances and billings in excess of contract revenue	126.1	118.9
Accrued salaries, wages, and benefits	31.1	39.7
Accrued income taxes	17.3	46.5
Current portion of warranty reserve	10.7	11.0
Current convertible notes	255.5	220.9
Operating lease liabilities, current	5.0	5.1
Other current liabilities	59.7	52.6
Total Current Liabilities	675.8	634.8
Long-term debt	450.6	221.6
Long-term deferred tax liabilities	46.3	60.2
Accrued pension liabilities	8.5	9.6
Operating lease liabilities, non-current	22.2	23.6
Other long-term liabilities	42.8	41.4
Total Liabilities	1,246.2	991.2
Equity
Common stock, par value $0.01 per share – 150,000,000 shares authorized, 36,375,301 and 36,185,829 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively	0.4	0.4
Additional paid-in capital	753.3	780.8
Treasury stock; 760,782 shares at both June 30, 2021 and December 31, 2020	(19.3)	(19.3)
Retained earnings	851.2	808.4
Accumulated other comprehensive (loss) income	(9.2)	2.4
Total Chart Industries, Inc. Shareholders’ Equity	1,576.4	1,572.7
Noncontrolling interests	7.4	6.6
Total Equity	1,583.8	1,579.3
TOTAL LIABILITIES AND EQUITY	$ 2,830.0	$ 2,570.5

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 7.5	$ 8.4
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	150,000,000	150,000,000
Common stock, shares issued (shares)	36,375,301	36,185,829
Common stock, shares outstanding (shares)	36,375,301	36,185,829
Treasury stock (shares)	760,782	760,782

XML

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Sales	$ 322.0	$ 289.5	$ 610.5	$ 591.4
Cost of sales	238.8	206.2	443.4	425.8
Gross profit	83.2	83.3	167.1	165.6
Selling, general, and administrative expenses	48.0	43.5	94.2	96.0
Amortization expense	9.6	14.0	18.4	28.0
Operating expenses	57.6	57.5	112.6	124.0
Operating income	25.6	25.8	54.5	41.6
Interest expense, net	2.2	7.6	4.2	14.8
Unrealized loss (gain) on investments in equity securities	12.5	(1.0)	9.2	3.8
Financing costs amortization	1.1	1.1	2.3	2.1
Foreign currency loss and other	1.7	1.2	1.5	1.5
Income from continuing operations before income taxes	8.1	16.9	37.3	19.4
Income tax expense	1.3	2.2	4.4	2.6
Net income from continuing operations	6.8	14.7	32.9	16.8
Income from discontinued operations, net of tax	0.0	6.3	0.0	12.7
Net income	6.8	21.0	32.9	29.5
Less: Income attributable to noncontrolling interests of continuing operations, net of taxes	0.3	0.9	0.8	0.9
Net income attributable to Chart Industries, Inc.	6.5	20.1	32.1	28.6
Net income attributable to Chart Industries, Inc.
Income from continuing operations	6.5	13.8	32.1	15.9
Income from discontinued operations, net of tax	0.0	6.3	0.0	12.7
Net income attributable to Chart Industries, Inc.	$ 6.5	$ 20.1	$ 32.1	$ 28.6
Basic earnings per common share attributable to Chart Industries, Inc.:
Income from continuing operations basic (usd per share)	$ 0.18	$ 0.39	$ 0.90	$ 0.45
Income from discontinued operations (usd per share)	0	0.18	0	0.36
Net income attributable to Chart Industries, Inc. (usd per share)	0.18	0.57	0.90	0.81
Diluted earnings per common share attributable to Chart Industries, Inc.
Income from continuing operations (usd per share)	0.16	0.39	0.79	0.45
Income from discontinued operations (usd per share)	0	0.18	0	0.35
Net income attributable to Chart Industries, Inc.	$ 0.16	$ 0.57	$ 0.79	$ 0.80
Weighted-average number of common shares outstanding:
Basic (shares)	35,610	35,180	35,580	35,480
Diluted (shares)	40,810	35,310	40,720	35,660
Comprehensive income, net of taxes	$ 14.4	$ 28.9	$ 21.3	$ 27.5
Less: Comprehensive income attributable to noncontrolling interests, net of taxes	0.3	0.9	0.8	0.9
Comprehensive income attributable to Chart Industries, Inc., net of taxes	$ 14.1	$ 28.0	$ 20.5	$ 26.6

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions		6 Months Ended
		Jun. 30, 2021	Jun. 30, 2020
OPERATING ACTIVITIES
Net income		$ 32.9	$ 29.5
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		39.3	47.5
Interest accretion of convertible notes discount		0.0	3.9
Employee share-based compensation expense		5.8	4.9
Financing costs amortization		2.3	2.1
Unrealized foreign currency transaction gain		(2.9)	(1.1)
Unrealized loss on investments in equity securities		9.2	3.8
Other non-cash operating activities		1.7	3.5
Changes in assets and liabilities, net of acquisitions:
Accounts receivable		(19.4)	18.1
Inventories		(65.1)	(29.2)
Unbilled contract revenues and other assets		(36.5)	13.3
Accounts payable and other liabilities		(4.4)	(21.8)
Customer advances and billings in excess of contract revenue		8.8	5.8
Net Cash (Used In) Provided By Operating Activities		(28.3)	80.3
INVESTING ACTIVITIES
Acquisition of businesses, net of cash acquired		(55.0)	0.0
Investments		(52.9)	0.0
Capital expenditures		(26.7)	(21.0)
Proceeds from sale of assets		0.0	0.8
Government grants		0.3	0.0
Net Cash Used In Investing Activities		(134.3)	(20.2)
FINANCING ACTIVITIES
Borrowings on revolving credit facilities		424.1	93.5
Repayments on revolving credit facilities		(192.5)	(121.4)
Repayments on term loan		0.0	(5.6)
Payments for debt issuance costs		0.0	(1.9)
Proceeds from exercise of stock options		6.6	2.6
Common stock repurchases from share-based compensation plans		(3.2)	(1.7)
Common stock repurchases	[1]	0.0	(19.3)
Net Cash Provided By (Used In) Financing Activities		235.0	(53.8)
Effect of exchange rate changes on cash and cash equivalents		0.3	(2.8)
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents	[2]	72.7	3.5
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period	[3]	126.1	120.0
CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD	[3]	$ 198.8	$ 123.5

[1] Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

[2] Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents represents cash flows of consolidated operations for all periods presented. For cash flows of discontinued operations, refer to Note 2, “Discontinued Operations.”

[3] Includes restricted cash and restricted cash equivalents of $1.0 in other current assets as of both June 30, 2021 and December 31, 2020 and $1.0 in other assets as of both June 30, 2020 and December 31, 2019. For further information regarding restricted cash and restricted cash equivalents balances, refer to Note 9, “Debt and Credit Arrangements.”

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parentheticals) - USD ($) $ in Millions		6 Months Ended
		Jun. 30, 2021	Dec. 31, 2020
Statement of Cash Flows [Abstract]
Common stock repurchases	[1]	$ 0.0
Restricted cash and cash equivalents, current		$ 1.0	$ 1.0

[1] Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

XML

Condensed Consolidated Statements of Equity (Unaudited) - USD ($) $ in Millions		Total	Cumulative Effect, Period of Adoption, Adjustment	[2]	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	[2]	Treasury Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	[2]	Accumulated Other Comprehensive Income (Loss)	Non-controlling Interests
Beginning balance at Dec. 31, 2019		$ 1,232.4			$ 0.4	$ 762.8			$ 0.0	$ 500.3			$ (35.9)	$ 4.8
Beginning balance (shares) at Dec. 31, 2019					35,800,000
Increase (Decrease) in Stockholders' Equity
Net income		8.5								8.5
Other comprehensive income (loss)		(9.9)											(9.9)
Share-based compensation expense		2.9				2.9
Common stock issued from share-based compensation plans		2.0				2.0
Common stock issued from share-based compensation plans (shares)					160,000
Common stock repurchases	[1]	(19.3)							(19.3)
Common stock repurchases from share-based compensation plans		(1.7)				(1.7)
Common stock repurchases from share-based compensation plans (in shares)					(10,000.00)
Ending balance at Mar. 31, 2020		1,214.9			$ 0.4	766.0			(19.3)	508.8			(45.8)	4.8
Ending balance (shares) at Mar. 31, 2020					35,950,000
Beginning balance at Dec. 31, 2019		1,232.4			$ 0.4	762.8			0.0	500.3			(35.9)	4.8
Beginning balance (shares) at Dec. 31, 2019					35,800,000
Increase (Decrease) in Stockholders' Equity
Net income		29.5
Ending balance at Jun. 30, 2020		1,246.4			$ 0.4	768.6			(19.3)	528.9			(37.9)	5.7
Ending balance (shares) at Jun. 30, 2020					35,990,000
Beginning balance at Mar. 31, 2020		1,214.9			$ 0.4	766.0			(19.3)	508.8			(45.8)	4.8
Beginning balance (shares) at Mar. 31, 2020					35,950,000
Increase (Decrease) in Stockholders' Equity
Net income		21.0								20.1				0.9
Other comprehensive income (loss)		7.9											7.9
Share-based compensation expense		2.0				2.0
Common stock issued from share-based compensation plans		0.6				0.6
Common stock issued from share-based compensation plans (shares)					40,000.00
Ending balance at Jun. 30, 2020		1,246.4			$ 0.4	768.6			(19.3)	528.9			(37.9)	5.7
Ending balance (shares) at Jun. 30, 2020					35,990,000
Beginning balance at Dec. 31, 2020		$ 1,579.3	$ (26.2)		$ 0.4	780.8	$ (36.9)		(19.3)	808.4	$ 10.7		2.4	6.6
Beginning balance (shares) at Dec. 31, 2020		36,185,829			36,190,000
Increase (Decrease) in Stockholders' Equity
Net income		$ 26.1								25.6				0.5
Other comprehensive income (loss)		(19.2)											(19.2)
Share-based compensation expense		3.4				3.4
Common stock issued from share-based compensation plans		5.6				5.6
Common stock issued from share-based compensation plans (shares)					180,000
Common stock repurchases from share-based compensation plans		(3.0)				(3.0)
Common stock repurchases from share-based compensation plans (in shares)					(20,000.00)
Other		0.0				0.1								(0.1)
Ending balance at Mar. 31, 2021		1,566.0			$ 0.4	750.0			(19.3)	844.7			(16.8)	7.0
Ending balance (shares) at Mar. 31, 2021					36,350,000
Beginning balance at Dec. 31, 2020		$ 1,579.3	$ (26.2)		$ 0.4	780.8	$ (36.9)		(19.3)	808.4	$ 10.7		2.4	6.6
Beginning balance (shares) at Dec. 31, 2020		36,185,829			36,190,000
Increase (Decrease) in Stockholders' Equity
Net income		$ 32.9
Ending balance at Jun. 30, 2021		$ 1,583.8			$ 0.4	753.3			(19.3)	851.2			(9.2)	7.4
Ending balance (shares) at Jun. 30, 2021		36,375,301			36,380,000
Beginning balance at Mar. 31, 2021		$ 1,566.0			$ 0.4	750.0			(19.3)	844.7			(16.8)	7.0
Beginning balance (shares) at Mar. 31, 2021					36,350,000
Increase (Decrease) in Stockholders' Equity
Net income		6.8								6.5				0.3
Other comprehensive income (loss)		7.6											7.6
Share-based compensation expense		2.4				2.4
Common stock issued from share-based compensation plans		0.9				0.9
Common stock issued from share-based compensation plans (shares)					30,000.00
Other		0.1												0.1
Ending balance at Jun. 30, 2021		$ 1,583.8			$ 0.4	$ 753.3			$ (19.3)	$ 851.2			$ (9.2)	$ 7.4
Ending balance (shares) at Jun. 30, 2021		36,375,301			36,380,000

[1] Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

[2] Refer to Note 1, “ Basis of Preparation” for discussion regarding the cumulative effect of change in accounting principle.

XML

Condensed Consolidated Statements of Equity (Unaudited) (Parentheticals) $ in Millions	3 Months Ended
	Mar. 31, 2020 USD ($)
Statement of Stockholders' Equity [Abstract]
Common stock repurchases	$ 19.3	[1]

[1] Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

XML

Basis of Preparation

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Basis of Preparation

Basis of Preparation

The accompanying unaudited condensed consolidated financial statements of Chart Industries, Inc. and its consolidated subsidiaries (herein referred to as the “Company,” “Chart,” “we,” “us,” or “our”) have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021.

Nature of Operations: We are a leading independent global manufacturer of highly engineered equipment servicing multiple applications in the energy and industrial Gas markets. Our unique product portfolio is used in every phase of the liquid gas supply chain, including upfront engineering, service and repair. Being at the forefront of the clean energy transition, Chart is a leading provider of technology, equipment and services related to liquefied natural gas, hydrogen, biogas and CO2 Capture amongst other applications. We are committed to excellence in environmental, social and corporate governance (ESG) issues both for our company as well as our customers. With over 25 global locations from the United States to Asia, Australia, India, Europe and South America, we maintain accountability and transparency to our team members, suppliers, customers and communities.

Principles of Consolidation: The unaudited condensed consolidated financial statements include the accounts of Chart Industries, Inc. and its subsidiaries. Intercompany accounts and transactions are eliminated in consolidation.

Reclassifications: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (CYRX) (refer to Note 2, “Discontinued Operations” for further information). Furthermore, we reorganized our reporting structure such that the composition of our reportable segments changed effective October 1, 2020 (refer to Note 3, “Reportable Segments” for further information). As such, certain reclassifications have been made to the statements of income and comprehensive income for the three and six months ended June 30, 2020 and certain notes to the unaudited condensed consolidated financial statements in order to conform to the 2021 presentation.

Use of Estimates: The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. These estimates may also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions. While our production has been considered “essential” in all locations we operate in, we have experienced, and may again experience in the future, temporary facility closures while awaiting appropriate government approvals in certain jurisdictions. The Covid-19 outbreak could also disrupt our supply chain and materially adversely impact our ability to secure supplies for our facilities, which could materially adversely affect our operations. There may also be long-term effects on our customers in and the economies of affected countries. As a result of these uncertainties, actual results could differ from those estimates and assumptions. If the economy or markets in which we operate remain weak or deteriorate further, our business, financial condition and results of operations may be materially and adversely impacted.

Share Repurchase Program: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on March 11, 2020, our Board of Directors authorized a share repurchase program for up to $75 million of the Company’s common stock over the next twelve months through various means, including open market transactions, block purchases, privately negotiated transactions or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. During the first quarter of 2020, we repurchased 0.76 shares of our common stock at an average price of $25.40 per share for a total purchase price of $19.3. We suspended the program on March 20, 2020 (the “Suspension Date”) in light of uncertainty resulting from the Covid-19 pandemic and the desire to conserve cash resources. On March 11, 2021, the share repurchase program expired with no further repurchases since the Suspension Date.

Recently Issued Accounting Standards (Not Yet Adopted): In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” and in January 2021, the FASB subsequently issued ASU 2021-01,

“Reference Rate Reform (Topic 848): Scope.” ASU 2020-04 and the subsequent modifications are identified as Accounting Standards Codification (“ASC”) 848 (“ASC 848”). ASC 848 simplifies the accounting for modifying contracts (including those in hedging relationships) that refer to LIBOR and other interbank offered rates that are expected to be discontinued due to reference rate reform. The amendments in ASC 848 are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments in ASC 848 must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. We expect application of the amendments to impact accounting for our senior secured revolving credit facility due June 2024. We are currently assessing the effect ASC 848 will have on our financial position, results of operations, and disclosures.

Recently Adopted Accounting Standards: In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entities Own Equity (Subtopic 815-40).” This ASU simplifies accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance effective January 1, 2021 under the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods.

As a result of the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our June 30, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our June 30, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. Lastly, we derecognized deferred income taxes associated with the convertible notes debt discount and adjusted deferred incomes taxes relative to unamortized debt issuance costs associated with our convertible notes due November 2024.

Interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized. Interest accretion of convertible notes discount and net income from continuing operations attributable to Chart Industries, Inc. for the three months ended June 30, 2021 would have been $2.1 and $4.9, respectively, without the adoption of ASU 2020-06. As such, net income from continuing operations attributable to Chart Industries, Inc. per common share (both basic and diluted) for the three months ended June 30, 2021 is $0.04 higher due to the effect of adoption of ASU 2020-06.

Interest accretion of convertible notes discount and net income from continuing operations attributable to Chart Industries, Inc. for the six months ended June 30, 2021 would have been $4.1 and $28.9, respectively, without the adoption of ASU 2020-06. As such, net income from continuing operations attributable to Chart Industries, Inc. per common share for the six months ended June 30, 2021 is $0.09 (basic) and $0.08 (diluted) higher due to the effect of adoption of ASU 2020-06.

As further described in Note 9, “Debt and Credit Arrangements,” on December 31, 2020, we amended the Indenture governing our convertible notes due November 2024 to eliminate share settlement thus leaving us with two settlement options: (1) cash settlement or (2) cash for par and any combination of cash and shares for the excess settlement amount above the $258.8 principal amount of our convertible notes due November 2024. ASU 2020-06 requires usage of the if-converted method to compute diluted earnings per share for our convertible notes due November 2024, however, based on the terms of the amended Indenture and the cessation of interest accretion expense recognition from the transition at adoption, the if-converted method was modified such that interest expense is no longer added to the numerator, and the denominator only includes incremental shares that would be issued upon conversion.

Impacts on Financial Statements

The following table summarizes the cumulative effect of the changes to our condensed consolidated balance sheet as of December 31, 2020 from the adoption of ASU 2020-06:

	Balance at December 31, 2020		Adjustments due to ASU 2020-06 adoption		Balance at January 1, 2021
Liabilities
Accrued income taxes	$	46.5	$	(0.2)	$	46.3
Current convertible notes (1)	220.9		34.0		254.9
Long-term deferred tax liabilities	60.2		(7.6)		52.6
Equity
Additional paid-in-capital	$	780.8	$	(36.9)	$	743.9
Retained earnings	808.4		10.7		819.1

_______________

(1)Current convertible notes is presented net of unamortized discount and debt issuance costs of $34.8 and $3.1, respectively at December 31, 2020. Current convertible notes is presented net of unamortized debt issuance costs of $3.9 at January 1, 2021.

In January 2020, the FASB issued ASU 2020-01, “Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).” This ASU clarifies the interactions between the measurement alternative in Topic 321, the equity method of accounting in Topic 323 and the application of guidance for certain forward contracts and purchased options that upon settlement or exercise would be accounted for under the equity method of accounting in Topic 815. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance effective January 1, 2021. The adoption of this guidance did not have a material impact on our financial position, results of operations or disclosures.

XML

Discontinued Operations

6 Months Ended

Jun. 30, 2021

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued Operations

As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (NASDAQ: CYRX) (the “Cryobiological Divestiture”). Our cryobiological products business asset group met the criteria to be held for sale. Furthermore, we determined that the assets held for sale qualified for discontinued operations. As such, the financial results of the cryobiological products business are reflected in our unaudited condensed consolidated statements of income and comprehensive income as discontinued operations for all prior periods presented.

Summarized Financial Information of Discontinued Operations

The following table represents income from discontinued operations, net of tax:

	Three Months Ended June 30, 2020		Six Months Ended June 30, 2020
Sales	$	20.9	$	40.1
Cost of sales	11.8		21.9
Selling, general and administrative expenses	1.5		2.9
Operating income (1)	7.6		15.3
Income before income taxes from discontinued operations	8.0		15.7
Income tax expense	1.7		3.0
Income from discontinued operations, net of tax	$	6.3	$	12.7

________________

(1)Includes depreciation expense of $0.3 and $0.6 for the three and six months ended June 30, 2020.

The following table represents a summary of cash flows related to discontinued operations:

	Three Months Ended June 30, 2020		Six Months Ended June 30, 2020
Net cash provided by (used in):
Operating activities	$	7.7	$	14.9
Investing activities	—		(0.1)
Net cash provided by discontinued operations	$	7.7	$	14.8

XML

Reportable Segments

6 Months Ended

Jun. 30, 2021

Segment Reporting [Abstract]

Reportable Segments

Reportable Segments

As reported in our Annual Report on Form 10-K for the year ended December 31, 2020, the structure of our internal organization is divided into the following four reportable segments, which are also our operating segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products and Repair, Service & Leasing.

Our Cryo Tank Solutions segment, which has principal operations in the United States, Europe and Asia, supplies bulk, microbulk and mobile equipment used in the storage, distribution, vaporization, and application of industrial gases and other applications. Our Heat Transfer Systems segment, which has principal operations in the United States, Europe and India, supplies mission critical engineered equipment and systems used in the separation, liquefaction, and purification of hydrocarbon and industrial gases that span gas-to-liquid applications. Our Specialty Products segment with locations globally supplies products used in our specialty market applications including hydrogen and helium equipment, HLNG vehicle tanks, carbon capture, utilization, and storage (“CO2 Capture”), food and beverage, space exploration, lasers, cannabis and water treatment, amongst others. Our Repair, Service & Leasing segment, which includes repair and service centers globally, provides installation, service, repair, maintenance, and refurbishment of cryogenic products as well as global equipment leasing solutions.

Corporate includes operating expenses for executive management, accounting, tax, treasury, corporate development, human resources, information technology, investor relations, legal, internal audit and risk management. Corporate support functions are not currently allocated to the segments. All prior period amounts presented in the tables below have been reclassified based on our current reportable segments.

We evaluate performance and allocate resources based on operating income as determined in our condensed consolidated statements of income and comprehensive income.

Segment Financial Information

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	97.8	$	65.2	$	106.8	$	54.6	$	(2.4)	$	—	$	322.0
Depreciation and amortization expense	3.8		9.5		3.4		2.7		—		0.4		19.8
Operating income (loss) (1) (2)	13.4		(0.5)		23.4		5.6		—		(16.3)		25.6

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	105.3	$	97.3	$	48.6	$	40.1	$	(1.8)	$	—	$	289.5
Depreciation and amortization expense	4.6		14.2		1.0		3.0		—		0.5		23.3
Operating income (loss) (1)	15.9		7.2		11.7		7.6		—		(16.6)		25.8

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	201.7	$	134.4	$	184.1	$	96.0	$	(5.7)	$	—	$	610.5
Depreciation and amortization expense	7.7		19.0		6.5		5.3		—		0.8		39.3
Operating income (loss) (1) (2)	29.0		3.4		41.3		13.9		—		(33.1)		54.5

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	203.3	$	210.2	$	101.5	$	80.8	$	(4.4)	$	—	$	591.4
Depreciation and amortization expense	9.0		28.3		2.4		6.3		—		0.9		46.9
Operating income (loss) (1)	27.5		12.7		25.5		12.2		—		(36.3)		41.6

_______________

(1)Restructuring costs for the:

•three months ended June 30, 2021 were $0.3 ($0.3 - Heat Transfer Systems).

•three months ended June 30, 2020 were $5.6 ($1.1 - Cryo Tank Solutions, $2.9 - Heat Transfer Systems, $1.6 - Corporate).

•six months ended June 30, 2021 were $1.0 ($0.3 - Cryo Tank Solutions, $0.7 - Heat Transfer Systems).

•six months ended June 30, 2020 were $10.8 ($2.9 - Cryo Tank Solutions, $5.7 - Heat Transfer Systems, $2.2 - Corporate).

(2)Includes acquisition-related contingent consideration adjustments of $1.2 and $2.0 in our Specialty Products segment for the three and six months ended June 30, 2021, respectively.

Sales by Geography

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	34.4	$	42.2	$	43.3	$	29.5	$	(1.0)	$	148.4
Europe, Middle East, Africa and India	32.7		8.8		53.3		9.1		(0.7)		103.2
Asia-Pacific	29.1		14.0		9.6		15.9		(0.7)		67.9
Rest of the World	1.6		0.2		0.6		0.1		—		2.5
Total	$	97.8	$	65.2	$	106.8	$	54.6	$	(2.4)	$	322.0

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	43.7	$	71.1	$	26.1	$	28.3	$	(0.9)	$	168.3
Europe, Middle East, Africa and India	32.2		10.2		19.9		9.8		(0.5)		71.6
Asia-Pacific	28.4		15.8		2.5		1.9		(0.4)		48.2
Rest of the World	1.0		0.2		0.1		0.1		—		1.4
Total	$	105.3	$	97.3	$	48.6	$	40.1	$	(1.8)	$	289.5

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	75.5	$	88.5	$	69.4	$	58.5	$	(2.7)	$	289.2
Europe, Middle East, Africa and India	70.4		16.6		98.9		19.6		(1.7)		203.8
Asia-Pacific	53.3		28.8		15.2		17.7		(1.3)		113.7
Rest of the World	2.5		0.5		0.6		0.2		—		3.8
Total	$	201.7	$	134.4	$	184.1	$	96.0	$	(5.7)	$	610.5

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	84.3	$	153.3	$	51.0	$	60.4	$	(2.2)	$	346.8
Europe, Middle East, Africa and India	66.5		19.7		45.5		16.5		(1.2)		147.0
Asia-Pacific	48.5		36.7		4.7		3.6		(0.9)		92.6
Rest of the World	4.0		0.5		0.3		0.3		(0.1)		5.0
Total	$	203.3	$	210.2	$	101.5	$	80.8	$	(4.4)	$	591.4

Total Assets

Corporate assets mainly include cash and cash equivalents and long-term deferred income taxes as well as certain corporate-specific property, plant and equipment, net and certain investments. Our allocation methodology for property, plant and equipment, net of the reportable segments differs from our allocation method of depreciation expense of a reportable segment and therefore, depreciation expense does not entirely align with the related depreciable assets of the reportable

segments. Furthermore, since finite-lived intangible assets are excluded from total assets of reportable segments while amortization expense is allocated to each of our reportable segments, amortization expense by segment inherently does not align with the related amortizable intangible assets of the reportable segments.

	June 30, 2021		December 31, 2020
Cryo Tank Solutions	$	400.4	$	399.2
Heat Transfer Systems	243.0		247.2
Specialty Products	265.6		178.3
Repair, Service & Leasing	175.2		142.6
Total assets of reportable segments	1,084.2		967.3
Goodwill (1)	896.1		865.9
Identifiable intangible assets, net (1)	491.0		493.1
Corporate	358.7		244.2
Total	$	2,830.0	$	2,570.5

_______________

(1)See Note 8, “Goodwill and Intangible Assets,” for further information related to goodwill and identifiable intangible assets, net.

XML

Revenue

6 Months Ended

Jun. 30, 2021

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

Disaggregation of Revenue

The following tables represent a disaggregation of revenue by timing of revenue along with the reportable segment for each category:

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	89.8	$	5.2	$	73.4	$	37.8	$	(1.5)	$	204.7
Over time	8.0		60.0		33.4		16.8		(0.9)		117.3
Total	$	97.8	$	65.2	$	106.8	$	54.6	$	(2.4)	$	322.0

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	94.4	$	8.1	$	32.6	$	25.9	$	(0.7)	$	160.3
Over time	10.9		89.2		16.0		14.2		(1.1)		129.2
Total	$	105.3	$	97.3	$	48.6	$	40.1	$	(1.8)	$	289.5

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	188.5	$	10.8	$	135.3	$	64.5	$	(4.4)	$	394.7
Over time	13.2		123.6		48.8		31.5		(1.3)		215.8
Total	$	201.7	$	134.4	$	184.1	$	96.0	$	(5.7)	$	610.5

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	184.2	$	15.2	$	71.4	$	53.9	$	(2.2)	$	322.5
Over time	19.1		195.0		30.1		26.9		(2.2)		268.9
Total	$	203.3	$	210.2	$	101.5	$	80.8	$	(4.4)	$	591.4

Refer to Note 3, “Reportable Segments,” for a table of revenue by reportable segment disaggregated by geography.

Contract Balances

The following table represents changes in our contract assets and contract liabilities balances:

	June 30, 2021		December 31, 2020		Year-to-date Change ($)		Year-to-date Change (%)
Contract assets
Accounts receivable, net of allowances	$	220.0	$	200.8	$	19.2	9.6	%
Unbilled contract revenue	68.2		79.4		(11.2)		(14.1)	%
Contract liabilities
Customer advances and billings in excess of contract revenue	$	126.1	$	118.9	$	7.2	6.1	%
Long-term deferred revenue	1.0		1.9		(0.9)		(47.4)	%

Revenue recognized for the three months ended June 30, 2021 and 2020, that was included in the contract liabilities balance at the beginning of each year was $25.1 and $34.8, respectively. Revenue recognized for the six months ended June 30, 2021 and 2020, that was included in the contract liabilities balance at the beginning of each year was $77.6 and $51.9, respectively. The amount of revenue recognized during the three and six months ended June 30, 2021 from performance obligations satisfied or partially satisfied in previous periods as a result of changes in the estimates of variable consideration related to long-term contracts, was not significant.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price of firm signed purchase orders or other written contractual commitments from customers for which work has not been performed, or is partially completed, and excludes unexercised contract options and potential orders. As of June 30, 2021, the estimated revenue expected to be recognized in the future related to remaining performance obligations was $1,083.9. We expect to recognize revenue on approximately 79.6% of the remaining performance obligations over the next 12 months and with the remaining over the next few years thereafter.

XML

Investments

6 Months Ended

Jun. 30, 2021

Investments, Debt and Equity Securities [Abstract]

Investments

Investments

Investments in equity securities

We measure certain of our investments in equity securities at fair value on a recurring basis. Furthermore, we categorize these investments in equity securities according to the fair value hierarchy as defined in Note 2, “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2020. Mark-to-market fair value adjustments in these investments in equity securities are classified as unrealized loss (gain) on investments in equity securities in our condensed consolidated statements of income and comprehensive income.

For certain other investments in equity securities that are not measured at fair value on a recurring basis, we measure such investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

For additional information, see Note 6, “Investments” in our Annual report on form 10-K for the year ended December 31, 2020.

The following table summarizes the components of our investments in equity securities:

	Investment in Equity Securities, Level 1 (1)		Investment in Equity Securities, Level 2 (1)		Subtotal		Investments in Equity Securities, All Others (3)		Investments in Equity Securities, Total
Balance at December 31, 2020	$	53.8	$	4.1	$	57.9	$	15.7	$	73.6
New investments (2)	—		—		—		45.0		45.0
(Decrease) increase in fair value of investments in equity securities	(19.8)		10.6		(9.2)		—		(9.2)
Foreign currency translation (losses) gains	(1.6)		—		(1.6)		0.4		(1.2)
Balance at June 30, 2021	$	32.4	$	14.7	$	47.1	$	61.1	$	108.2

_______________

(1)Our investment in McPhy (Euronext Paris: MCPHY - ISIN; FR001742329) represents a Level 1 investment while our investment in Stabilis Energy, Inc. represents a Level 2 investment. For the three and six months ended June 30, 2021, we recognized an unrealized loss of $17.2 and $19.8, respectively, in our Level 1 investment and an unrealized gain of $4.7 and $10.6, respectively, in our Level 2 investment.

(2)During the second quarter of 2021, we completed an investment in Earthly Labs Inc. (“Earthly Labs”) in the amount of $5.0 for approximately 15% of its equity. Earthly Labs is the leading provider of small-scale carbon capture systems offering an affordable, small footprint technology platform called “CiCi ®” to capture, recycle, reuse, track and sell CO2. Earthly Labs proprietary approach includes hardware, software and services to address half of all existing carbon dioxide emissions from industrial sources while converting molecules to value.

During the first quarter of 2021, we completed an investment in Transform Materials LLC (“Transform Materials”) in the amount of $25.0 for approximately 5% of its equity. Transform Materials is a sustainable chemical technology company that uses microwave plasma to convert natural gas into acetylene and hydrogen. Its highly selective, cost-effective, net-carbon-negative process converts the methane in natural gas into high-value products suitable for direct use or downstream reactions.

Also, during the first quarter of 2021, we completed an investment in Svante Inc. (“Svante”) in the amount of $15.0 for under 10% of its capital stock on a fully diluted basis. Svante offers companies in emissions-intensive industries a commercially viable way to capture large-scale CO2 emissions from existing infrastructure, either for safe storage or to be recycled for further industrial use in a closed loop.

(3)Our investments in HTEC Hydrogen Technology & Energy Corporation, Svante, Transform Materials and Earthly Labs are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.

Equity method accounting investments

Our equity investments accounted for under the equity method of accounting include a 50% ownership interest in a joint venture with Hudson Products de Mexico S.A. de CV which totaled $2.9 and $2.8 at June 30, 2021 and December 31, 2020, respectively. This investment is operated and managed by our joint venture partner and as such, we do not have control over the joint venture and therefore it is not consolidated. Additionally, we have a 25% ownership interest in Liberty LNG, which was valued at $2.3 and $2.1 at June 30, 2021 and December 31, 2020, respectively.

During the second quarter of 2021, on May 19, 2021, we completed an investment in Cryomotive GmbH (“Cryomotive”) in the amount of 6.5 million euros (equivalent to $7.9) for a 24.9% ownership interest. Our equity method investment in Cryomotive was $7.7 at June 30, 2021. Cryomotive is a leading green-tech mobility startup in Germany developing a disruptive clean hydrogen storage and refueling technology platform focused on compressed cold hydrogen and cryogenic high-pressure storage. Cryomotive’s proprietary CcH2 CRYOGAS technology aims to decarbonize long-haul commercial vehicles while keeping the range and fueling times similar to diesel powered vehicles.

Our equity in earnings from these equity method accounting investments were not material for the periods presented.

XML

Leases

6 Months Ended

Jun. 30, 2021

Leases [Abstract]

Leases

Leases

As of June 30, 2021 and December 31, 2020, operating right-of-use (“ROU”) assets and lease liabilities were $27.5 and $27.2 ($5.0 of which was current) and $29.0 and $28.7 ($5.1 of which was current), respectively. The weighted-average remaining term for lease contracts was 5.2 years at June 30, 2021, with maturity dates ranging from July 2021 to February 2029. The weighted-average discount rate was 2.3% at June 30, 2021. ROU assets are classified as property, plant and equipment, net in the condensed consolidated balance sheets.

We incurred $3.0 of rental expense under operating leases for both the three months ended June 30, 2021 and 2020, and $6.0 and $5.9 for the six months ended June 30, 2021 and 2020, respectively. Certain operating leases contain rent escalation clauses and lease concessions that require additional rental payments in the later years of the term. Rent expense for these types of leases is recognized on a straight-line basis over the minimum lease term. Adjustments for straight-line rental expense for the respective periods was not material and as such, the majority of expense recognized was reflected in cash provided by operating activities for the respective periods. This expense consisted primarily of payments for base rent on building and equipment leases. Payments related to short-term lease costs and taxes and variable service charges on leased properties were immaterial. In addition, we have the right, but no obligation, to renew certain leases for various renewal terms.

The following table summarizes future minimum lease payments for non-cancelable operating leases as of June 30, 2021:

2021	$	3.8
2022	6.4
2023	5.8
2024	5.3
2025	4.5
Thereafter (1)	3.6
Total future minimum lease payments	$	29.4

_______________

(1)     As of June 30, 2021, future minimum lease payments for non-cancelable operating leases for the period subsequent to 2025 relate to eight leased facilities.

XML

Inventories

6 Months Ended

Jun. 30, 2021

Inventory Disclosure [Abstract]

Inventories

Inventories

The following table summarizes the components of inventory:

	June 30, 2021		December 31, 2020
Raw materials and supplies	$	161.2	$	124.7
Work in process	68.1		57.8
Finished goods	80.8		65.9
Total inventories, net	$	310.1	$	248.4

The allowance for excess and obsolete inventory balance at June 30, 2021 and December 31, 2020 was $9.9 and $9.7, respectively. For discussion regarding the change in inventories, net, refer to Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Quarterly Report on Form 10-Q.

XML

Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Goodwill

The following table represents the changes in goodwill by segment:

	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Consolidated
Balance at December 31, 2020	$	93.2	$	435.2	$	172.4	$	165.1	$	865.9
Goodwill acquired during the period (1)	—		—		34.5		—		34.5
Foreign currency translation adjustments and other	(3.4)		(1.9)		0.1		—		(5.2)
Purchase price adjustments (2)	—		—		0.9		—		0.9
Balance at June 30, 2021	$	89.8	$	433.3	$	207.9	$	165.1	$	896.1

_______________

(1)For further information regarding goodwill acquired and the purchase price adjustments during the period refer to Note 11, “Business Combinations.”

(2)During the first six months of 2021, we recorded purchase price adjustments that decreased goodwill by $0.9 in Specialty Products related to the Blue-In-Green, LLC acquisition.

Amounts included in accumulated goodwill impairment loss at both June 30, 2021 and December 31, 2020 were $129.0 ($23.5 - Cryo Tank Solutions, $49.3 - Heat Transfer Systems, $35.8 - Specialty Products, $20.4 - Repair, Service & Leasing).

Intangible Assets

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill) (1):

		June 30, 2021				December 31, 2020
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Customer relationships	13 years	$	311.6	$	(71.2)	$	302.5	$	(59.9)
Unpatented technology	12 years	115.5		(26.9)		110.4		(22.3)
Patents and other	6 years	5.0		(0.2)		8.4		(1.8)
Trademarks and trade names	13 years	3.5		(1.7)		3.6		(1.4)
Land use rights	50 years	11.2		(1.5)		11.1		(1.4)
Total finite-lived intangible assets	14 years	446.8		(101.5)		436.0		(86.8)
Indefinite-lived intangible assets:
Trademarks and trade names		145.7		—		143.9		—
Total intangible assets		$	592.5	$	(101.5)	$	579.9	$	(86.8)

_______________

(1)Amounts include the impact of foreign currency translation. Fully amortized or impaired amounts are written off.

Amortization expense for intangible assets subject to amortization was $9.6 and $14.0 for the three months ended June 30, 2021 and 2020, respectively, and $18.4 and $28.0 for the six months ended June 30, 2021 and 2020, respectively. We estimate amortization expense to be recognized during the next five years as follows:

For the Year Ending December 31,
2021	$	37.2
2022	36.1
2023	35.6
2024	35.2
2025	34.3

Government Grants

We received certain government grants related to land use rights for capacity expansion in China (“China Government Grants”). China Government Grants are generally recorded in other current liabilities and other long-term liabilities in the unaudited condensed consolidated balance sheets and generally recognized into income over the useful life of the associated assets (10 to 50 years).

China Government Grants are presented in our unaudited condensed consolidated balance sheets as follows:

	June 30, 2021		December 31, 2020
Current	$	0.5	$	0.5
Long-term	7.3		7.3
Total China Government Grants	$	7.8	$	7.8

XML

Debt and Credit Arrangements

6 Months Ended

Jun. 30, 2021

Debt Disclosure [Abstract]

Debt and Credit Arrangements

Debt and Credit Arrangements

Summary of Outstanding Borrowings

The following table represents the components of our borrowings:

	June 30, 2021		December 31, 2020
Senior secured revolving credit facility and term loan:
Term loan due June 2024 (1)	$	103.1	$	103.1
Senior secured revolving credit facility due June 2024 (2) (3)	351.8		123.5
Unamortized debt issuance costs	(4.3)		(5.0)
Senior secured revolving credit facility and term loan, net of debt issuance costs	450.6		221.6
Convertible notes due November 2024:
Principal amount	258.8		258.8
Unamortized discount (4)	—		(34.8)
Unamortized debt issuance costs	(3.3)		(3.1)
Convertible notes due November 2024, net of unamortized discount and debt issuance costs	255.5		220.9
Total debt, net of unamortized discount and debt issuance costs	706.1		442.5
Less: current maturities	255.5		220.9
Long-term debt	$	450.6	$	221.6

_______________

(1)As of June 30, 2021, there were $103.1 in borrowings outstanding under the term loan due June 2024, which is due at maturity, bearing an interest rate of 2.0% (2.5% as of December 31, 2020).

(2)The senior secured revolving credit facility due 2024 includes $100.0 sub limit for letters of credit, a $250.0 sub limit for discretionary letters of credit and $50.0 sub limit for swingline loans. As of June 30, 2021, there were $351.8 in borrowings outstanding under the senior secured revolving credit facility due 2024 bearing a weighted-average interest rate of 1.9% (2.1% as of December 31, 2020) and $45.2 in letters of credit and bank guarantees outstanding supported by the senior secured revolving credit facility due 2024. As of June 30, 2021, the senior secured revolving credit facility due 2024 had availability of $153.0.

(3)A portion of borrowings outstanding under our senior secured revolving credit facility due 2024 are denominated in euros (“EUR Revolver Borrowings”). EUR Revolver Borrowings outstanding were 86.5 million euros (equivalent to $102.8) and 74.5 million euros (equivalent to $91.4) at June 30, 2021 and December 31, 2020, respectively. During the three and six months ended June 30, 2021, we recognized an unrealized foreign currency gain of $8.9 and $5.0, respectively, relative to the translation of the EUR Revolver Borrowings outstanding during the reporting period. This unrealized foreign currency gain is classified as foreign currency loss and other in the condensed consolidated statements of income for the three and six months ended June 30, 2021.

(4)We derecognized the debt discount associated with the convertible notes due November 2024 upon adoption of ASU 2020-06 on January 1, 2021.

Senior Secured Revolving Credit Facility and Term Loan

On June 14, 2019, we entered into the Fourth Amended and Restated Credit Agreement, which includes a senior secured revolving credit facility (the “SSRCF”) and a term loan (together, the “2024 Credit Facilities”). The 2024 Credit Facilities mature on June 14, 2024.

•The SSRCF has a borrowing capacity of $550.0.

•The principal amount of the term loan is $450.0.

•The 2024 Credit Facilities bear interest at a base rate margin determined on a leveraged-based scale which ranges from 25 to 150 basis points for alternative base rate loans and 125 to 250 basis points for LIBOR loans.

•Interest and fees are payable on a quarterly basis (or if earlier, at the end of each interest period for LIBOR loans).

Significant financial covenants for the 2024 Credit Facilities include financial maintenance covenants that, as of the last day of any fiscal quarter ending on and after June 30, 2019, (i) require the ratio of the amount of Chart and its subsidiaries’ consolidated total net indebtedness to consolidated EBITDA to be less than specified maximum ratio levels and (ii) require the ratio of the amount of Chart and its subsidiaries’ consolidated EBITDA to consolidated cash interest expense to be greater than a specified minimum ratio level. The 2024 Credit Facilities include a number of other customary covenants including, but not limited to, restrictions on our ability to incur additional indebtedness, create liens or other encumbrances, sell assets, enter into sale and lease-back transactions, make certain payments, investments, loans, advances or guarantees, make acquisitions and engage in mergers or consolidations and pay dividends or distributions. At June 30, 2021, we were in compliance with all covenants.

The 2024 Credit Facilities also contain customary events of default. If such an event of default occurs, the lenders thereunder would be entitled to take various actions, including the acceleration of amounts due and all actions permitted to be taken by a secured creditor. The 2024 Credit Facilities are guaranteed by Chart and substantially all of its U.S. subsidiaries and secured by substantially all of the assets of Chart and our U.S. subsidiaries and 65% of the capital stock of our material non-U.S. subsidiaries (as defined by the Fourth Amended and Restated Credit Agreement) that are owned by U.S. subsidiaries.

On September 28, 2020 and April 20, 2020, we amended our 2024 Credit Facilities. The amendments, among other things, (i) reduce the LIBO Screen Rate (as defined in the Credit Agreement) floor by half, effectively reducing all interest payable by Chart (ii) provide Chart with further flexibility to complete divestitures at its discretion by changing the “catch-all” permitted divestiture basket from a small annual cap to a more substantial life-of the-facility cap, (iii) adjust the pricing grid in order to accommodate potentially higher leverage ratios, (iv) adjust factoring related definitions and other related provisions to provide Chart with greater flexibility to enter into such arrangements in the future, (v) incorporate a “cash hoarding” prevention covenant and (vi) incorporate various amendments to reflect interest rate floor and other changes to the Loan Syndications and Trading Association and Loan Market Association market standards for credit agreements. The terms and conditions under the 2024 Credit Facilities are otherwise substantially the same as those prior to the amendments. We recorded $1.9 in deferred debt issuance costs related to these amendments which are being amortized over the remaining term of the 2024 Credit Facilities.

We recorded $6.1 in deferred debt issuance costs in conjunction with the 2024 Credit Facilities, which is included in long-term debt in the unaudited condensed consolidated balance sheet at June 30, 2021, associated with the term loan, which is being amortized over its five-year term beginning in July 2019.

We paid $11.9 in deferred debt issuance costs related to the SSRCF. Deferred debt issuance costs are presented in other assets in the unaudited condensed consolidated balance sheets and are being amortized over the term of the SSRCF. At June 30, 2021, unamortized debt issuance costs associated with the SSRCF were $6.7.

The following table summarizes interest expense and financing costs amortization related to the 2024 Credit Facilities:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Interest expense, term loan due June 2024	$	0.5	$	4.0	$	1.1	$	8.2
Interest expense, senior secured revolving credit facility due June 2024	1.3		0.6		2.0		1.2
Interest expense, senior secured revolving credit facility and term loan due June 2024	$	1.8	$	4.6	$	3.1	$	9.4
Financing costs amortization, senior secured revolving credit facility and term loan due June 2024	$	0.8	$	0.9	$	1.8	$	1.7

2024 Convertible Notes

On November 6, 2017, we issued 1.00% Convertible Senior Subordinated Notes due November 2024 (the “2024 Notes”) in the aggregate principal amount of $258.8, pursuant to an Indenture, dated as of such date (the “Indenture”). On December 31, 2020, we entered into the First Supplemental Indenture (the “Supplemental Indenture”) to the Indenture, between Chart and Wells Fargo Bank, National Association, as trustee, governing the 2024 Notes. Pursuant to the Supplemental Indenture, Chart irrevocably elected (i) to eliminate Chart’s option to elect Physical Settlement (as defined in the Indenture) on any conversion of 2024 Notes that occurs on or after the date of the Supplemental Indenture and (ii) that, with respect to any Combination Settlement (as defined in the Indenture) for a conversion of 2024 Notes, the Specified Dollar Amount (as defined in the Indenture) that will be settled in cash per $1,000 principal amount of the Notes shall be no lower than $1,000. The 2024 Notes bear interest at an annual rate of 1.00%, payable on May 15 and November 15 of each year, beginning on May 15, 2018, and will mature on November 15, 2024 unless earlier converted or repurchased.

The 2024 Notes are senior subordinated unsecured obligations of the Company and are not guaranteed by any of our subsidiaries. The 2024 Notes are senior in right of payment to our future subordinated debt, equal in right of payment with the Company’s future senior subordinated debt and are subordinated in right of payment to our existing and future senior indebtedness, including indebtedness under our existing credit agreement.

Prior to December 31, 2020, a conversion of the 2024 Notes could have been settled in cash, shares of our common stock or a combination of cash and shares of our common stock, at our election (subject to, and in accordance with, the settlement provisions of the Indenture). After December 31, 2020, a conversion of the 2024 Notes may be settled in either (1) cash or (2) cash for the principal amount of the 2024 Notes and any combination of cash and shares for the excess settlement amount above the principal amount of the 2024 Notes, at our election (subject to, and in accordance with, the settlement provisions of the Indenture and Supplemental Indenture). The initial conversion rate for the 2024 Notes is 17.0285 shares of common stock (subject to adjustment as provided for in the Indenture) per $1,000 principal amount of the 2024 Notes, which is equal to an initial conversion price of approximately $58.725 per share, representing a conversion premium of approximately 35% above the closing price of our common stock of $43.50 per share on October 31, 2017. In addition, following certain corporate events that occur prior to the maturity date as described in the Indenture, we will pay a make-whole premium by increasing the conversion rate for a holder who elects to convert its 2024 Notes in connection with such a corporate event in certain circumstances. For purposes of calculating earnings per share, if the average market price of our common stock exceeds the applicable conversion price during the periods reported, shares contingently issuable under the 2024 Notes will have a dilutive effect with respect to our common stock. Since our closing common stock price of $146.32 at the end of the period exceeded the conversion price of $58.725, the if-converted value exceeded the principal amount of the 2024 Notes by approximately $386.0 at June 30, 2021. As described below, we entered into convertible note hedge transactions, which are expected to reduce the potential dilution with respect to our common stock upon conversion of the 2024 Notes.

Holders of the 2024 Notes may convert their 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding August 15, 2024 only under the following circumstances: (1) during any fiscal quarter commencing after December 31, 2017 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Notes for each trading day of such measurement period was less than 97% of the product of the last reported sale price of our common stock and the applicable conversion rate for the 2024 Notes on each such trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after August 15, 2024 until the close of business on the second scheduled trading day immediately preceding November 15, 2024, holders may convert their 2024 Notes at the option of the holder regardless of the foregoing circumstances.

As of July 1, 2021, the 2024 Notes continue to be convertible at the option of the shareholders. This conversion right, which will remain available until September 30, 2021, was triggered since the closing price of our common stock was greater than or equal to $76.3425 (130% of the conversion price of the 2024 Notes) for at least 20 trading days during the last 30 trading days ending on June 30, 2021. Since the holders of the 2024 Notes could potentially convert their 2024 Notes at their option during the three month period subsequent to June 30, 2021, the $258.8 principal amount of the 2024 Notes was classified as a current liability in the consolidated balance sheet at June 30, 2021. As of December 31, 2020, the 2024 Notes were convertible at the option of the holders, and the liability component of the 2024 Notes was classified as a current liability. We will reassess the convertibility of the 2024 Notes and the related balance sheet classification on a quarterly basis. There have been no conversions as of the date of this filing.

Prior to the adoption of ASU 2020-06, we allocated the gross proceeds of the 2024 Notes between the liability and equity components of the 2024 Notes. The initial liability component of $200.1, which was recorded as long-term debt, represented the fair value of similar debt instruments that have no conversion rights. The initial equity component of $58.7, which was recorded as additional paid-in capital, represented the debt discount and was calculated as the difference between the fair value of the liability component and gross proceeds of the 2024 Notes. The liability component was recognized at the present value of its associated cash flows using a 4.8% straight-debt rate and was being accreted to interest expense over the term of the 2024 Notes.

After the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our June 30, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our June 30, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06 and transition, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Refer to Note 1, “Basis of Preparation” for further discussion.

Prior to the adoption of ASU 2020-06, we recorded $5.3 in deferred debt issuance costs associated with the 2024 Notes, which was being amortized over the term of the 2024 Notes using the effective interest method. We also recorded $1.5 in equity issuance costs, which was recorded as a reduction to additional paid-in capital. After the adoption of ASU 2020-06, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. We amortize the adjusted unamortized debt issuance costs balance over the term of the 2024 Notes using the effective interest method. Refer to Note 1, “Basis of Preparation” for further discussion. Furthermore, interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized.

The following table summarizes interest accretion of the 2024 Notes discount, 1.0% contractual interest coupon and financing costs amortization associated with the 2024 Notes:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
2024 Notes, interest accretion of convertible notes discount	$	—	$	2.0	$	—	$	3.9
2024 Notes, 1.0% contractual interest coupon	0.7		0.7		1.3		1.3
2024 Notes, total interest expense	$	0.7	$	2.7	$	1.3	$	5.2
2024 Notes, financing costs amortization	$	0.3	$	0.2	$	0.5	$	0.4

Convertible Note Hedge and Warrant Transactions Associated with the 2024 Notes

In connection with the pricing of the 2024 Notes, we entered into convertible note hedge transactions (the “Note Hedge Transactions”) with certain parties, including the initial purchasers of the 2024 Notes (the “Option Counterparties”). The Note Hedge Transactions are expected generally to reduce the potential dilution upon any future conversion of the 2024 Notes. Payments for the Note Hedge Transactions totaled approximately $59.5 and were recorded as a reduction to additional paid-in capital in the December 31, 2017 consolidated balance sheet.

We also entered into separate, privately negotiated warrant transactions (the “Warrant Transactions”) with the Option Counterparties to acquire up to 4.41 shares of our common stock. Proceeds received from the issuance of the Warrant Transactions totaled approximately $46.0 and were recorded as an addition to additional paid-in capital in the December 31, 2017 consolidated balance sheet. The strike price of the Warrant Transactions will initially be $71.775 per share (subject to adjustment), which is approximately 65% above the last reported sale price of our common stock on October 31, 2017. The Warrant Transactions could have a dilutive effect to our stockholders to the extent that the market price per share of our common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.

The Note Hedge Transactions and Warrant Transactions effectively increased the conversion price of the 2024 Notes. The net cost of the Note Hedge Transactions and Warrant Transactions was approximately $13.5.

Foreign Facilities

In various markets where we do business, we have local credit facilities to meet local working capital demands, fund letters of credit and bank guarantees, and support other short-term cash requirements. The facilities generally have variable interest rates and are denominated in local currency but may, in some cases, facilitate borrowings in multiple currencies. We are permitted to borrow up to USD equivalent $77.2 under certain of our foreign facilities. As of June 30, 2021 and December 31, 2020 there were none outstanding in USD equivalent in borrowings outstanding under these facilities.

Certain of our foreign facilities allow us to request bank guarantees and letters of credit. None of these facilities allow revolving credit borrowings. We have foreign letters of credit and bank guarantees that totaled USD equivalent $51.4 and $47.7 as of June 30, 2021 and December 31, 2020, respectively.

Letters of Credit

Chart Energy & Chemicals, Inc., a wholly-owned subsidiary of the Company, had $1.0 in deposits in a bank outside of the SSRCF to secure letters of credit. The deposits are treated as restricted cash and restricted cash equivalents in the unaudited condensed consolidated balance sheets $1.0 in other current assets at both June 30, 2021 and December 31, 2020.

Fair Value Disclosures

The fair value of the 2024 Notes was approximately 255% and 210% of their par value as of June 30, 2021 and December 31, 2020, respectively. The 2024 Notes are actively quoted instruments and, accordingly, the fair value of the 2024 Notes was determined using Level 1 inputs.

XML

Product Warranties

6 Months Ended

Jun. 30, 2021

Product Warranties Disclosures [Abstract]

Product Warranties

Product Warranties

We provide product warranties with varying terms and durations for the majority of our products. We estimate our warranty reserve by considering historical and projected warranty claims, historical and projected cost-per-claim, and knowledge of specific product issues that are outside our typical experience. We record warranty expense in cost of sales in the unaudited condensed consolidated statements of income and comprehensive income. Product warranty claims not expected to occur within one year are included as part of other long-term liabilities in the unaudited condensed consolidated balance sheets.

The following table represents changes in our consolidated warranty reserve:

Balance at December 31, 2020	$	11.9
Issued – warranty expense	(2.7)
Warranty usage	2.4
Balance at June 30, 2021	$	11.6

XML

Business Combinations

6 Months Ended

Jun. 30, 2021

Business Combination and Asset Acquisition [Abstract]

Business Combinations

Business Combinations

Cryo Technologies Acquisition

On February 16, 2021, we acquired 100% of the equity interests of Cryogenic Gas Technologies, Inc. (“Cryo Technologies”) for approximately $55.0 in cash (subject to certain customary adjustments), net of $0.6 cash acquired. Cryo Technologies is a global leader in custom engineered process systems to separate, purify, refrigerate, liquefy and distribute high value industrial gases such as hydrogen, helium, argon and hydrocarbons with design capabilities for cold boxes for hydrogen and helium use. The distribution systems Cryo Technologies supplies are located within the helium and hydrogen liquefaction facilities and are inclusive of trailer loading systems, which facilitates the first step in product distribution. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $20.5 and $34.5, respectively. The purchase price allocation reported at March 31, 2021 was preliminary and was based on provisional fair values. During the second quarter of 2021 we received and analyzed new information about certain intangible assets and subsequently increased their fair value by $17.6. Net assets includes $19.5 in intangible assets, which consists of customer relationships, unpatented technology, trademarks and trade names, backlog and non-competition agreements. The acquisition consideration allocation is preliminary and shall be further revised as we finalize third-party valuations and other analyses to include identifiable intangible assets during the remainder of the measurement period, which shall not exceed twelve months from the closing of the acquisition.

Sustainable Energy Solutions, Inc. Acquisition

On December 23, 2020, we completed the acquisition of Sustainable Energy Solutions, Inc. (“SES”). SES’s Cryogenic Carbon Capture™ (CCC) technology eliminates most emissions from fossil fuels while enabling better use of intermittent renewables through grid-scale energy storage. The stock purchase was completed for a closing purchase price of $20.0 in cash at closing, subject to a post-closing working capital adjustment, plus a potential earn-out not to exceed $25.0. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $13.4 and $24.0, respectively. Net assets includes $17.3 in intangible assets, which consists of unpatented technology, trade names and non-compete contracts.

BlueInGreen, LLC Acquisition

On November 3, 2020, we completed the acquisition of BlueInGreen, LLC (“BIG”), a leading dissolved-gas expert providing custom-engineered solutions for water treatment and industrial process applications that delivers tangible economic, social and environmental value. The stock purchase was completed for a purchase price of $20.0 in cash at closing (subject to customary adjustments), plus a potential earn-out not to exceed $6.0. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $7.9 and $15.7, respectively. The purchase price allocation reported at December 31, 2020 was preliminary and was based on provisional fair values. During the first six months of 2021, we received and analyzed new information about certain intangible assets and subsequently decreased their estimated fair value by $0.9. Net assets includes $6.2 in intangible assets, which consists of non-compete contracts, unpatented technology, trademarks and trade names, certifications and licenses and customer relationships.

Alabama Trailers Acquisition

On October 13, 2020, we completed the acquisition of the Theodore, Alabama cryogenic trailer and hydrogen trailer (transport) assets of Worthington Industries, Inc. (NYSE: WOR) for $10.0 in cash (“Alabama Trailers”). Worthington Industries, Inc. exited the hydrogen trailer business and sold the business to Chart at a discount. As a result of the acquisition, we recorded a bargain purchase gain of $5.0. Alabama Trailers designs, manufactures and sells cryogenic trailers and hydrogen trailers used in industrial gas and energy applications.

The purchase price allocations of Cryo Technologies, SES, BIG and Alabama Trailers are preliminary and are based on provisional fair values and subject to revision as we finalize third-party valuations and other analyses. Final determination of the fair values may result in further adjustments to the value of net assets acquired.

Contingent Consideration

The fair value of contingent consideration was $16.9 for SES and $3.2 for BIG at the date of acquisitions and was valued according to a discounted cash flow approach, which included assumptions regarding the probability of achieving certain targets and a discount rate applied to the potential payments. Potential payments are measured between the period commencing July 1, 2021 and ending on December 31, 2028 based on the attainment of certain earnings targets. The potential payments related to both SES and BIG contingent consideration on a combined basis is between $0.0 and $31.0. For the three and six months ended June 30, 2021, the estimated fair value of contingent consideration related to SES increased by $1.3 and $2.0, respectively. For the three months ended June 30, 2021, the estimated fair value of contingent consideration related to BIG decreased by $0.1. For the six months ended June 30, 2021 the estimated fair value of contingent consideration related to BIG was unchanged.

Valuations are performed using Level 3 inputs as defined in Note 2, “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2020 and are evaluated on a quarterly basis based on forecasted sales and earnings targets. Contingent consideration liabilities are classified as other current liabilities and other long-term liabilities in the condensed consolidated balance sheets. Changes in fair value of contingent consideration, including accretion, are recorded as selling, general and administrative expenses in the condensed consolidated statements of income and comprehensive income.

The following table represents the changes to our contingent consideration liabilities:

	SES		BIG		Total
Balance at December 31, 2020	$	16.9	$	3.2	$	20.1
Increase in fair value of contingent consideration liabilities	2.0		—		2.0
Balance at June 30, 2021	$	18.9	$	3.2	$	22.1

XML

Accumulated Other Comprehensive (Loss) Income

6 Months Ended

Jun. 30, 2021

Equity [Abstract]

Accumulated Other Comprehensive (Loss) Income

Accumulated Other Comprehensive (Loss) Income

The components of accumulated other comprehensive (loss) income are as follows:

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at March 31, 2021	$	(5.8)	$	(11.0)	$	(16.8)
Other comprehensive income	7.3		—		7.3
Amounts reclassified from accumulated other comprehensive loss, net of income taxes	—		0.3		0.3
Net current-period other comprehensive income, net of taxes	7.3		0.3		7.6
Balance at June 30, 2021	$	1.5	$	(10.7)	$	(9.2)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at March 31, 2020	$	(35.2)	$	(10.6)	$	(45.8)
Other comprehensive income	7.5		—		7.5
Amounts reclassified from accumulated other comprehensive loss, net of income taxes	—		0.4		0.4
Net current-period other comprehensive income, net of taxes	7.5		0.4		7.9
Balance at June 30, 2020	$	(27.7)	$	(10.2)	$	(37.9)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive income (loss)
Balance at December 31, 2020	$	13.8	$	(11.4)	$	2.4
Other comprehensive loss	(12.3)		—		(12.3)
Amounts reclassified from accumulated other comprehensive income (loss), net of taxes	—		0.7		0.7
Net current-period other comprehensive (loss) income, net of taxes	(12.3)		0.7		(11.6)
Balance at June 30, 2021	$	1.5	$	(10.7)	$	(9.2)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at December 31, 2019	$	(25.0)	$	(10.9)	$	(35.9)
Other comprehensive loss	(2.7)		—		(2.7)
Amounts reclassified from accumulated other comprehensive loss, net of taxes	—		0.7		0.7
Net current-period other comprehensive (loss) income, net of taxes	(2.7)		0.7		(2.0)
Balance at June 30, 2020	$	(27.7)	$	(10.2)	$	(37.9)

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2021

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

The following table represents calculations of net earnings per share of common stock:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$	6.5	$	13.8	$	32.1	$	15.9
Income from discontinued operations, net of tax	—		6.3		—		12.7
Net income attributable to Chart Industries, Inc.	$	6.5	$	20.1	$	32.1	$	28.6
Earnings per common share – basic:
Income from continuing operations	$	0.18	$	0.39	$	0.90	$	0.45
Income from discontinued operations	—		0.18		—		0.36
Net income attributable to Chart Industries, Inc.	$	0.18	$	0.57	$	0.90	$	0.81
Earnings per common share – diluted:
Income from continuing operations	$	0.16	$	0.39	$	0.79	$	0.45
Income from discontinued operations	—		0.18		—		0.35
Net income attributable to Chart Industries, Inc.	$	0.16	$	0.57	$	0.79	$	0.80
Weighted average number of common shares outstanding – basic	35.61		35.18		35.58		35.48
Incremental shares issuable upon assumed conversion and exercise of share-based awards	0.31		0.13		0.32		0.18
Incremental shares issuable due to dilutive effect of convertible notes	2.64		—		2.61		—
Incremental shares issuable due to dilutive effect of warrants	2.25		—		2.21		—
Weighted average number of common shares outstanding – diluted	40.81		35.31		40.72		35.66

Diluted earnings per share does not reflect the following potential common shares as the effect would be anti-dilutive:

	Three Months Ended June 30,		Six Months Ended June 30,
	2021	2020	2021	2020
Share-based awards	0.06	0.65	0.06	0.51
Convertible note hedge and capped call transactions (1)	2.64	—	2.61	—
Warrants	—	4.41	—	4.41
Total anti-dilutive securities	2.70	5.06	2.67	4.92

 _______________

(1)The convertible note hedge offsets any dilution upon actual conversion of the 2024 Notes up to a common stock price of $71.775 per share. For further information, refer to Note 9, “Debt and Credit Arrangements.”

XML

Income Taxes

6 Months Ended

Jun. 30, 2021

Income Tax Disclosure [Abstract]

Income Taxes

Income TaxesIncome tax expense of $1.3 and $2.2 for the three months ended June 30, 2021 and 2020, respectively, represents taxes on both U.S. and foreign earnings at a combined effective income tax rate of 16.0% and 13.0%, respectively. Income tax expense of $4.4 and $2.6 for the six months ended June 30, 2021 and 2020, respectively, represents taxes on both U.S. and foreign earnings at a combined effective income tax rate of 11.8% and 13.4%, respectively.

The effective income tax rate of 16.0% and 11.8% for the three and six months ended June 30, 2021 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by some of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by our certain foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

The effective income tax rate of 13.0% and 13.4% for the three and six months ended June 30, 2020 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by certain of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by certain of our foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

As of both June 30, 2021 and December 31, 2020, we had a liability for gross unrecognized tax benefits of $1.9. This amount includes $1.3 of unrecognized tax benefits as of both June 30, 2021 and December 31, 2020, which, if ultimately recognized, would reduce our annual effective income tax rate. We recognized interest and penalties of $0.3 related to uncertain tax positions in income tax expense as of June 30, 2021.

XML

Share-based Compensation

6 Months Ended

Jun. 30, 2021

Share-based Payment Arrangement, Noncash Expense [Abstract]

Share-based Compensation

Share-based Compensation

During the six months ended June 30, 2021, we granted 0.06 stock options, 0.05 restricted stock units and 0.03 performance units. The total fair value of awards granted to employees during the six months ended June 30, 2021 was $12.5. In addition, our non-employee directors received stock awards with a total fair value of $0.2. During the six months ended June 30, 2021, participants in our stock option plans exercised options to purchase 0.12 shares of our common stock.

Stock options generally have a four-year graded vesting period. Restricted stock and restricted stock units generally vest ratably over a three-year period. Performance units generally vest at the end of a three-year performance period based on the attainment of certain pre-determined performance condition targets. During the six months ended June 30, 2021, 0.08 restricted stock and restricted stock units vested and 0.01 performance units vested.

Share-based compensation expense was $2.4 and $2.0 for the three months ended June 30, 2021 and 2020, respectively and $5.8 and $4.9 for the six months ended June 30, 2021 and 2020, respectively. Share-based compensation expense is included in selling, general, and administrative expenses in the unaudited condensed consolidated statements of income and comprehensive income. As of June 30, 2021, total share-based compensation of $15.2 is expected to be recognized over the weighted-average period of approximately 2.2 years.

XML

Commitment and Contingencies

6 Months Ended

Jun. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Environmental

We are subject to federal, state, local, and foreign environmental laws and regulations concerning, among other matters, waste water effluents, air emissions, and handling and disposal of hazardous materials, such as cleaning fluids. We are involved with environmental compliance, investigation, monitoring, and remediation activities at certain of our owned and formerly owned manufacturing facilities and at one owned facility that is leased to a third party, and, except for these continuing remediation efforts, believe we are currently in substantial compliance with all known environmental regulations. At June 30, 2021 and December 31, 2020, we had undiscounted accrued environmental reserves of $0.2 and $0.3, respectively.

Legal Proceedings

Stainless Steel Cryobiological Tank Legal Proceedings

During the second quarter of 2018, Chart was named in a number of lawsuits (including lawsuits filed in the U.S. District Court for the Northern District of California) filed against Chart and other defendants with respect to the alleged failure of a stainless steel cryobiological storage tank (model MVE 808AF-GB) at the Pacific Fertility Center in San Francisco, California. In May and June of 2021, the first five of the federal lawsuits went to trial, and on June 10, 2021, the jury reached a verdict against Chart in favor of the plaintiffs in those lawsuits in the amount of $14.9, of which 90% ($13.5) is attributable to Chart.

Chart strongly disagrees with the June 10, 2021 verdict. In response to the June 10, 2021 verdict, we intend to file post-trial motions, once the judgment is entered. Additionally, we have the option to file an appeal. While we continue to vigorously contest the result in this case, we have recorded a loss contingency accrual and corresponding charge to net income for $13.5 in the amount of the jury verdict attributable to Chart. The loss contingency accrual is included in other current liabilities in our unaudited condensed consolidated balance sheet at June 30, 2021. Chart expects that any potential loss

associated with the verdict will be covered by existing product liability insurance, subject to previously issued reservations of rights by the insurance carriers. Accordingly, we have recorded an offsetting $13.5 loss recovery receivable with a corresponding credit to net income. The loss recovery receivable is included in other current assets in our unaudited condensed consolidated balance sheet at June 30, 2021.

There remain approximately 139 additional individual cases with respect to the Pacific Fertility Center incident on the docket in the U.S. District Court for the Northern District of California, the next five of which are currently scheduled for trial in January 2022. In addition to the cases filed in the U.S. District Court for the Northern District of California, Chart is currently a defendant in 50 individual cases in the San Francisco Superior Court.

We have asserted various defenses against the claims in the lawsuits, which remain in various stages of development, including a defense that since manufacture, we were not in any way involved with the installation, ongoing maintenance or monitoring of the tank or related fertility center cryogenic systems at any time since the initial delivery of the tank. We continue to evaluate the merits of such claims for each specific case in light of the information available to date regarding use, maintenance and operation of the tank that was sold to the Pacific Fertility Center through an independent distributor, and which had been out of our control for six years prior to the alleged failure. Based on our current evaluation of the remaining cases, an accrual related to any damages that may result from the remaining lawsuits has not been recorded as of June 30, 2021 because a potential loss is not currently probable. Although a loss associated with the claims in the lawsuits is reasonably possible, an estimate of such potential loss cannot be made. In connection with the Cryobiological Divestiture, Chart retained certain potential liabilities and claims, including the claims asserted in connection with this litigation.

We are occasionally subject to various legal claims related to performance under contracts, product liability, taxes, employment matters, environmental matters, intellectual property, and other matters incidental to the normal course of our business. Based on our historical experience in litigating these claims, as well as our current assessment of the underlying merits of the claims and applicable insurance, if any, management believes that the final resolution of these matters, including the Pacific Fertility Center cases described above, will not have a material adverse effect on our financial position, liquidity, cash flows, or results of operations. Future developments may, however, result in resolution of these legal claims in a way that could have a material adverse effect.

XML

Restructuring Activities

6 Months Ended

Jun. 30, 2021

Restructuring and Related Activities [Abstract]

Restructuring Activities

Restructuring Activities

Restructuring costs of $0.3 and $1.0 for the three and six months ended June 30, 2021, respectively, were primarily related to employee severance costs. As previously reported, on July 17, 2020, we announced internally our intention to transfer operations of our heat exchanger leased facility in Tulsa, Oklahoma to our Beasley, Texas location at which we own 260 acres of land. This transfer is a cost reduction measure within our Heat Transfer Systems segment to continue to structure the business for profitable growth and capacity efficiency. During the first six months of 2021, the leased facility in Tulsa, Oklahoma was repurposed as a flexible manufacturing, engineering and research and development site serving multiple applications across our operating segments. Total costs related to this transfer and Tulsa facility repurposing, are expected to be approximately $9.0, of which $2.7 was spent in 2020. With respect to 2021, we incurred $0.3 and $0.7 of restructuring costs for the three and six months ended June 30, 2021, respectively, primarily related to employee severance costs, which is reflected in the tables below under the Heat Transfer Systems segment. We incurred an additional $4.8 and $5.2 in costs (not reflected in the tables below) for the three and six months ended June 30, 2021, respectively, which are associated with moving and facility start-up costs attributable to the relocation of our air cooled heat exchangers product lines from our Tulsa, Oklahoma facility to our Beasley, Texas facility. This project is complete as of June 30, 2021 although we may incur further costs in the remainder of 2021. We are closely monitoring our end markets and order rates and will continue to take appropriate and timely actions as necessary.

Restructuring costs of $5.6 and $10.8 for the three and six months ended June 30, 2020, respectively, were related to certain cost reduction actions taken primarily in our Cryo Tank Solutions and Heat Transfer Systems segments. These costs were primarily related to employee severance costs.

The following table summarizes severance and other restructuring costs, which includes employee-related costs, facility rent and exit costs, relocation, recruiting, travel and other:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Severance:
Cost of sales	$	—	$	1.6	$	—	$	3.9
Selling, general, and administrative expenses	—		1.9		0.3		4.8
Total severance costs	—		3.5		0.3		8.7
Other restructuring:
Cost of sales	0.3		—		0.7		—
Selling, general, and administrative expenses	—		2.1		—		2.1
Total other restructuring costs	0.3		2.1		0.7		2.1
Total restructuring costs	$	0.3	$	5.6	$	1.0	$	10.8

The following tables summarize our restructuring activities for the three and six months ended June 30, 2021 and 2020:

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at March 31, 2021	$	0.5	$	—	$	—	$	—	$	—	$	0.5
Restructuring charges	—		0.3		—		—		—		0.3
Cash payments and other	(0.2)		(0.4)		—		—		—		(0.6)
Balance at June 30, 2021	$	0.3	$	(0.1)	$	—	$	—	$	—	$	0.2

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at March 31, 2020	$	1.5	$	0.5	$	—	$	—	$	0.8	$	2.8
Restructuring charges	1.1		2.9		—		—		1.6		5.6
Cash payments and other	(1.2)		(3.2)		—		—		(2.1)		(6.5)
Balance at June 30, 2020	$	1.4	$	0.2	$	—	$	—	$	0.3	$	1.9

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 31, 2020	$	0.5	$	0.2	$	—	$	—	$	0.1	$	0.8
Restructuring charges	0.3		0.7		—		—		—		1.0
Cash payments and other	(0.5)		(1.0)		—		—		(0.1)		(1.6)
Balance at June 30, 2021	$	0.3	$	(0.1)	$	—	$	—	$	—	$	0.2

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 31, 2019	$	0.5	$	0.2	$	—	$	—	$	0.2	$	0.9
Restructuring charges	2.9		5.7		—		—		2.2		10.8
Cash payments and other	(2.0)		(5.7)		—		—		(2.1)		(9.8)
Balance at June 30, 2020	$	1.4	$	0.2	$	—	$	—	$	0.3	$	1.9

XML

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventSubsequent to the end of the second quarter of 2021, on July 1, 2021, we acquired 100% of the equity interests of L.A. Turbine (“LAT”) for approximately $80 million in cash (subject to certain customary adjustments). LAT is a global leader in turboexpander design, engineering, manufacturing, assembly and testing process for new and aftermarket equipment, with significant in-house engineering expertise. Due to the timing of the LAT acquisition, the initial accounting for the business combination is incomplete. As such, we are unable to disclose certain information with respect to the LAT acquisition including the preliminary estimated fair value of the assets acquired and liabilities assumed. We anticipate that we will complete the initial accounting for the business combination during the third quarter of 2021.

XML

Basis of Preparation (Policies)

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Principles of Consolidation

Principles of Consolidation: The unaudited condensed consolidated financial statements include the accounts of Chart Industries, Inc. and its subsidiaries. Intercompany accounts and transactions are eliminated in consolidation.

Reclassifications: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (CYRX) (refer to Note 2, “Discontinued Operations” for further information). Furthermore, we reorganized our reporting structure such that the composition of our reportable segments changed effective October 1, 2020 (refer to Note 3, “Reportable Segments” for further information). As such, certain reclassifications have been made to the statements of income and comprehensive income for the three and six months ended June 30, 2020 and certain notes to the unaudited condensed consolidated financial statements in order to conform to the 2021 presentation.

Use of Estimates

Use of Estimates: The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. These estimates may also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions.

Recently Issued and Adopted Accounting Standards

Recently Issued Accounting Standards (Not Yet Adopted): In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” and in January 2021, the FASB subsequently issued ASU 2021-01,

“Reference Rate Reform (Topic 848): Scope.” ASU 2020-04 and the subsequent modifications are identified as Accounting Standards Codification (“ASC”) 848 (“ASC 848”). ASC 848 simplifies the accounting for modifying contracts (including those in hedging relationships) that refer to LIBOR and other interbank offered rates that are expected to be discontinued due to reference rate reform. The amendments in ASC 848 are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments in ASC 848 must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. We expect application of the amendments to impact accounting for our senior secured revolving credit facility due June 2024. We are currently assessing the effect ASC 848 will have on our financial position, results of operations, and disclosures.

Recently Adopted Accounting Standards: In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entities Own Equity (Subtopic 815-40).” This ASU simplifies accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance effective January 1, 2021 under the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods.

As a result of the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our June 30, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our June 30, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. Lastly, we derecognized deferred income taxes associated with the convertible notes debt discount and adjusted deferred incomes taxes relative to unamortized debt issuance costs associated with our convertible notes due November 2024.

Interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized. Interest accretion of convertible notes discount and net income from continuing operations attributable to Chart Industries, Inc. for the three months ended June 30, 2021 would have been $2.1 and $4.9, respectively, without the adoption of ASU 2020-06. As such, net income from continuing operations attributable to Chart Industries, Inc. per common share (both basic and diluted) for the three months ended June 30, 2021 is $0.04 higher due to the effect of adoption of ASU 2020-06.

Interest accretion of convertible notes discount and net income from continuing operations attributable to Chart Industries, Inc. for the six months ended June 30, 2021 would have been $4.1 and $28.9, respectively, without the adoption of ASU 2020-06. As such, net income from continuing operations attributable to Chart Industries, Inc. per common share for the six months ended June 30, 2021 is $0.09 (basic) and $0.08 (diluted) higher due to the effect of adoption of ASU 2020-06.

As further described in Note 9, “Debt and Credit Arrangements,” on December 31, 2020, we amended the Indenture governing our convertible notes due November 2024 to eliminate share settlement thus leaving us with two settlement options: (1) cash settlement or (2) cash for par and any combination of cash and shares for the excess settlement amount above the $258.8 principal amount of our convertible notes due November 2024. ASU 2020-06 requires usage of the if-converted method to compute diluted earnings per share for our convertible notes due November 2024, however, based on the terms of the amended Indenture and the cessation of interest accretion expense recognition from the transition at adoption, the if-converted method was modified such that interest expense is no longer added to the numerator, and the denominator only includes incremental shares that would be issued upon conversion.

Impacts on Financial Statements

The following table summarizes the cumulative effect of the changes to our condensed consolidated balance sheet as of December 31, 2020 from the adoption of ASU 2020-06:

	Balance at December 31, 2020		Adjustments due to ASU 2020-06 adoption		Balance at January 1, 2021
Liabilities
Accrued income taxes	$	46.5	$	(0.2)	$	46.3
Current convertible notes (1)	220.9		34.0		254.9
Long-term deferred tax liabilities	60.2		(7.6)		52.6
Equity
Additional paid-in-capital	$	780.8	$	(36.9)	$	743.9
Retained earnings	808.4		10.7		819.1

_______________

(1)Current convertible notes is presented net of unamortized discount and debt issuance costs of $34.8 and $3.1, respectively at December 31, 2020. Current convertible notes is presented net of unamortized debt issuance costs of $3.9 at January 1, 2021.

In January 2020, the FASB issued ASU 2020-01, “Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).” This ASU clarifies the interactions between the measurement alternative in Topic 321, the equity method of accounting in Topic 323 and the application of guidance for certain forward contracts and purchased options that upon settlement or exercise would be accounted for under the equity method of accounting in Topic 815. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance effective January 1, 2021. The adoption of this guidance did not have a material impact on our financial position, results of operations or disclosures.

XML

Basis of Preparation (Tables)

6 Months Ended

Jun. 30, 2021

Accounting Policies [Abstract]

Schedule of Impact on Financial Statements

The following table summarizes the cumulative effect of the changes to our condensed consolidated balance sheet as of December 31, 2020 from the adoption of ASU 2020-06:

	Balance at December 31, 2020		Adjustments due to ASU 2020-06 adoption		Balance at January 1, 2021
Liabilities
Accrued income taxes	$	46.5	$	(0.2)	$	46.3
Current convertible notes (1)	220.9		34.0		254.9
Long-term deferred tax liabilities	60.2		(7.6)		52.6
Equity
Additional paid-in-capital	$	780.8	$	(36.9)	$	743.9
Retained earnings	808.4		10.7		819.1

_______________

(1)Current convertible notes is presented net of unamortized discount and debt issuance costs of $34.8 and $3.1, respectively at December 31, 2020. Current convertible notes is presented net of unamortized debt issuance costs of $3.9 at January 1, 2021.

XML

Discontinued Operations (Tables)

6 Months Ended

Jun. 30, 2021

Discontinued Operations and Disposal Groups [Abstract]

Summarized financial information of discontinued operations

The following table represents income from discontinued operations, net of tax:

	Three Months Ended June 30, 2020		Six Months Ended June 30, 2020
Sales	$	20.9	$	40.1
Cost of sales	11.8		21.9
Selling, general and administrative expenses	1.5		2.9
Operating income (1)	7.6		15.3
Income before income taxes from discontinued operations	8.0		15.7
Income tax expense	1.7		3.0
Income from discontinued operations, net of tax	$	6.3	$	12.7

________________

(1)Includes depreciation expense of $0.3 and $0.6 for the three and six months ended June 30, 2020.

The following table represents a summary of cash flows related to discontinued operations:

	Three Months Ended June 30, 2020		Six Months Ended June 30, 2020
Net cash provided by (used in):
Operating activities	$	7.7	$	14.9
Investing activities	—		(0.1)
Net cash provided by discontinued operations	$	7.7	$	14.8

XML

Reportable Segments (Tables)

6 Months Ended

Jun. 30, 2021

Segment Reporting [Abstract]

Schedule of reportable and product sales information segments

Segment Financial Information

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	97.8	$	65.2	$	106.8	$	54.6	$	(2.4)	$	—	$	322.0
Depreciation and amortization expense	3.8		9.5		3.4		2.7		—		0.4		19.8
Operating income (loss) (1) (2)	13.4		(0.5)		23.4		5.6		—		(16.3)		25.6

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	105.3	$	97.3	$	48.6	$	40.1	$	(1.8)	$	—	$	289.5
Depreciation and amortization expense	4.6		14.2		1.0		3.0		—		0.5		23.3
Operating income (loss) (1)	15.9		7.2		11.7		7.6		—		(16.6)		25.8

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	201.7	$	134.4	$	184.1	$	96.0	$	(5.7)	$	—	$	610.5
Depreciation and amortization expense	7.7		19.0		6.5		5.3		—		0.8		39.3
Operating income (loss) (1) (2)	29.0		3.4		41.3		13.9		—		(33.1)		54.5

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	203.3	$	210.2	$	101.5	$	80.8	$	(4.4)	$	—	$	591.4
Depreciation and amortization expense	9.0		28.3		2.4		6.3		—		0.9		46.9
Operating income (loss) (1)	27.5		12.7		25.5		12.2		—		(36.3)		41.6

_______________

(1)Restructuring costs for the:

•three months ended June 30, 2021 were $0.3 ($0.3 - Heat Transfer Systems).

•three months ended June 30, 2020 were $5.6 ($1.1 - Cryo Tank Solutions, $2.9 - Heat Transfer Systems, $1.6 - Corporate).

•six months ended June 30, 2021 were $1.0 ($0.3 - Cryo Tank Solutions, $0.7 - Heat Transfer Systems).

•six months ended June 30, 2020 were $10.8 ($2.9 - Cryo Tank Solutions, $5.7 - Heat Transfer Systems, $2.2 - Corporate).

(2)Includes acquisition-related contingent consideration adjustments of $1.2 and $2.0 in our Specialty Products segment for the three and six months ended June 30, 2021, respectively.

Sales by Geography

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	34.4	$	42.2	$	43.3	$	29.5	$	(1.0)	$	148.4
Europe, Middle East, Africa and India	32.7		8.8		53.3		9.1		(0.7)		103.2
Asia-Pacific	29.1		14.0		9.6		15.9		(0.7)		67.9
Rest of the World	1.6		0.2		0.6		0.1		—		2.5
Total	$	97.8	$	65.2	$	106.8	$	54.6	$	(2.4)	$	322.0

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	43.7	$	71.1	$	26.1	$	28.3	$	(0.9)	$	168.3
Europe, Middle East, Africa and India	32.2		10.2		19.9		9.8		(0.5)		71.6
Asia-Pacific	28.4		15.8		2.5		1.9		(0.4)		48.2
Rest of the World	1.0		0.2		0.1		0.1		—		1.4
Total	$	105.3	$	97.3	$	48.6	$	40.1	$	(1.8)	$	289.5

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	75.5	$	88.5	$	69.4	$	58.5	$	(2.7)	$	289.2
Europe, Middle East, Africa and India	70.4		16.6		98.9		19.6		(1.7)		203.8
Asia-Pacific	53.3		28.8		15.2		17.7		(1.3)		113.7
Rest of the World	2.5		0.5		0.6		0.2		—		3.8
Total	$	201.7	$	134.4	$	184.1	$	96.0	$	(5.7)	$	610.5

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	84.3	$	153.3	$	51.0	$	60.4	$	(2.2)	$	346.8
Europe, Middle East, Africa and India	66.5		19.7		45.5		16.5		(1.2)		147.0
Asia-Pacific	48.5		36.7		4.7		3.6		(0.9)		92.6
Rest of the World	4.0		0.5		0.3		0.3		(0.1)		5.0
Total	$	203.3	$	210.2	$	101.5	$	80.8	$	(4.4)	$	591.4

Segment assets

	June 30, 2021		December 31, 2020
Cryo Tank Solutions	$	400.4	$	399.2
Heat Transfer Systems	243.0		247.2
Specialty Products	265.6		178.3
Repair, Service & Leasing	175.2		142.6
Total assets of reportable segments	1,084.2		967.3
Goodwill (1)	896.1		865.9
Identifiable intangible assets, net (1)	491.0		493.1
Corporate	358.7		244.2
Total	$	2,830.0	$	2,570.5

_______________

(1)See Note 8, “Goodwill and Intangible Assets,” for further information related to goodwill and identifiable intangible assets, net.

XML

Revenue (Tables)

6 Months Ended

Jun. 30, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of revenue by timing

The following tables represent a disaggregation of revenue by timing of revenue along with the reportable segment for each category:

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	89.8	$	5.2	$	73.4	$	37.8	$	(1.5)	$	204.7
Over time	8.0		60.0		33.4		16.8		(0.9)		117.3
Total	$	97.8	$	65.2	$	106.8	$	54.6	$	(2.4)	$	322.0

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	94.4	$	8.1	$	32.6	$	25.9	$	(0.7)	$	160.3
Over time	10.9		89.2		16.0		14.2		(1.1)		129.2
Total	$	105.3	$	97.3	$	48.6	$	40.1	$	(1.8)	$	289.5

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	188.5	$	10.8	$	135.3	$	64.5	$	(4.4)	$	394.7
Over time	13.2		123.6		48.8		31.5		(1.3)		215.8
Total	$	201.7	$	134.4	$	184.1	$	96.0	$	(5.7)	$	610.5

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	184.2	$	15.2	$	71.4	$	53.9	$	(2.2)	$	322.5
Over time	19.1		195.0		30.1		26.9		(2.2)		268.9
Total	$	203.3	$	210.2	$	101.5	$	80.8	$	(4.4)	$	591.4

Changes in contract assets and contract liabilities balances

The following table represents changes in our contract assets and contract liabilities balances:

	June 30, 2021		December 31, 2020		Year-to-date Change ($)		Year-to-date Change (%)
Contract assets
Accounts receivable, net of allowances	$	220.0	$	200.8	$	19.2	9.6	%
Unbilled contract revenue	68.2		79.4		(11.2)		(14.1)	%
Contract liabilities
Customer advances and billings in excess of contract revenue	$	126.1	$	118.9	$	7.2	6.1	%
Long-term deferred revenue	1.0		1.9		(0.9)		(47.4)	%

XML

Investments (Tables)

6 Months Ended

Jun. 30, 2021

Investments, Debt and Equity Securities [Abstract]

Schedule of investments

The following table summarizes the components of our investments in equity securities:

	Investment in Equity Securities, Level 1 (1)		Investment in Equity Securities, Level 2 (1)		Subtotal		Investments in Equity Securities, All Others (3)		Investments in Equity Securities, Total
Balance at December 31, 2020	$	53.8	$	4.1	$	57.9	$	15.7	$	73.6
New investments (2)	—		—		—		45.0		45.0
(Decrease) increase in fair value of investments in equity securities	(19.8)		10.6		(9.2)		—		(9.2)
Foreign currency translation (losses) gains	(1.6)		—		(1.6)		0.4		(1.2)
Balance at June 30, 2021	$	32.4	$	14.7	$	47.1	$	61.1	$	108.2

_______________

(1)Our investment in McPhy (Euronext Paris: MCPHY - ISIN; FR001742329) represents a Level 1 investment while our investment in Stabilis Energy, Inc. represents a Level 2 investment. For the three and six months ended June 30, 2021, we recognized an unrealized loss of $17.2 and $19.8, respectively, in our Level 1 investment and an unrealized gain of $4.7 and $10.6, respectively, in our Level 2 investment.

(2)During the second quarter of 2021, we completed an investment in Earthly Labs Inc. (“Earthly Labs”) in the amount of $5.0 for approximately 15% of its equity. Earthly Labs is the leading provider of small-scale carbon capture systems offering an affordable, small footprint technology platform called “CiCi ®” to capture, recycle, reuse, track and sell CO2. Earthly Labs proprietary approach includes hardware, software and services to address half of all existing carbon dioxide emissions from industrial sources while converting molecules to value.

During the first quarter of 2021, we completed an investment in Transform Materials LLC (“Transform Materials”) in the amount of $25.0 for approximately 5% of its equity. Transform Materials is a sustainable chemical technology company that uses microwave plasma to convert natural gas into acetylene and hydrogen. Its highly selective, cost-effective, net-carbon-negative process converts the methane in natural gas into high-value products suitable for direct use or downstream reactions.

Also, during the first quarter of 2021, we completed an investment in Svante Inc. (“Svante”) in the amount of $15.0 for under 10% of its capital stock on a fully diluted basis. Svante offers companies in emissions-intensive industries a commercially viable way to capture large-scale CO2 emissions from existing infrastructure, either for safe storage or to be recycled for further industrial use in a closed loop.

(3)Our investments in HTEC Hydrogen Technology & Energy Corporation, Svante, Transform Materials and Earthly Labs are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.

XML

Leases (Tables)

6 Months Ended

Jun. 30, 2021

Leases [Abstract]

Schedule of operating lease future minimum payments

The following table summarizes future minimum lease payments for non-cancelable operating leases as of June 30, 2021:

2021	$	3.8
2022	6.4
2023	5.8
2024	5.3
2025	4.5
Thereafter (1)	3.6
Total future minimum lease payments	$	29.4

_______________

(1)     As of June 30, 2021, future minimum lease payments for non-cancelable operating leases for the period subsequent to 2025 relate to eight leased facilities.

XML

Inventories (Tables)

6 Months Ended

Jun. 30, 2021

Inventory Disclosure [Abstract]

Summarized components of inventory

The following table summarizes the components of inventory:

	June 30, 2021		December 31, 2020
Raw materials and supplies	$	161.2	$	124.7
Work in process	68.1		57.8
Finished goods	80.8		65.9
Total inventories, net	$	310.1	$	248.4

XML

Goodwill and Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of goodwill by segment

The following table represents the changes in goodwill by segment:

	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Consolidated
Balance at December 31, 2020	$	93.2	$	435.2	$	172.4	$	165.1	$	865.9
Goodwill acquired during the period (1)	—		—		34.5		—		34.5
Foreign currency translation adjustments and other	(3.4)		(1.9)		0.1		—		(5.2)
Purchase price adjustments (2)	—		—		0.9		—		0.9
Balance at June 30, 2021	$	89.8	$	433.3	$	207.9	$	165.1	$	896.1

_______________

(1)For further information regarding goodwill acquired and the purchase price adjustments during the period refer to Note 11, “Business Combinations.”

(2)During the first six months of 2021, we recorded purchase price adjustments that decreased goodwill by $0.9 in Specialty Products related to the Blue-In-Green, LLC acquisition.

Schedule of finite-lived intangible assets

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill) (1):

		June 30, 2021				December 31, 2020
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Customer relationships	13 years	$	311.6	$	(71.2)	$	302.5	$	(59.9)
Unpatented technology	12 years	115.5		(26.9)		110.4		(22.3)
Patents and other	6 years	5.0		(0.2)		8.4		(1.8)
Trademarks and trade names	13 years	3.5		(1.7)		3.6		(1.4)
Land use rights	50 years	11.2		(1.5)		11.1		(1.4)
Total finite-lived intangible assets	14 years	446.8		(101.5)		436.0		(86.8)
Indefinite-lived intangible assets:
Trademarks and trade names		145.7		—		143.9		—
Total intangible assets		$	592.5	$	(101.5)	$	579.9	$	(86.8)

_______________

(1)Amounts include the impact of foreign currency translation. Fully amortized or impaired amounts are written off.

Schedule of indefinite-lived intangible assets

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill) (1):

		June 30, 2021				December 31, 2020
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Customer relationships	13 years	$	311.6	$	(71.2)	$	302.5	$	(59.9)
Unpatented technology	12 years	115.5		(26.9)		110.4		(22.3)
Patents and other	6 years	5.0		(0.2)		8.4		(1.8)
Trademarks and trade names	13 years	3.5		(1.7)		3.6		(1.4)
Land use rights	50 years	11.2		(1.5)		11.1		(1.4)
Total finite-lived intangible assets	14 years	446.8		(101.5)		436.0		(86.8)
Indefinite-lived intangible assets:
Trademarks and trade names		145.7		—		143.9		—
Total intangible assets		$	592.5	$	(101.5)	$	579.9	$	(86.8)

_______________

(1)Amounts include the impact of foreign currency translation. Fully amortized or impaired amounts are written off.

Schedule of estimated future amortization

We estimate amortization expense to be recognized during the next five years as follows:

For the Year Ending December 31,
2021	$	37.2
2022	36.1
2023	35.6
2024	35.2
2025	34.3

Schedule of government grants

China Government Grants are presented in our unaudited condensed consolidated balance sheets as follows:

	June 30, 2021		December 31, 2020
Current	$	0.5	$	0.5
Long-term	7.3		7.3
Total China Government Grants	$	7.8	$	7.8

XML

Debt and Credit Arrangements (Tables)

6 Months Ended

Jun. 30, 2021

Debt Disclosure [Abstract]

Summary of outstanding borrowings

The following table represents the components of our borrowings:

	June 30, 2021		December 31, 2020
Senior secured revolving credit facility and term loan:
Term loan due June 2024 (1)	$	103.1	$	103.1
Senior secured revolving credit facility due June 2024 (2) (3)	351.8		123.5
Unamortized debt issuance costs	(4.3)		(5.0)
Senior secured revolving credit facility and term loan, net of debt issuance costs	450.6		221.6
Convertible notes due November 2024:
Principal amount	258.8		258.8
Unamortized discount (4)	—		(34.8)
Unamortized debt issuance costs	(3.3)		(3.1)
Convertible notes due November 2024, net of unamortized discount and debt issuance costs	255.5		220.9
Total debt, net of unamortized discount and debt issuance costs	706.1		442.5
Less: current maturities	255.5		220.9
Long-term debt	$	450.6	$	221.6

_______________

(1)As of June 30, 2021, there were $103.1 in borrowings outstanding under the term loan due June 2024, which is due at maturity, bearing an interest rate of 2.0% (2.5% as of December 31, 2020).

(2)The senior secured revolving credit facility due 2024 includes $100.0 sub limit for letters of credit, a $250.0 sub limit for discretionary letters of credit and $50.0 sub limit for swingline loans. As of June 30, 2021, there were $351.8 in borrowings outstanding under the senior secured revolving credit facility due 2024 bearing a weighted-average interest rate of 1.9% (2.1% as of December 31, 2020) and $45.2 in letters of credit and bank guarantees outstanding supported by the senior secured revolving credit facility due 2024. As of June 30, 2021, the senior secured revolving credit facility due 2024 had availability of $153.0.

(3)A portion of borrowings outstanding under our senior secured revolving credit facility due 2024 are denominated in euros (“EUR Revolver Borrowings”). EUR Revolver Borrowings outstanding were 86.5 million euros (equivalent to $102.8) and 74.5 million euros (equivalent to $91.4) at June 30, 2021 and December 31, 2020, respectively. During the three and six months ended June 30, 2021, we recognized an unrealized foreign currency gain of $8.9 and $5.0, respectively, relative to the translation of the EUR Revolver Borrowings outstanding during the reporting period. This unrealized foreign currency gain is classified as foreign currency loss and other in the condensed consolidated statements of income for the three and six months ended June 30, 2021.

(4)We derecognized the debt discount associated with the convertible notes due November 2024 upon adoption of ASU 2020-06 on January 1, 2021.

Schedule of interest expense and financing cost amortization

The following table summarizes interest expense and financing costs amortization related to the 2024 Credit Facilities:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Interest expense, term loan due June 2024	$	0.5	$	4.0	$	1.1	$	8.2
Interest expense, senior secured revolving credit facility due June 2024	1.3		0.6		2.0		1.2
Interest expense, senior secured revolving credit facility and term loan due June 2024	$	1.8	$	4.6	$	3.1	$	9.4
Financing costs amortization, senior secured revolving credit facility and term loan due June 2024	$	0.8	$	0.9	$	1.8	$	1.7

Schedule of interest accretion

The following table summarizes interest accretion of the 2024 Notes discount, 1.0% contractual interest coupon and financing costs amortization associated with the 2024 Notes:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
2024 Notes, interest accretion of convertible notes discount	$	—	$	2.0	$	—	$	3.9
2024 Notes, 1.0% contractual interest coupon	0.7		0.7		1.3		1.3
2024 Notes, total interest expense	$	0.7	$	2.7	$	1.3	$	5.2
2024 Notes, financing costs amortization	$	0.3	$	0.2	$	0.5	$	0.4

XML

Product Warranties (Tables)

6 Months Ended

Jun. 30, 2021

Product Warranties Disclosures [Abstract]

Rollforward of consolidated warranty reserve

The following table represents changes in our consolidated warranty reserve:

Balance at December 31, 2020	$	11.9
Issued – warranty expense	(2.7)
Warranty usage	2.4
Balance at June 30, 2021	$	11.6

XML

Business Combinations (Tables)

6 Months Ended

Jun. 30, 2021

Business Combination and Asset Acquisition [Abstract]

Schedule of changes in contingent consideration

The following table represents the changes to our contingent consideration liabilities:

	SES		BIG		Total
Balance at December 31, 2020	$	16.9	$	3.2	$	20.1
Increase in fair value of contingent consideration liabilities	2.0		—		2.0
Balance at June 30, 2021	$	18.9	$	3.2	$	22.1

XML

Accumulated Other Comprehensive (Loss) Income (Tables)

6 Months Ended

Jun. 30, 2021

Equity [Abstract]

Schedule of changes in accumulated other comprehensive loss

The components of accumulated other comprehensive (loss) income are as follows:

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at March 31, 2021	$	(5.8)	$	(11.0)	$	(16.8)
Other comprehensive income	7.3		—		7.3
Amounts reclassified from accumulated other comprehensive loss, net of income taxes	—		0.3		0.3
Net current-period other comprehensive income, net of taxes	7.3		0.3		7.6
Balance at June 30, 2021	$	1.5	$	(10.7)	$	(9.2)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at March 31, 2020	$	(35.2)	$	(10.6)	$	(45.8)
Other comprehensive income	7.5		—		7.5
Amounts reclassified from accumulated other comprehensive loss, net of income taxes	—		0.4		0.4
Net current-period other comprehensive income, net of taxes	7.5		0.4		7.9
Balance at June 30, 2020	$	(27.7)	$	(10.2)	$	(37.9)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive income (loss)
Balance at December 31, 2020	$	13.8	$	(11.4)	$	2.4
Other comprehensive loss	(12.3)		—		(12.3)
Amounts reclassified from accumulated other comprehensive income (loss), net of taxes	—		0.7		0.7
Net current-period other comprehensive (loss) income, net of taxes	(12.3)		0.7		(11.6)
Balance at June 30, 2021	$	1.5	$	(10.7)	$	(9.2)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at December 31, 2019	$	(25.0)	$	(10.9)	$	(35.9)
Other comprehensive loss	(2.7)		—		(2.7)
Amounts reclassified from accumulated other comprehensive loss, net of taxes	—		0.7		0.7
Net current-period other comprehensive (loss) income, net of taxes	(2.7)		0.7		(2.0)
Balance at June 30, 2020	$	(27.7)	$	(10.2)	$	(37.9)

XML

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2021

Earnings Per Share [Abstract]

Calculation of net income per share

The following table represents calculations of net earnings per share of common stock:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$	6.5	$	13.8	$	32.1	$	15.9
Income from discontinued operations, net of tax	—		6.3		—		12.7
Net income attributable to Chart Industries, Inc.	$	6.5	$	20.1	$	32.1	$	28.6
Earnings per common share – basic:
Income from continuing operations	$	0.18	$	0.39	$	0.90	$	0.45
Income from discontinued operations	—		0.18		—		0.36
Net income attributable to Chart Industries, Inc.	$	0.18	$	0.57	$	0.90	$	0.81
Earnings per common share – diluted:
Income from continuing operations	$	0.16	$	0.39	$	0.79	$	0.45
Income from discontinued operations	—		0.18		—		0.35
Net income attributable to Chart Industries, Inc.	$	0.16	$	0.57	$	0.79	$	0.80
Weighted average number of common shares outstanding – basic	35.61		35.18		35.58		35.48
Incremental shares issuable upon assumed conversion and exercise of share-based awards	0.31		0.13		0.32		0.18
Incremental shares issuable due to dilutive effect of convertible notes	2.64		—		2.61		—
Incremental shares issuable due to dilutive effect of warrants	2.25		—		2.21		—
Weighted average number of common shares outstanding – diluted	40.81		35.31		40.72		35.66

Schedule of antidilutive securities

Diluted earnings per share does not reflect the following potential common shares as the effect would be anti-dilutive:

	Three Months Ended June 30,		Six Months Ended June 30,
	2021	2020	2021	2020
Share-based awards	0.06	0.65	0.06	0.51
Convertible note hedge and capped call transactions (1)	2.64	—	2.61	—
Warrants	—	4.41	—	4.41
Total anti-dilutive securities	2.70	5.06	2.67	4.92

 _______________

(1)The convertible note hedge offsets any dilution upon actual conversion of the 2024 Notes up to a common stock price of $71.775 per share. For further information, refer to Note 9, “Debt and Credit Arrangements.”

XML

Restructuring Activities (Tables)

6 Months Ended

Jun. 30, 2021

Restructuring and Related Activities [Abstract]

Summary of severance and other restructuring costs

The following table summarizes severance and other restructuring costs, which includes employee-related costs, facility rent and exit costs, relocation, recruiting, travel and other:

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Severance:
Cost of sales	$	—	$	1.6	$	—	$	3.9
Selling, general, and administrative expenses	—		1.9		0.3		4.8
Total severance costs	—		3.5		0.3		8.7
Other restructuring:
Cost of sales	0.3		—		0.7		—
Selling, general, and administrative expenses	—		2.1		—		2.1
Total other restructuring costs	0.3		2.1		0.7		2.1
Total restructuring costs	$	0.3	$	5.6	$	1.0	$	10.8

Schedule of rollforward of restructuring cost

The following tables summarize our restructuring activities for the three and six months ended June 30, 2021 and 2020:

	Three Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at March 31, 2021	$	0.5	$	—	$	—	$	—	$	—	$	0.5
Restructuring charges	—		0.3		—		—		—		0.3
Cash payments and other	(0.2)		(0.4)		—		—		—		(0.6)
Balance at June 30, 2021	$	0.3	$	(0.1)	$	—	$	—	$	—	$	0.2

	Three Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at March 31, 2020	$	1.5	$	0.5	$	—	$	—	$	0.8	$	2.8
Restructuring charges	1.1		2.9		—		—		1.6		5.6
Cash payments and other	(1.2)		(3.2)		—		—		(2.1)		(6.5)
Balance at June 30, 2020	$	1.4	$	0.2	$	—	$	—	$	0.3	$	1.9

	Six Months Ended June 30, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 31, 2020	$	0.5	$	0.2	$	—	$	—	$	0.1	$	0.8
Restructuring charges	0.3		0.7		—		—		—		1.0
Cash payments and other	(0.5)		(1.0)		—		—		(0.1)		(1.6)
Balance at June 30, 2021	$	0.3	$	(0.1)	$	—	$	—	$	—	$	0.2

	Six Months Ended June 30, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 31, 2019	$	0.5	$	0.2	$	—	$	—	$	0.2	$	0.9
Restructuring charges	2.9		5.7		—		—		2.2		10.8
Cash payments and other	(2.0)		(5.7)		—		—		(2.1)		(9.8)
Balance at June 30, 2020	$	1.4	$	0.2	$	—	$	—	$	0.3	$	1.9

XML

Basis of Preparation - Narratives (Details) $ / shares in Units, shares in Thousands		3 Months Ended			6 Months Ended
		Jun. 30, 2021 USD ($) location $ / shares	Jun. 30, 2020 USD ($) $ / shares	Mar. 31, 2020 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) location $ / shares	Jun. 30, 2020 USD ($) $ / shares	Jan. 01, 2021 USD ($)	Dec. 31, 2020 USD ($)	Mar. 11, 2020 USD ($)	Nov. 06, 2017 USD ($)
Debt and Equity Securities, FV-NI
Number of locations (location) | location		25			25
Shares authorized for repurchase								$ 75,000,000	$ 75,000,000
Shares repurchased during the period (shares) | shares				760
Weighted average share price of shares repurchased (per share) | $ / shares				$ 25.40
Common stock repurchases	[1]			$ 19,300,000
Interest expense, net		$ 2,200,000	$ 7,600,000		$ 4,200,000	$ 14,800,000
Income from continuing operations		$ 6,500,000	$ 13,800,000		$ 32,100,000	$ 15,900,000
Income from continuing operations basic (usd per share) | $ / shares		$ 0.18	$ 0.39		$ 0.90	$ 0.45
Income from continuing operations diluted (usd per share) | $ / shares		$ 0.16	$ 0.39		$ 0.79	$ 0.45
Scenario, Plan
Debt and Equity Securities, FV-NI
Interest expense, net		$ 2,100,000			$ 4,100,000
Income from continuing operations		$ 4,900,000			$ 28,900,000
Income from continuing operations basic (usd per share) | $ / shares		$ 0.04			$ 0.09
Income from continuing operations diluted (usd per share) | $ / shares		$ 0.04			$ 0.08
Convertible Notes, due 2024 | Convertible Debt
Debt and Equity Securities, FV-NI
Principal amount		$ 258,800,000	$ 258,800,000		$ 258,800,000	$ 258,800,000		258,800,000		$ 258,800,000
Interest expense, net		700,000	$ 700,000		1,300,000	$ 1,300,000
Unamortized discount		0			0			34,800,000
Unamortized debt issuance costs		$ 3,300,000			$ 3,300,000		$ 3,900,000	$ 3,100,000

[1] Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

XML

Basis of Preparation - Impact on Financial Statements (Details) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Liabilities
Accrued income taxes	$ 17.3	$ 46.5
Current convertible notes	255.5	220.9
Long-term deferred tax liabilities	46.3	60.2
Equity
Additional paid-in capital	753.3	780.8
Retained earnings	$ 851.2	808.4
Cumulative Effect, Period of Adoption, Adjustment
Liabilities
Accrued income taxes		(0.2)
Current convertible notes		34.0
Long-term deferred tax liabilities		(7.6)
Equity
Additional paid-in capital		(36.9)
Retained earnings		10.7
Cumulative Effect, Period of Adoption, Adjusted Balance
Liabilities
Accrued income taxes		46.3
Current convertible notes		254.9
Long-term deferred tax liabilities		52.6
Equity
Additional paid-in capital		743.9
Retained earnings		$ 819.1

XML

Discontinued Operations - Income from Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Summarized Financial Information of Discontinued Operations
Income from discontinued operations, net of tax	$ 0.0	$ 6.3	$ 0.0	$ 12.7
Disposed of by held for sale
Summarized Financial Information of Discontinued Operations
Depreciation expense, discontinued operations		0.3		0.6
Disposed of by held for sale | Cryobiological products business
Summarized Financial Information of Discontinued Operations
Sales		20.9		40.1
Cost of sales		11.8		21.9
Selling, general and administrative expenses		1.5		2.9
Operating income		7.6		15.3
Income before income taxes from discontinued operations		8.0		15.7
Income tax expense		1.7		3.0
Income from discontinued operations, net of tax		$ 6.3		$ 12.7

XML

Discontinued Operations - Cash Flows Related to Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2020
Net cash provided by (used in):
Operating activities	$ 7.7	$ 14.9
Investing activities	0.0	(0.1)
Net cash provided by discontinued operations	$ 7.7	$ 14.8

XML

Reportable Segments - Narratives (Details)	6 Months Ended
	Jun. 30, 2021 segment
Segment Reporting [Abstract]
Number of reportable segments (segment)	4

XML

Reportable Segments - Segment Income (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Segment Reporting Information
Sales to external customers	$ 322.0	$ 289.5	$ 610.5	$ 591.4
Depreciation and amortization expense	19.8	23.3	39.3	46.9
Operating income (loss)	25.6	25.8	54.5	41.6
Restructuring costs	0.3	5.6	1.0	10.8
Increase in fair value of contingent consideration liabilities			2.0
Operating Segments | Cryo Tank Solutions
Segment Reporting Information
Sales to external customers	97.8	105.3	201.7	203.3
Depreciation and amortization expense	3.8	4.6	7.7	9.0
Operating income (loss)	13.4	15.9	29.0	27.5
Restructuring costs	0.0	1.1	0.3	2.9
Operating Segments | Heat Transfer Systems
Segment Reporting Information
Sales to external customers	65.2	97.3	134.4	210.2
Depreciation and amortization expense	9.5	14.2	19.0	28.3
Operating income (loss)	(0.5)	7.2	3.4	12.7
Restructuring costs	0.3	2.9	0.7	5.7
Operating Segments | Specialty Products
Segment Reporting Information
Sales to external customers	106.8	48.6	184.1	101.5
Depreciation and amortization expense	3.4	1.0	6.5	2.4
Operating income (loss)	23.4	11.7	41.3	25.5
Restructuring costs	0.0	0.0	0.0	0.0
Increase in fair value of contingent consideration liabilities	1.2		2.0
Operating Segments | Repair, Service & Leasing
Segment Reporting Information
Sales to external customers	54.6	40.1	96.0	80.8
Depreciation and amortization expense	2.7	3.0	5.3	6.3
Operating income (loss)	5.6	7.6	13.9	12.2
Restructuring costs	0.0	0.0	0.0	0.0
Intersegment Eliminations
Segment Reporting Information
Sales to external customers	(2.4)	(1.8)	(5.7)	(4.4)
Depreciation and amortization expense	0.0	0.0	0.0	0.0
Operating income (loss)	0.0	0.0	0.0	0.0
Corporate
Segment Reporting Information
Sales to external customers	0.0	0.0	0.0	0.0
Depreciation and amortization expense	0.4	0.5	0.8	0.9
Operating income (loss)	(16.3)	(16.6)	(33.1)	(36.3)
Restructuring costs	$ 0.0	$ 1.6	$ 0.0	$ 2.2

XML

Reportable Segments - Product Sales Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Segment Reporting Information
Sales to external customers	$ 322.0	$ 289.5	$ 610.5	$ 591.4
North America
Segment Reporting Information
Sales to external customers	148.4	168.3	289.2	346.8
Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	103.2	71.6	203.8	147.0
Asia-Pacific
Segment Reporting Information
Sales to external customers	67.9	48.2	113.7	92.6
Rest of the World
Segment Reporting Information
Sales to external customers	2.5	1.4	3.8	5.0
Operating Segments | Cryo Tank Solutions
Segment Reporting Information
Sales to external customers	97.8	105.3	201.7	203.3
Operating Segments | Cryo Tank Solutions | North America
Segment Reporting Information
Sales to external customers	34.4	43.7	75.5	84.3
Operating Segments | Cryo Tank Solutions | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	32.7	32.2	70.4	66.5
Operating Segments | Cryo Tank Solutions | Asia-Pacific
Segment Reporting Information
Sales to external customers	29.1	28.4	53.3	48.5
Operating Segments | Cryo Tank Solutions | Rest of the World
Segment Reporting Information
Sales to external customers	1.6	1.0	2.5	4.0
Operating Segments | Heat Transfer Systems
Segment Reporting Information
Sales to external customers	65.2	97.3	134.4	210.2
Operating Segments | Heat Transfer Systems | North America
Segment Reporting Information
Sales to external customers	42.2	71.1	88.5	153.3
Operating Segments | Heat Transfer Systems | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	8.8	10.2	16.6	19.7
Operating Segments | Heat Transfer Systems | Asia-Pacific
Segment Reporting Information
Sales to external customers	14.0	15.8	28.8	36.7
Operating Segments | Heat Transfer Systems | Rest of the World
Segment Reporting Information
Sales to external customers	0.2	0.2	0.5	0.5
Operating Segments | Specialty Products
Segment Reporting Information
Sales to external customers	106.8	48.6	184.1	101.5
Operating Segments | Specialty Products | North America
Segment Reporting Information
Sales to external customers	43.3	26.1	69.4	51.0
Operating Segments | Specialty Products | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	53.3	19.9	98.9	45.5
Operating Segments | Specialty Products | Asia-Pacific
Segment Reporting Information
Sales to external customers	9.6	2.5	15.2	4.7
Operating Segments | Specialty Products | Rest of the World
Segment Reporting Information
Sales to external customers	0.6	0.1	0.6	0.3
Operating Segments | Repair, Service & Leasing
Segment Reporting Information
Sales to external customers	54.6	40.1	96.0	80.8
Operating Segments | Repair, Service & Leasing | North America
Segment Reporting Information
Sales to external customers	29.5	28.3	58.5	60.4
Operating Segments | Repair, Service & Leasing | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	9.1	9.8	19.6	16.5
Operating Segments | Repair, Service & Leasing | Asia-Pacific
Segment Reporting Information
Sales to external customers	15.9	1.9	17.7	3.6
Operating Segments | Repair, Service & Leasing | Rest of the World
Segment Reporting Information
Sales to external customers	0.1	0.1	0.2	0.3
Intersegment Eliminations
Segment Reporting Information
Sales to external customers	(2.4)	(1.8)	(5.7)	(4.4)
Intersegment Eliminations | North America
Segment Reporting Information
Sales to external customers	(1.0)	(0.9)	(2.7)	(2.2)
Intersegment Eliminations | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	(0.7)	(0.5)	(1.7)	(1.2)
Intersegment Eliminations | Asia-Pacific
Segment Reporting Information
Sales to external customers	(0.7)	(0.4)	(1.3)	(0.9)
Intersegment Eliminations | Rest of the World
Segment Reporting Information
Sales to external customers	$ 0.0	$ 0.0	$ 0.0	$ (0.1)

XML

Reportable Segments - Assets (Details) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Assets
Assets	$ 2,830.0	$ 2,570.5
Goodwill	896.1	865.9
Identifiable intangible assets, net	491.0	493.1
Cryo Tank Solutions
Assets
Goodwill	89.8	93.2
Heat Transfer Systems
Assets
Goodwill	433.3	435.2
Specialty Products
Assets
Goodwill	207.9	172.4
Repair, Service & Leasing
Assets
Goodwill	165.1	165.1
Operating Segments
Assets
Assets	1,084.2	967.3
Operating Segments | Cryo Tank Solutions
Assets
Assets	400.4	399.2
Operating Segments | Heat Transfer Systems
Assets
Assets	243.0	247.2
Operating Segments | Specialty Products
Assets
Assets	265.6	178.3
Operating Segments | Repair, Service & Leasing
Assets
Assets	175.2	142.6
Corporate
Assets
Assets	$ 358.7	$ 244.2

XML

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Disaggregation of Revenue
Sales to external customers	$ 322.0	$ 289.5	$ 610.5	$ 591.4
Point in time
Disaggregation of Revenue
Sales to external customers	204.7	160.3	394.7	322.5
Over time
Disaggregation of Revenue
Sales to external customers	117.3	129.2	215.8	268.9
Operating Segments | Cryo Tank Solutions
Disaggregation of Revenue
Sales to external customers	97.8	105.3	201.7	203.3
Operating Segments | Cryo Tank Solutions | Point in time
Disaggregation of Revenue
Sales to external customers	89.8	94.4	188.5	184.2
Operating Segments | Cryo Tank Solutions | Over time
Disaggregation of Revenue
Sales to external customers	8.0	10.9	13.2	19.1
Operating Segments | Heat Transfer Systems
Disaggregation of Revenue
Sales to external customers	65.2	97.3	134.4	210.2
Operating Segments | Heat Transfer Systems | Point in time
Disaggregation of Revenue
Sales to external customers	5.2	8.1	10.8	15.2
Operating Segments | Heat Transfer Systems | Over time
Disaggregation of Revenue
Sales to external customers	60.0	89.2	123.6	195.0
Operating Segments | Specialty Products
Disaggregation of Revenue
Sales to external customers	106.8	48.6	184.1	101.5
Operating Segments | Specialty Products | Point in time
Disaggregation of Revenue
Sales to external customers	73.4	32.6	135.3	71.4
Operating Segments | Specialty Products | Over time
Disaggregation of Revenue
Sales to external customers	33.4	16.0	48.8	30.1
Operating Segments | Repair, Service & Leasing
Disaggregation of Revenue
Sales to external customers	54.6	40.1	96.0	80.8
Operating Segments | Repair, Service & Leasing | Point in time
Disaggregation of Revenue
Sales to external customers	37.8	25.9	64.5	53.9
Operating Segments | Repair, Service & Leasing | Over time
Disaggregation of Revenue
Sales to external customers	16.8	14.2	31.5	26.9
Intersegment Eliminations
Disaggregation of Revenue
Sales to external customers	(2.4)	(1.8)	(5.7)	(4.4)
Intersegment Eliminations | Point in time
Disaggregation of Revenue
Sales to external customers	(1.5)	(0.7)	(4.4)	(2.2)
Intersegment Eliminations | Over time
Disaggregation of Revenue
Sales to external customers	$ (0.9)	$ (1.1)	$ (1.3)	$ (2.2)

XML

Revenue - Change in Contract Assets and Liabilities (Details) $ in Millions	6 Months Ended
	Jun. 30, 2021 USD ($)
Contract assets
Beginning accounts receivable, net of allowances	$ 200.8
Change in accounts receivable	19.2
Ending accounts receivable, net of allowances	220.0
Beginning unbilled contract revenue	79.4
Change in unbilled contract revenue	(11.2)
Ending unbilled contract revenue	$ 68.2
Change in accounts receivable (as a percentage)	9.60%
Change in unbilled contract revenue (as a percentage)	(14.10%)
Contract liabilities
Beginning balance customer advances and billings in excess of contract revenue	$ 118.9
Change in customer advances and billings in excess of contract revenue	7.2
Ending balance customer advances and billings in excess of contract revenue	126.1
Beginning long-term deferred revenue	1.9
Change in long-term deferred revenue	(0.9)
Ending long-term deferred revenue	$ 1.0
Change in customer advances and billings in excess of contract revenue (as a percentage)	6.10%
Change in long-term deferred revenue (as a percentage)	(47.40%)

XML

Revenue - Narratives (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue from Contract with Customer [Abstract]
Contract revenue recognized	$ (25.1)	$ 34.8	$ 77.6	$ 51.9
Remaining performance obligation	$ 1,083.9		$ 1,083.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-07-01
Disaggregation of Revenue
Revenue, remaining performance obligation	79.60%		79.60%
Performance obligations expected to be satisfied, expected timing	12 months		12 months

XML

Investments (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
Debt and Equity Securities, FV-NI
Beginning balance		$ 73.6
New investments		45.0
(Decrease) increase in fair value of investments in equity securities		(9.2)
Foreign currency translation (losses) gains		(1.2)
Ending balance	$ 108.2	108.2
Subtotal
Debt and Equity Securities, FV-NI
Beginning balance		57.9
New investments		0.0
(Decrease) increase in fair value of investments in equity securities		(9.2)
Foreign currency translation (losses) gains		(1.6)
Ending balance	47.1	47.1
Investment in Equity Securities Level 1
Debt and Equity Securities, FV-NI
Beginning balance		53.8
New investments		0.0
(Decrease) increase in fair value of investments in equity securities	(17.2)	(19.8)
Foreign currency translation (losses) gains		(1.6)
Ending balance	32.4	32.4
Investment in Equity Securities, Level 2
Debt and Equity Securities, FV-NI
Beginning balance		4.1
New investments		0.0
(Decrease) increase in fair value of investments in equity securities	4.7	10.6
Foreign currency translation (losses) gains		0.0
Ending balance	14.7	14.7
Investments in Equity Securities, All Others
Debt and Equity Securities, FV-NI
Beginning balance		15.7
New investments		45.0
(Decrease) increase in fair value of investments in equity securities		0.0
Foreign currency translation (losses) gains		0.4
Ending balance	$ 61.1	$ 61.1

XML

Investments - Narratives (Details) € in Millions, $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	May 19, 2021 USD ($)	May 19, 2021 EUR (€)	Mar. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Debt and Equity Securities, FV-NI
(Decrease) increase in fair value of investments in equity securities		$ (9.2)
New investments		45.0
Value of investment	$ 108.2	108.2				$ 73.6
Investment in Equity Securities Level 1
Debt and Equity Securities, FV-NI
(Decrease) increase in fair value of investments in equity securities	(17.2)	(19.8)
New investments		0.0
Value of investment	32.4	32.4				53.8
Investment in Equity Securities, Level 2
Debt and Equity Securities, FV-NI
(Decrease) increase in fair value of investments in equity securities	4.7	10.6
New investments		0.0
Value of investment	14.7	14.7				4.1
Investments in Equity Securities, All Others
Debt and Equity Securities, FV-NI
(Decrease) increase in fair value of investments in equity securities		0.0
New investments		45.0
Value of investment	61.1	$ 61.1				15.7
Earthly Labs Inc.
Debt and Equity Securities, FV-NI
New investments	$ 5.0
Equity investments, ownership interest (percent)	15.00%	15.00%
Transform Materials
Debt and Equity Securities, FV-NI
Equity investments, ownership interest (percent)	5.00%	5.00%
Value of investment	$ 25.0	$ 25.0
Svante Inc.
Debt and Equity Securities, FV-NI
Equity investments, ownership interest (percent)					10.00%
Value of investment					$ 15.0
Liberty LNG
Debt and Equity Securities, FV-NI
Equity investments, ownership interest (percent)	25.00%	25.00%
(Decrease) increase in fair value of investments in equity securities	$ 2.3	$ 2.3				$ 2.1
Cryomotive GmbH
Debt and Equity Securities, FV-NI
Equity investments, ownership interest (percent)			24.90%	24.90%
Value of investment	$ 7.7	$ 7.7	$ 7.9	€ 6.5
Hudson Products de Mexico S.A. de CV | Investment in Joint Venture
Debt and Equity Securities, FV-NI
Equity investments, ownership interest (percent)	50.00%	50.00%				50.00%
(Decrease) increase in fair value of investments in equity securities	$ 2.9	$ 2.9				$ 2.8

XML

Leases - Narratives (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021 USD ($) facility	Jun. 30, 2020 USD ($)	Jun. 30, 2021 USD ($) facility	Jun. 30, 2020 USD ($)	Dec. 31, 2020 USD ($)
Leases [Abstract]
Right of use assets	$ 27.5		$ 27.5		$ 29.0
Operating lease liability	27.2		27.2		28.7
Operating lease liabilities, current	$ 5.0		$ 5.0		$ 5.1
Weighted average lease term	5 years 2 months 12 days		5 years 2 months 12 days
Operating lease weighted average discount rate (percent)	2.30%		2.30%
Operating lease rent expense	$ 3.0	$ 3.0	$ 6.0	$ 5.9
Number of operating contracts | facility	8		8

XML

Leases - Future Minimum Payments (Details) $ in Millions	Jun. 30, 2021 USD ($)
Future minimum lease payments for non-cancelable operating leases
2021	$ 3.8
2022	6.4
2023	5.8
2024	5.3
2025	4.5
Thereafter	3.6
Total future minimum lease payments	$ 29.4

XML

Inventories (Details) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 161.2	$ 124.7
Work in process	68.1	57.8
Finished goods	80.8	65.9
Total inventories, net	310.1	248.4
Inventory valuation reserve	$ 9.9	$ 9.7

XML

Goodwill and Intangible Assets - Goodwill (Details) $ in Millions	6 Months Ended
	Jun. 30, 2021 USD ($)
Goodwill
Beginning balance, goodwill	$ 865.9
Goodwill acquired during the period	34.5
Foreign currency translation adjustments and other	(5.2)
Purchase price adjustments	0.9
Ending balance, goodwill	896.1
Cryo Tank Solutions
Goodwill
Beginning balance, goodwill	93.2
Goodwill acquired during the period	0.0
Foreign currency translation adjustments and other	(3.4)
Purchase price adjustments	0.0
Ending balance, goodwill	89.8
Heat Transfer Systems
Goodwill
Beginning balance, goodwill	435.2
Goodwill acquired during the period	0.0
Foreign currency translation adjustments and other	(1.9)
Purchase price adjustments	0.0
Ending balance, goodwill	433.3
Specialty Products
Goodwill
Beginning balance, goodwill	172.4
Goodwill acquired during the period	34.5
Foreign currency translation adjustments and other	0.1
Purchase price adjustments	0.9
Ending balance, goodwill	207.9
Repair, Service & Leasing
Goodwill
Beginning balance, goodwill	165.1
Goodwill acquired during the period	0.0
Foreign currency translation adjustments and other	0.0
Purchase price adjustments	0.0
Ending balance, goodwill	$ 165.1

XML

Goodwill and Intangible Assets - Narratives (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	$ 129.0		$ 129.0		$ 129.0
Amortization expense	9.6	$ 14.0	18.4	$ 28.0
Cryo Tank Solutions
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	23.5		23.5		23.5
Heat Transfer Systems
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	49.3		49.3		49.3
Specialty Products
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	35.8		35.8		35.8
Repair, Service & Leasing
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	$ 20.4		$ 20.4		$ 20.4
Government grants | Minimum
Finite-Lived Intangible Assets
Finite lived intangible assets useful life (in years)			10 years
Government grants | Maximum
Finite-Lived Intangible Assets
Finite lived intangible assets useful life (in years)			50 years

XML

Goodwill and Intangible Assets - Intangible Assets (Excluding Goodwill) (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	14 years
Gross Carrying Amount	$ 446.8	$ 436.0
Accumulated Amortization	(101.5)	(86.8)
Total intangible assets	592.5	579.9
Trademarks and trade names
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Indefinite-lived intangible assets	$ 145.7	143.9
Customer relationships
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	13 years
Gross Carrying Amount	$ 311.6	302.5
Accumulated Amortization	$ (71.2)	(59.9)
Unpatented technology
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	12 years
Gross Carrying Amount	$ 115.5	110.4
Accumulated Amortization	$ (26.9)	(22.3)
Patents and other
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	6 years
Gross Carrying Amount	$ 5.0	8.4
Accumulated Amortization	$ (0.2)	(1.8)
Trademarks and trade names
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	13 years
Gross Carrying Amount	$ 3.5	3.6
Accumulated Amortization	$ (1.7)	(1.4)
Land use rights
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	50 years
Gross Carrying Amount	$ 11.2	11.1
Accumulated Amortization	$ (1.5)	$ (1.4)

XML

Goodwill and Intangible Assets - Future Amortization Expense (Details) $ in Millions	Jun. 30, 2021 USD ($)
Estimated Amortization Expense for Intangible Assets
2021	$ 37.2
2022	36.1
2023	35.6
2024	35.2
2025	$ 34.3

XML

Goodwill and Intangible Assets - Government Grants (Details) - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets
Gross carrying amount	$ 446.8	$ 436.0
Government grants
Finite-Lived Intangible Assets
Gross carrying amount	7.8	7.8
Government grants | Current
Finite-Lived Intangible Assets
Gross carrying amount	0.5	0.5
Government grants | Long-term
Finite-Lived Intangible Assets
Gross carrying amount	$ 7.3	$ 7.3

XML

Debt and Credit Arrangements - Summary of Outstanding Borrowings (Details) € in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2021 EUR (€)	Jan. 01, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 EUR (€)	Jun. 14, 2019 USD ($)	Nov. 06, 2017 USD ($)
Debt Instrument
Total debt, net of unamortized discount and debt issuance costs	$ 706,100,000		$ 706,100,000				$ 442,500,000
Less: current maturities	255,500,000		255,500,000				220,900,000
Long-term debt	450,600,000		450,600,000				221,600,000
Foreign currency transaction gain	(1,700,000)	$ (1,200,000)	(1,500,000)	$ (1,500,000)
Convertible Notes, due 2024 | Convertible Debt
Debt Instrument
Unamortized debt issuance costs	(3,300,000)		(3,300,000)			$ (3,900,000)	(3,100,000)
Principal amount	258,800,000	$ 258,800,000	258,800,000	$ 258,800,000			258,800,000			$ 258,800,000
Unamortized discount	0		0				(34,800,000)
Convertible Debt	255,500,000		255,500,000				220,900,000
Debt instrument stated interest rate (percent)										1.00%
Revolving Credit Facility | Credit Facilities 2019
Debt Instrument
Unamortized debt issuance costs	(4,300,000)		(4,300,000)				(5,000,000.0)
Senior secured revolving credit facility and term loan, net of debt issuance costs	450,600,000		450,600,000				221,600,000
Revolving Credit Facility | Term loan
Debt Instrument
Long term debt	$ 103,100,000		$ 103,100,000				$ 103,100,000
Principal amount									$ 450,000,000.0
Debt instrument stated interest rate (percent)	2.00%		2.00%		2.00%		2.50%	2.50%
Revolving Credit Facility | Senior secured revolving credit facility
Debt Instrument
Long term debt	$ 351,800,000		$ 351,800,000				$ 123,500,000
Unamortized debt issuance costs	$ (6,700,000)		$ (6,700,000)
Maximum borrowing capacity									$ 550,000,000.0
Weighted average interest rate (percent)	1.90%		1.90%		1.90%		2.10%	2.10%
Letters of credit outstanding	$ 45,200,000		$ 45,200,000
Line of credit remaining borrowing amount	153,000,000.0		153,000,000.0
Revolving Credit Facility | Euro senior secured revolving credit facility
Debt Instrument
Long term debt	102,800,000		102,800,000		€ 86.5		$ 91,400,000	€ 74.5
Foreign currency transaction gain	8,900,000		5,000,000.0
Revolving Credit Facility Sub-limit - Letters of Credit | Senior secured revolving credit facility
Debt Instrument
Maximum borrowing capacity	100,000,000.0		100,000,000.0
Revolving Credit Facility Sub-limit - Discretionary Letters of Credit | Senior secured revolving credit facility
Debt Instrument
Maximum borrowing capacity	250,000,000.0		250,000,000.0
Revolving Credit Facility Sub-limit - Swingline | Senior secured revolving credit facility
Debt Instrument
Maximum borrowing capacity	$ 50,000,000.0		$ 50,000,000.0

XML

Debt and Credit Arrangements - Senior Secured Revolving Credit Facility and Term Loan (Details) - USD ($)			6 Months Ended
	Apr. 20, 2020	Jun. 14, 2019	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Debt Instrument
Payments for debt issuance costs			$ 0	$ 1,900,000
Revolving Credit Facility | Credit Facilities 2019
Debt Instrument
Maximum percentage of capital stock guaranteed by company			65.00%
Unamortized debt issuance costs			$ 4,300,000		$ 5,000,000.0
Revolving Credit Facility | Credit Facilities 2019 | Adjusted Base Rate | Minimum
Debt Instrument
Debt instrument variable interest rate (percent)		0.25%
Revolving Credit Facility | Credit Facilities 2019 | Adjusted Base Rate | Maximum
Debt Instrument
Debt instrument variable interest rate (percent)		1.50%
Revolving Credit Facility | Credit Facilities 2019 | LIBOR | Minimum
Debt Instrument
Debt instrument variable interest rate (percent)		1.25%
Revolving Credit Facility | Credit Facilities 2019 | LIBOR | Maximum
Debt Instrument
Debt instrument variable interest rate (percent)		2.50%
Revolving Credit Facility | Senior secured revolving credit facility
Debt Instrument
Maximum borrowing capacity		$ 550,000,000.0
Payments for debt issuance costs	$ 1,900,000		11,900,000
Unamortized debt issuance costs			6,700,000
Revolving Credit Facility | Term loan
Debt Instrument
Principal amount		$ 450,000,000.0
Debt issuance costs			$ 6,100,000
Debt issuance cost, amortization term			5 years

XML

Debt and Credit Arrangements - Interest Expense and Financing Cost Amortization (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Debt Instrument
Interest expense excluding amortization	$ 2.2	$ 7.6	$ 4.2	$ 14.8
Financing costs amortization	1.1	1.1	2.3	2.1
Revolving Credit Facility
Debt Instrument
Interest expense excluding amortization	1.8	4.6	3.1	9.4
Financing costs amortization	0.8	0.9	1.8	1.7
Revolving Credit Facility | Term loan
Debt Instrument
Interest expense excluding amortization	0.5	4.0	1.1	8.2
Revolving Credit Facility | Senior secured revolving credit facility
Debt Instrument
Interest expense excluding amortization	$ 1.3	$ 0.6	$ 2.0	$ 1.2

XML

Debt and Credit Arrangements - 2024 Notes Narratives (Details) $ / shares in Units, shares in Thousands		1 Months Ended	6 Months Ended
	Nov. 06, 2017 USD ($)	Dec. 31, 2017 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) day $ / shares	Jul. 01, 2021 $ / shares	Dec. 31, 2020 USD ($)	Jun. 30, 2020 USD ($)	Oct. 31, 2017 $ / shares
Debt Instrument
Share price (usd per share) | $ / shares			$ 146.32				$ 43.50
Convertible Debt | Convertible Notes, due 2024
Debt Instrument
Debt instrument stated interest rate (percent)	1.00%
Debt instrument face amount	$ 258,800,000		$ 258,800,000		$ 258,800,000	$ 258,800,000
Share conversion rate(per share)	0.0170285
Debt instrument, conversion price (usd per share) | $ / shares							$ 58.725
Debt instrument, conversion premium							35.00%
Value of securities above principal amount of debt if converted			$ 386,000,000.0
Debt instrument, threshold for consecutive trading days | day			20
Debt instrument, threshold for consecutive trading days | day			30
Applicable conversion price threshold (as percentage)			130.00%
Maximum days after five trading days			5 days
Applicable conversion price, less than (as percentage)			97.00%
Debt instrument effective interest rate	4.80%
Non cash payment for derivative instrument		$ 59,500,000
Number of shares underlying warrant | shares		4,410
Proceeds from issuances of warrants		$ 46,000,000.0
Percentage above previous sales price							65.00%
Net cost of convertible note hedge and warrant			$ 13,500,000
Convertible Debt | Convertible Notes, due 2024 | Subsequent Event
Debt Instrument
Debt instrument, conversion price (usd per share) | $ / shares				$ 76.3425
Applicable conversion price threshold (as percentage)				130.00%
Convertible Debt | Convertible Notes, due 2024 | Maximum
Debt Instrument
Debt instrument, conversion price (usd per share) | $ / shares		$ 71.775
Convertible Debt | Convertible Notes, due 2024 | Liability Component
Debt Instrument
Debt instrument face amount	$ 200,100,000
Debt issuance costs	5,300,000
Convertible Debt | Convertible Notes, due 2024 | Equity Component
Debt Instrument
Debt instrument face amount	58,700,000
Debt issuance costs	$ 1,500,000

XML

Debt and Credit Arrangements - Notes Interest Accretion Schedule (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Nov. 06, 2017
Debt Instrument
Interest accretion of convertible notes discount			$ 0.0	$ 3.9
Interest expense excluding amortization	$ 2.2	$ 7.6	4.2	14.8
Financing costs amortization	1.1	1.1	2.3	2.1
Convertible Debt | Convertible Notes, due 2024
Debt Instrument
Interest accretion of convertible notes discount	0.0	2.0	0.0	3.9
Interest expense excluding amortization	0.7	0.7	1.3	1.3
Total interest expense	0.7	2.7	1.3	5.2
Financing costs amortization	$ 0.3	$ 0.2	$ 0.5	$ 0.4
Debt instrument stated interest rate (percent)					1.00%

XML

Debt and Credit Arrangements - Foreign Facilities (Details) - Foreign facilities - Revolving Credit Facility - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Debt Instrument
Maximum borrowing capacity	$ 77.2
Letters of credit outstanding	$ 51.4	$ 47.7

XML

Debt and Credit Arrangements - Letters of Credit (Details) - USD ($) $ in Millions	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Restricted cash	$ 1.0
Restricted cash, noncurrent		$ 1.0	$ 1.0

XML

Debt and Credit Arrangements - Fair Value Disclosures about Debt (Details)	Jun. 30, 2021	Dec. 31, 2020
Convertible Debt | Convertible Notes, due 2024
Debt Instrument
Debt instrument percentage over par value	255.00%	210.00%

XML

Product Warranties (Details) $ in Millions	6 Months Ended
	Jun. 30, 2021 USD ($)
Movement in Standard Product Warranty Accrual
Beginning balance standard product warranty accrual	$ 11.9
Issued – warranty expense	(2.7)
Warranty usage	2.4
Ending balance standard product warranty accrual	$ 11.6

XML

Business Combinations - Narratives (Details) - USD ($) $ in Millions					3 Months Ended	6 Months Ended
	Feb. 16, 2021	Dec. 23, 2020	Nov. 03, 2020	Oct. 13, 2020	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Business Acquisition
Payment for acquisition of businesses, net of cash acquired						$ 55.0	$ 0.0
Cash acquired from acquisition	$ 0.6
Goodwill					$ 896.1	896.1		$ 865.9
Contingent consideration					22.1	22.1		20.1
Increase in fair value of contingent consideration liabilities						2.0
Cryogenic Technologies
Business Acquisition
Voting percentage acquired	100.00%
Payment for acquisition of businesses, net of cash acquired	$ 55.0
Net assets acquired, excluding goodwill	20.5
Goodwill	$ 34.5
Increase (decrease) in estimated fair value of intangibles					17.6
Identifiable intangible assets					19.5	19.5
SES
Business Acquisition
Net assets acquired, excluding goodwill		$ 13.4
Goodwill		24.0
Identifiable intangible assets		17.3
Payments for acquisition of business excluding working capital adjustments		20.0
Potential earn-out not to exceed amount		25.0
Contingent consideration		$ 16.9			18.9	18.9		16.9
Increase in fair value of contingent consideration liabilities					1.3	2.0
BIG
Business Acquisition
Net assets acquired, excluding goodwill			$ 7.9
Goodwill			15.7
Increase (decrease) in estimated fair value of intangibles						(0.9)
Identifiable intangible assets			6.2
Payments for acquisition of business excluding working capital adjustments			20.0
Potential earn-out not to exceed amount			6.0
Contingent consideration			$ 3.2		3.2	3.2		$ 3.2
Increase in fair value of contingent consideration liabilities					(0.1)	0.0
Alabama Trailers
Business Acquisition
Payments for acquisition of business excluding working capital adjustments				$ 10.0
Gain on bargain purchase				$ 5.0
Sustainable Energy Solutions And Blue In Green LLC | Minimum | Scenario, Plan
Business Acquisition
Contingent consideration					0.0	0.0
Sustainable Energy Solutions And Blue In Green LLC | Maximum | Scenario, Plan
Business Acquisition
Contingent consideration					$ 31.0	$ 31.0

XML

Business Combinations - Contingent Consideration Rollforward (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
Contingent Consideration
Balance at December 31, 2020		$ 20.1
Increase in fair value of contingent consideration liabilities		2.0
Balance at June 30, 2021	$ 22.1	22.1
SES
Contingent Consideration
Balance at December 31, 2020		16.9
Increase in fair value of contingent consideration liabilities	1.3	2.0
Balance at June 30, 2021	18.9	18.9
BIG
Contingent Consideration
Balance at December 31, 2020		3.2
Increase in fair value of contingent consideration liabilities	(0.1)	0.0
Balance at June 30, 2021	$ 3.2	$ 3.2

XML

Accumulated Other Comprehensive (Loss) Income - Accumulated Other Comprehensive Loss Rollforward (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Accumulated Other Comprehensive Loss
Beginning balance	$ 1,566.0	$ 1,214.9	$ 1,579.3	$ 1,232.4
Ending balance	1,583.8	1,246.4	1,583.8	1,246.4
Accumulated other comprehensive income (loss)
Accumulated Other Comprehensive Loss
Beginning balance	(16.8)	(45.8)	2.4	(35.9)
Other comprehensive income (loss)	7.3	7.5	(12.3)	(2.7)
Amounts reclassified from accumulated other comprehensive income (loss), net of taxes	0.3	0.4	0.7	0.7
Net current-period other comprehensive (loss) income, net of taxes	7.6	7.9	(11.6)	(2.0)
Ending balance	(9.2)	(37.9)	(9.2)	(37.9)
Foreign currency translation adjustments
Accumulated Other Comprehensive Loss
Beginning balance	(5.8)	(35.2)	13.8	(25.0)
Other comprehensive income (loss)	7.3	7.5	(12.3)	(2.7)
Amounts reclassified from accumulated other comprehensive income (loss), net of taxes	0.0	0.0	0.0	0.0
Net current-period other comprehensive (loss) income, net of taxes	7.3	7.5	(12.3)	(2.7)
Ending balance	1.5	(27.7)	1.5	(27.7)
Pension liability adjustments, net of taxes
Accumulated Other Comprehensive Loss
Beginning balance	(11.0)	(10.6)	(11.4)	(10.9)
Other comprehensive income (loss)	0.0	0.0	0.0	0.0
Amounts reclassified from accumulated other comprehensive income (loss), net of taxes	0.3	0.4	0.7	0.7
Net current-period other comprehensive (loss) income, net of taxes	0.3	0.4	0.7	0.7
Ending balance	$ (10.7)	$ (10.2)	$ (10.7)	$ (10.2)

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$ 6.5	$ 13.8	$ 32.1	$ 15.9
Income from discontinued operations, net of tax	0.0	6.3	0.0	12.7
Net income attributable to Chart Industries, Inc.	$ 6.5	$ 20.1	$ 32.1	$ 28.6
Earnings per common share – basic:
Income from continuing operations basic (usd per share)	$ 0.18	$ 0.39	$ 0.90	$ 0.45
Income from discontinued operations (usd per share)	0	0.18	0	0.36
Net income attributable to Chart Industries, Inc. (usd per share)	0.18	0.57	0.90	0.81
Earnings per common share – diluted:
Income from continuing operations diluted (usd per share)	0.16	0.39	0.79	0.45
Income from discontinued operations (usd per share)	0	0.18	0	0.35
Net income attributable to Chart Industries, Inc. (usd per share)	$ 0.16	$ 0.57	$ 0.79	$ 0.80
Weighted average number of common shares outstanding — basic (shares)	35,610	35,180	35,580	35,480
Incremental shares issuable upon assumed conversion and exercise of share-based awards (shares)	310	130	320	180
Incremental shares issuable due to dilutive effect of convertible (shares)	2,640	0	2,610	0
Incremental shares issuable due to dilutive effect of warrants (shares)	2,250	0	2,210	0
Weighted average number of common shares outstanding – diluted (shares)	40,810	35,310	40,720	35,660

XML

Earnings Per Share - Antidilutive Securities (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total anti-dilutive securities	2,700	5,060	2,670	4,920
Share-based awards
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total anti-dilutive securities	60	650	60	510
Convertible note hedge and capped call transactions
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total anti-dilutive securities	2,640	0	2,610	0
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total anti-dilutive securities	0	4,410	0	4,410

XML

Earnings Per Share - Narratives (Details) - Convertible Notes, due 2024 - Convertible Debt - $ / shares	Dec. 31, 2017	Oct. 31, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share
Debt instrument, conversion price (usd per share)		$ 58.725
Maximum
Antidilutive Securities Excluded from Computation of Earnings Per Share
Debt instrument, conversion price (usd per share)	$ 71.775

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income tax expense	$ 1.3	$ 2.2	$ 4.4	$ 2.6
Effective income tax rate (percent)	16.00%	13.00%	11.80%	13.40%
Unrecognized tax benefits	$ 1.9		$ 1.9		$ 1.9
Unrecognized tax benefit that would impact effective tax rate	1.3		1.3		$ 1.3
Income tax penalties and interest accrued	$ 0.3		$ 0.3

XML

Share-based Compensation (Details) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, fair value of awards granted			$ 12.5
Allocated share-based compensation expense	$ 2.4	$ 2.0
Employee share-based compensation expense			5.8	$ 4.9
Share based compensation expense not yet recognized	$ 15.2		$ 15.2
Period in which unrecognized share based compensation will be recognized (in years)			2 years 2 months 12 days
Director
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, fair value of restricted shares granted			$ 0.2
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, shares granted (shares)			60
Share-based compensation, shares exercised (shares)			120
Share-based compensation, vesting period (in years)			4 years
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, restricted shares granted (shares)			50
Share-based compensation, vesting period (in years)			3 years
Share-based compensation, shares vested other than options (shares)			80
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, restricted shares granted (shares)			30
Share-based compensation, vesting period (in years)			3 years
Share-based compensation, shares vested other than options (shares)			10
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, shares vested other than options (shares)			80

XML

Commitment and Contingencies - Narratives (Details) $ in Millions	Jun. 10, 2021 USD ($) lawsuit	Jun. 30, 2021 USD ($) lawsuit property	Dec. 31, 2020 USD ($)
Contingencies
Number of properties (property) | property		1
Accrued environmental reserve		$ 0.2	$ 0.3
Pacific Fertility Center
Contingencies
Loss contingency accrual	$ 13.5
Loss contingency, receivable		$ 13.5
Pacific Fertility Center | Settled Litigation
Contingencies
Number of lawsuits | lawsuit	5
Loss contingency, damages awarded, value	$ 14.9
Percentage of loss allocated to entity	90.00%
Loss contingency, estimate of possible loss	$ 13.5
Pacific Fertility Center | Pending Litigation
Contingencies
Number of lawsuits | lawsuit		139
San Francisco Superior Court | Pending Litigation
Contingencies
Number of lawsuits | lawsuit		50

XML

Restructuring Activities - Narratives (Details) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)	Dec. 31, 2020 USD ($)	Jul. 17, 2020 a
Restructuring Cost and Reserve
Restructuring costs	$ 0.3	$ 5.6	$ 1.0	$ 10.8
Facility In Beasley, Texas
Restructuring Cost and Reserve
Area of land (acres) | a						260
Lease facility in Tulsa, Oklahoma | Facility Closing
Restructuring Cost and Reserve
Restructuring costs					$ 2.7
Lease facility in Tulsa, Oklahoma | Facility Closing | Scenario, Plan
Restructuring Cost and Reserve
Restructuring costs			9.0
Tulsa, Oklahoma Facility To Our Beasley, Texas Facility | Facility Start-Up
Restructuring Cost and Reserve
Restructuring costs	$ 4.8		$ 5.2

XML

Restructuring Activities - Restructuring Charges (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Restructuring Cost and Reserve
Severance costs	$ 0.0	$ 3.5	$ 0.3	$ 8.7
Other restructuring costs	0.3	2.1	0.7	2.1
Total restructuring costs	0.3	5.6	1.0	10.8
Cost of sales
Restructuring Cost and Reserve
Severance costs	0.0	1.6	0.0	3.9
Other restructuring costs	0.3	0.0	0.7	0.0
Selling, general, and administrative expenses
Restructuring Cost and Reserve
Severance costs	0.0	1.9	0.3	4.8
Other restructuring costs	$ 0.0	$ 2.1	$ 0.0	$ 2.1

XML

Restructuring Activities - Rollforward (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Restructuring Reserve
Beginning balance, restructuring accrual	$ 0.5	$ 2.8	$ 0.8	$ 0.9	$ 0.9
Restructuring charges	0.3	5.6	1.0	10.8
Cash payments and other	(0.6)	(6.5)	(1.6)	(9.8)
Ending balance, restructuring accrual	0.2	1.9	0.2	1.9	0.8
Operating Segments | Cryo Tank Solutions
Restructuring Reserve
Beginning balance, restructuring accrual	0.5	1.5	0.5	0.5	0.5
Restructuring charges	0.0	1.1	0.3	2.9
Cash payments and other	(0.2)	(1.2)	(0.5)	(2.0)
Ending balance, restructuring accrual	0.3	1.4	0.3	1.4	0.5
Operating Segments | Heat Transfer Systems
Restructuring Reserve
Beginning balance, restructuring accrual	0.0	0.5	0.2	0.2	0.2
Restructuring charges	0.3	2.9	0.7	5.7
Cash payments and other	(0.4)	(3.2)	(1.0)	(5.7)
Ending balance, restructuring accrual	(0.1)	0.2	(0.1)	0.2	0.2
Operating Segments | Specialty Products
Restructuring Reserve
Beginning balance, restructuring accrual	0.0	0.0	0.0	0.0	0.0
Restructuring charges	0.0	0.0	0.0	0.0
Cash payments and other	0.0	0.0	0.0	0.0
Ending balance, restructuring accrual	0.0	0.0	0.0	0.0	0.0
Operating Segments | Repair, Service & Leasing
Restructuring Reserve
Beginning balance, restructuring accrual	0.0	0.0	0.0	0.0	0.0
Restructuring charges	0.0	0.0	0.0	0.0
Cash payments and other	0.0	0.0	0.0	0.0
Ending balance, restructuring accrual	0.0	0.0	0.0	0.0	0.0
Corporate
Restructuring Reserve
Beginning balance, restructuring accrual	0.0	0.8	0.1	0.2	0.2
Restructuring charges	0.0	1.6	0.0	2.2
Cash payments and other	0.0	(2.1)	(0.1)	(2.1)
Ending balance, restructuring accrual	$ 0.0	$ 0.3	$ 0.0	$ 0.3	$ 0.1

XML

Subsequent Events (Details) - USD ($) $ in Millions		6 Months Ended
	Jul. 01, 2021	Jun. 30, 2021
Subsequent Event
Payments to acquire equity interest		$ 45.0
Subsequent Event | L.A Turbine
Subsequent Event
Ownership percentage	100.00%
Payments to acquire equity interest	$ 80.0